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Abstract 
Cartilage lesions are known to heal poorly and their tissue engineering with optimal 
scaffolds are widely studied. If the cartilage lesion is deep, there is a need to also repair 
the underlying bone (i.e. subchondral bone) and the lesion is called an osteochondral 
lesion. There are several methods used for osteochondral tissue engineering and various 
scaffold compositions are being studied. The studied scaffold compositions include the 
one scaffold method, where only one scaffold is used for the osteochondral lesion, or 
independent structures for cartilage and bone. These two scaffolds could be combined 
during processing, before surgery or in surgery to obtain osteochondral solutions for 
cartilage repair. 
In this thesis, freeze-drying was used to manufacture highly porous scaffolds with an 
interconnected pore structure. Natural polymer-based scaffolds often lack the required 
mechanical stability. Therefore, natural polymer-based hybrids with improved stiffness 
were manufactured for cartilage tissue engineering scaffolds. Synthetic polymer-based 
composites with improved osteoconductivity were manufactured for bone or osteo-
chondral tissue engineering scaffolds. The scaffolds were studied to determine the struc-
ture of the scaffolds, the effect of the fibrous filler mesh or filler particles on the charac-
teristics of the hybrids or composites, and the suitability of the hybrids for cartilage tis-
sue engineering and the composites for bone or osteochondral tissue engineering. The 
majority of the studied scaffolds were also cultured with cells in vitro to define the suit-
ability of the scaffolds for tissue engineering. 
The results show the freeze-drying method to be useful for manufacturing highly porous 
hybrid and composite scaffolds with improved properties compared with plain polymer 
scaffolds. Also, all the studied scaffolds had an interconnected porous structure. Im-
proved wettability characteristics showed the method of cross-linking collagen post 
freeze-drying to be more effective way of cross-linking collagen compared to cross-
linking collagen prior to freeze-drying. Synthetic polymer-based composites with an 
inhomogeneous scaffold structure with ɴ-tricalcium phosphate (TCP) or bioactive glass 
(BG) filler particles showed improved osteoconductivity. TCP was found to improve 
the cell proliferation and alkaline phosphatase (ALP) activity of adipose stem cells 
(ASCs) over plain poly(L/D,L)lactide 70/30 (PLA70) scaffolds or PLA70+BG compos-
ites. A porous polymer matrix with a highly porous fibrous filler was successfully com-
bined into highly porous freeze-dried hybrids with a natural polymer matrix (colla-
gen/chitosan and poly(L/D)lactide 96/4 fibres (PLA96)) and composites with a syn-
thetic polymer matrix (poly(D,L-lactide-co-glycolide)70/30 (PLGA)) with bioactive 
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glass fibres (BGf). The PLA96 fibrous mesh improved the penetration of the chondro-
cytes into the hybrids compared with plain natural polymer scaffolds. 
The manufactured scaffolds were found to be applicable for cartilage, bone and osteo-
chondral tissue engineering applications. Based on the structures developed in this the-
sis, more optimal scaffold structures are currently being studied. 
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Abbreviations  
2D Two-dimensional 
3D Three-dimensional 
ɴ-TCP ɴ-Tricalcium phosphate 
ASC Adipose stem cells 
ALP Alkaline phosphatase 
BG Bioactive glass 
CA Contact angle 
CaP Calcium phosphate 
DSC Differential scanning calorimeter 
ECM Extracellular matrix 
EDC 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride 
ESEM Environmental scanning electron microscopy 
GAG Glycosaminoglycan 
GPC Gel permeation chromatography 
HA Hyaluronic acid 
HAp Hydroxyapatite 
HCl Hydrochloric acid 
i.v. Inherent viscosity 
kGy KiloGray, SI unit for radiation dose 
Mn Number average molecular weight 
Mw Weight average molecular weight 
MSC Mesenchymal stem cell 
NHS N-Hydroxysuccinimide 
OA Osteoarthritis 
PBS Phosphate buffered saline solution 
PCL Polycaprolactone 
PGA Polyglycolide 
PLA Polylactide 
PLGA Poly(lactide-co-glycolide) 
PLLA Poly(L-lactictide) 
PLCL Poly(lactide-co-ܭ-caprolactone) 
PTFE Polytetrafluoroethylene (Teflon) 
PVA Poly(vinyl alcohol) 
RT Room temperature 
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SEM Scanning electron microscopy 
Td Denaturation temperature 
Tg Glass transition temperature 
TGA Thermogravimetric analysis 
v/v Volume to volume 
w/v Weight to volume 
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The abbreviations for different scaffold types.  
To be noted: the most frequently studied collagen scaffolds with 1.0 wt% of collagen 
cross-linked with EDC+NHS post freeze-drying are marked simply as “Col”. 
Abbreviation Scaffold materials Matrix material Filler Cross-linking Publi-cation 
Natural polymer-based scaffolds 
Col0.3NoE Collagen 0.3 wt% collagen No No I 
Col0.3(E) Collagen 0.3 wt% collagen No EDC prior I 
Col0.3E Collagen 0.3 wt% collagen No EDC post I 
Col0.5NoE Collagen 0.5 wt% collagen No No I 
Col0.5(E) Collagen 0.5 wt% collagen No EDC prior I 
Col0.5E Collagen 0.5 wt% collagen No EDC post I 
Col1.0NoE Collagen 1.0 wt% collagen No No I 
Col1.0(E) Collagen 1.0 wt% collagen No EDC prior I 
Col1.0E Collagen 1.0 wt% collagen No EDC post I 
Col Collagen 1.0 wt% collagen No EDC+NHS post IV 
Col2.0 Collagen 2.0 wt% collagen No No I 
Col2.0(E) Collagen 2.0 wt% collagen No EDC prior I 
Col2.0E Collagen 2.0 wt% collagen No EDC post I 
Chi Chitosan 1.0 wt% chitosan No No  IV 
C1C1 Collagen+Chitosan 1.0 wt% collagen and chitosan 1:1 (v/v) No EDC+NHS post IV 
C2C1 Collagen+Chitosan 1.0 wt% collagen and chitosan 2:1 (v/v) No EDC+NHS post IV 
ColPLA Collagen+PLA96/4 0.5 wt% collagen PLA mesh EDC+NHS post IV 
ChiPLA Chitosan+PLA96/4 0.5 wt% chitosan PLA mesh EDC+NHS post IV 
C1C1PLA Collagen+ Chitosan+PLA96/4 
0.5 wt% collagen and 
chitosan 1:1 (v/v) PLA mesh EDC+NHS post IV 
C2C1PLA Collagen+ Chitosan+PLA96/4 
0.5 wt% collagen and 
chitosan 2:1 (v/v) PLA mesh EDC+NHS post IV 
Synthetic polymer-based scaffolds 
PLA2 PLA70/30 2.0 wt% PLA70/30 No No II, III 
PLA3 PLA70/30 3.0 wt% PLA70/30 No No III 
PLA2TCP5 PLA70/30+ȕ-TCP 2.0 wt% PLA70/30 5 wt% ȕ-TCP No III 
PLA2TCP10 PLA70/30+ȕ-TCP 2.0 wt% PLA70/30 10 wt% ȕ-TCP No II, III 
PLA2TCP20 PLA70/30+ȕ-TCP 2.0 wt% PLA70/30 20 wt% ȕ-TCP No II, III 
PLA3TCP5 PLA70/30+ȕ-TCP 3.0 wt% PLA70/30 5 wt% ȕ-TCP No III 
PLA3TCP10 PLA70/30+ȕ-TCP 3.0 wt% PLA70/30 10 wt% ȕ-TCP No III 
PLA3TCP20 PLA70/30+ȕ-TCP 3.0 wt% PLA70/30 20 wt% ȕ-TCP No III 
PLA2BG10 PLA70/30+BaG0127 2.0 wt% PLA70/30 10 wt% BaG No II 
PLA2BG20 PLA70/30+BaG0127 2.0 wt% PLA70/30 20 wt% BaG No II 
PLGA1 PLGA1 5.0 wt% PLGA1 No No V 
PLGA2 PLGA2 5.0 wt% PLGA2 No No V 
PLGA1BG1 PLGA1+BG1 3 wt% PLGA1 BG mesh No V 
PLGA2BG2 PLGA2+BG2 3 wt% PLGA1 BG mesh No V 
 
The following abbreviations are used to mark out the different forms of BG components 
in the scaffolds:  
 
BGf Bioactive glass fibre 
BGp Bioactive glass particle 
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Definitions 
Allogenic From individuals of the same species 
Allograft Graft  from a  donor  of  the  same species  as  the  recipient  but  not  
genetically identical 
Autograft Graft obtained from one part of a patient’s body for use on  
another part 
Autologous Originating from the recipient rather than from a donor 
Avascular Lacking blood vessels 
Bioabsorbable Capable of being degraded or dissolved and subsequently me-
tabolized within an organism 
Biodegradation Capable of being decomposed by bacteria or other biological 
means 
Blend A uniform combination of two or more materials 
Carding Mechanical process that disentangles, cleans and intermixes  
fibres to produce a continuous randomly oriented web, i.e.  
a carded mesh 
Composite A combination of two or more distinctly different materials 
where each component contributes positively to the properties of 
the final product 
Hybrid A combination of two or more materials or of material and space 
to allow a superposition of their properties 
In vitro Taking place in a test tube, culture dish, or elsewhere outside  
a living organism 
In vivo Taking place in a living organism 
In situ In the natural, original, or appropriate position 
Modulus A force exerted under specific strain 
Needle punching A process that uses needles with barbs along the shaft of the 
needle  that  grabs  the  top  layer  of  fibres  and  tangles  them  with  
the inner layers of fibres as the needle enters the carded mesh 
Osteoblast Bone-forming cell 
Osteoclast A large multinucleate bone cell which absorbs bone tissue  
during growth and healing 
Osteoconductive Supports bone growth and encourages the ingrowth of  
surrounding bone 
Osteocyte A bone cell  that  is  formed when an osteoblast  becomes embed-
ded in the material it has secreted 
xiii 
 
Osteoid Un mineralized organic component of bone 
Osteoinductive Capable of promoting the differentiation of progenitor cells 
down an osteoblastic lineage 
Osteointegration Integrates into surrounding bone 
Strength Ability of a material to withstand an applied load without failure 
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1 Introduction 
There is a growing need to find adequate tissue replacements for damaged or diseased tissues. The 
best tissue replacement would in general be autologous tissue, an autograft, from the patient. How-
ever, on many occasions this is not possible because of a shortage of tissue or a lack of undamaged 
replacement tissue. Tissue engineering has become one of the most promising ways to regenerate 
new tissues and to overcome the lack of donor tissues for use as tissue transplants and to avoid pos-
sible undesirable tissue reactions (Langer 2000). Tissue engineering scaffolds serve as a template 
for new tissue formation. Since material properties, scaffold geometries as well as the types of cells 
and their seeding procedures all affect the formation of new tissue, there are still numerous studies 
to be done to find out the best possible scaffolds for different tissue engineering applications (Fisher 
& Mauck 2013). 
Cartilage tissue is avascular by nature and it possesses relatively low cell number density. Therefore, 
cartilage defects are known to heal poorly because cartilage tissue does not possess the ability to 
heal after trauma (Kinner et al. 2005). The use of autologous transplants would be an optimal way 
to replace the damaged tissue. However, the need for a second operation to collect the tissue to be 
transplanted is always a risk and an inconvenience. Because the healing of native cartilage is chal-
lenging, the tissue engineering of new cartilage tissue is also rather challenging. If the cartilage le-
sion is deep, the underlying bone can also be affected, making the lesion an osteochondral lesion. In 
this case, there is also the need to repair the underlying bone as well (Panseri et al. 2012). For load 
bearing applications such as cartilage and bone tissue, there is a need for more mechanically stable 
constructs that can keep their porosity open even after loading. In addition, highly biomimetic mate-
rials and structures are required for optimal scaffolds. On many occasions, one particular type of 
material is not enough to obtain the best scaffold properties, and a more complex scaffold structure 
manufactured using multiple or combined processing methods may be required. Therefore, scaf-
folds with more than one material component and with more complex structures, composites, with 
two or more components have been studied for the purpose (Chen et al. 2002; Seo & Park 2010).  
Current treatments for articular cartilage repair are autologous chondrocytes implantation (ACI) and 
matrix-assisted chodrocyte implantation (MACI) (Nukavarapu & Dorcemus 2013). However, the 
current repair techniques for damaged articular cartilage are inadequate and need development since 
they mainly result in fibrotic cartilage formation. In addition, the scaffolds currently used are thin 
membranes that have limited biomechanical properties, and act mainly as a cover to keep the blood 
clot at the repair site. The main challenge has been to manufacture highly porous scaffolds with 
adequate mechanical properties. An optimal cartilage tissue engineering scaffold would give struc-
tural support to the lesion during healing. Such a scaffold would also allow early load bearing, giv-
ing  the  tissue  mechanical  stimulus  as  well  as  shortening  recovery  time.  Therefore,  there  is  still  a  
need for dimensionally, mechanically and functionally optimal scaffolds for articular cartilage tis-
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sue engineering (Kock et al. 2012). The manufacturing of dimensionally and mechanically stable, 
highly porous and functional scaffolds is studied in this thesis in order to obtain an optimal tissue 
engineering scaffolds for cartilage or osteochondral lesions. 
Many kinds of manufacturing methods have been applied in the manufacture of porous tissue engi-
neering scaffolds, such as particulate leaching, different textile technologies, phase separation, high 
pressure based methods, melt based technologies and rapid prototyping (Gomes & Reis 2004). This 
thesis focuses on freeze-drying, a thermally induced phase separation, where highly porous tissue 
engineering scaffolds with interconnected pore structures can be manufactured from both natural 
and synthetic bioabsorbable polymers (Liu et al. 2007). In addition, composite structures manufac-
tured from different filler materials as well as different filler compositions can also be processed by 
freeze-drying. To achieve the best properties for cartilage or bone tissue engineering scaffolds, it is 
important to find out the optimal material properties, the required geometry of the scaffold and the 
optimum combination of different structures for the application (Hutmacher 2000). Materials that 
best mimic the target tissue are often the naturally occurring components of the native tissue. How-
ever, these materials cannot usually be used on their own as scaffolds because they lack some other 
necessary property such as the required mechanical stability. 
To overcome the limitations of current cartilage repair scaffolds with poor mechanical properties, 
this thesis focuses on the manufacturing of freeze-dried composite structures with highly porous 
structures, biomimetic components and improved biomechanical properties. The literature review 
provides an overview of the manufacturing of porous scaffolds for cartilage and osteochondral tis-
sue engineering. In the experimental part, highly porous scaffolds were manufactured by freeze-
drying in order to find ways to improve the properties of the freeze-dried scaffolds to meet the re-
quirements of the high demanding tissues of cartilage and bone. Different natural and synthetic 
polymer-based composite scaffolds were manufactured, and the effects of particle or fibrous fillers 
were studied as composite structures and compared with plain polymer scaffolds. The tissue engi-
neering scaffolds were studied to determine the structure of the manufactured composite scaffolds, 
to find out the characteristics of the composites, and to assess the feasibility of the composites for 
cartilage, bone or osteochondral tissue engineering applications. 
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2 Porous scaffolds for tissue engineering 
2.1 Scaffold composition 
Tissue engineering scaffolds require many specific characteristics. For example, highly flexible, 
stiff, rigid or soft components may be required, depending on the application. Also, for some appli-
cations, some specific materials are shown to induce tissue regeneration and, therefore, would be 
best suited for the application. To achieve the optimal characteristics for the scaffold, different 
kinds of composite structures have been developed in order to mimic the characteristics of native 
tissue as well as possible (Mohamad Yunos et al. 2008; Moutos & Guilak 2008). No ideal combina-
tion of a specific composite structure, composite materials or composite filler exists because differ-
ent tissue engineering applications require different properties from the scaffold. This means that 
different scaffold materials manufactured with different kinds of fabrication methods are often 
combined to achieve the goal. 
2.1.1 Scaffold microstructure 
The microstructure of a scaffold is a crucial factor for a tissue engineering construct to work prop-
erly. Generally, the majority of the cell culture studies are carried out in two-dimensional (2D) sur-
roundings such as in well plates or Petri dishes. However, almost all tissue cells in the body exist in 
3D constructs in a native extracellular matrix (ECM) (Lee et al. 2008). Therefore, almost all tissue 
engineering scaffolds are 3D structures. The microstructure of the scaffold has a great effect on cell-
material interaction. Four different types of microstructures, each with associated advantages and 
disadvantages, are listed below (Gibson et al. 2010):  
1) One-dimensional (1D) fibre structures: 
Cells cultured on individual fibres (length and diameter of the fibres can vary) 
2) Impermeable, two-dimensional (2D) substrates: 
Cells cultured in a 2D environment. Assessment of material chemistry, mechanics and mi-
cro-scale patterning 
3) Three-dimensional (3D), nanoporous hydrogel scaffolds: 
Cells on top of hydrogel (i.e. interacting with 2D substrate with nano-scale surface) or en-
capsulated inside 3D structure (the cells have to degrade the surrounding hydrogel to move 
or extend process) 
4) Three-dimensional (micro-porous) scaffolds: 
Cells are able to spread in three dimensions because of high porosity (typically >90%) and, 
depending on scaffold pore size, they can either be aligned along one-dimensional scaffold 
struts or attached to multiple struts and spread in three dimensions 
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The porosity and pore size of scaffolds are thought to be one of the major properties for tissue-
engineered scaffolds (Yang et al. 2001). High porosity, over 90%, is thought to enhance cell inte-
gration and nutrition exchange in tissue engineering scaffolds. The optimal pore size in the scaffold 
is more or less determined by the application and the type of cell used. The optimal pore sizes are 
typically in the range of 20–500 µm (Gibson et al. 2010). High porosity, pore size and interconnec-
tivity play significant roles in the migration of cells inside the scaffold, as well as nutrition and 
waste exchange (Hutmacher 2000). The properties of an ideal tissue engineering scaffold depend on 
the application, but nevertheless, various mutual properties are still required. 
A tissue engineering scaffold should: 
- be biocompatible to support cell viability and biodegradable so that the new tissue replaces 
the scaffold after time 
- be a highly porous 3D structure with interconnected pores in order to allow cells to migrate 
inside the scaffold 
- have appropriate porosity for the used cells, so that the cells stay inside the scaffold, prolif-
erate and form new tissue 
- have  appropriate  strength  for  the  application,  for  the  mechanical  stimuli  to  be  as  close  as  
possible to the native tissue 
- have an appropriate degradation time for the application, assisting the tissue in growth and 
subsequently forming new tissue (Chen et al. 2002; Lee et al. 2008; Yang et al. 2001; Mikos 
& Temenoff 2000; Ma 2004; Jagur-Grodzinski 2006; Tsang & Bhatia 2006; Weigel et al. 
2006; Liu et al. 2007) 
The majority of tissue engineering scaffolds are made of polymers because of the easy control over 
biodegradability and processability they offer (Chen et al. 2002). However, there is a growing trend 
towards the use of composite scaffolds. Tissue engineering composites can be either polymer-
polymer constructions, or, for example, polymer-ceramic or polymer-bioactive glass constructions. 
To ideally mimic the structure of the native tissue to be replaced, it is often necessary to rely on 
composite structures rather that just one-component scaffolds. Also, one more specific composite 
structure, hybrid structures, which combine the advantages of both synthetic and natural biomate-
rials, have attracted attention for the development of tissue engineering scaffolds (Chen et al. 2002; 
Liu et al. 2007). Furthermore, it might not be possible to manufacture the eligible geometry of the 
scaffold with only one component structure because the structure may lack some essential property 
such as the required mechanical strength. It may also not be possible to manufacture the geometry 
required with only one component because, for example, not all polymers can be processed into 
fibres. 
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2.1.2 Composites and hybrids 
Composites 
A composite is a combination of two or more distinctly different materials, where each component 
contributes positively to the properties of the final product. A composite is usually a construct with 
a matrix (the major component in the system) and filler (acting often as reinforcement). Composites 
can be divided into different categories based on the matrix material used (polymer, ceramic or 
metal). The filler material in the composites can be in various forms such as particles (nano- or mi-
croparticles), fibres (short or long) or textiles (Hull & Clyne 1996).  Four basic types of composite 
structures are represented in Figure 1.  
A 
 
 
B 
C 
 
 
D 
Figure 1. Schematic representations of basic composite structures. A) Long-fibre composite, B) 
short-fibre composite, C) particle reinforced composite, and D) laminate. (In all figures, matrix in 
white and filler/reinforcement in black.) 
The  composite  can  be  reinforced  with  long  fibres  (Figure  1A),  where  the  fibres  are  continuous  
throughout the matrix. The packing of fibres is more irregular and misalignment of the fibres is 
more likely for lower fibre contents. Short-fibre composites contain short fibres dispersed in the 
matrix (Fibre 1B). The orientation of short fibres is more random than for long fibres and fibre ori-
entation changes during processing especially when extensional flow and shear flow is present in 
melt processing. Particle-reinforced composites contain particles (for example nano- or microparti-
cles), randomly dispersed into the matrix (Figure 1C). A laminate structure comprises separate lay-
ers or laminae stacked in a pre-determined arrangement (Figure 1D). Each laminae may contain 
long or short fibres and they can be aligned in one or more directions or be randomly distributed in 
two or three dimensions. Textiles fabricated by using conventional textile technology processes 
(weaving, braiding and knitting) can also be used as reinforcements. Woven, non-woven, braided 
and knitted structures are examples of textiles used for composite reinforcement. Some of the tex-
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tiles can be thought of as long-fibre reinforcement and some as laminate reinforcement structures, 
depending on the application. (Hull & Clyne 1996) 
Usually, it is not possible to achieve the required properties and structure for an ideal tissue engi-
neering scaffold using only one component scaffold or only one material. Therefore, composites 
with at least two different materials or two different components (matrix and filler) are often needed 
to achieve an optimal tissue engineering scaffold and to mimic the natural ECM environment (Mou-
tos & Guilak 2008; Mohamad Yunos et al. 2008). The property of the composite is highly depended 
on the quality of matrix-filler interface. The interfacial bond strength of the matrix and filler can be 
influenced in multiple ways, such as with coupling agents or interfacial chemical reactions (Hull & 
Clyne 1996). 
Composite structures can be used for tailoring the functional or mechanical properties of the scaf-
fold. Examples of additional functionality for tissue engineering scaffolds are bioactivity, tailored 
degradation profile or controlled drug release. Many kinds of reinforcements are used to enhance 
the mechanical properties of scaffolds, and many times the reinforcing phase is used to transfer the 
load from the mechanically weaker matrix (Hull & Clyne 1996). For example, long bioactive glass 
fibres are used to improve the mechanical and degradation properties of polylactide-based scaffolds 
for load-bearing applications (Lehtonen et al. 2013b). In addition, bioactive glass fibre-reinforced 
starch-polycaprolactone (SPCL) composites have been manufactured using compression moulding 
of SPCL in layers with bioactive glass fibres to enhance the initial mechanical properties of the 
polymer (Jukola et al. 2008). Multilayered and fibre reinforced polymer composites have been 
manufactured for spinal surgery in order to obtain a bioresorbable composite with a bioactive agent 
for potential osteoconductive properties and adequate compressive properties for the application 
(Huttunen et al. 2006). Particle fillers can be used, for example, to modify the degradation 
6ehaveiour and to neutralize the acidic degradation products of self-reinforced polylactide in com-
posites containing osteoconductive bioceramic particles (Niemelä 2005). The drug release of multi-
ple drugs with a multilayer composite was developed to release the active agents in different phases 
(Nikkola et al. 2008). Osteoconductive, biodegradable bone filling composite releasing rifampicin 
was manufactured for the treatment of osteomyelitis with an improved drug release profile using 
bioceramic filler (Ahola et al. 2012). As an example of textile reinforcement, polylactide knitted 
mesh was used together with copolymer of caprolactone and lactic acid as a film to obtain a flexible 
membrane with different layers to enhance more rapid tissue ingrowth onto the porous mesh and to 
prevent tissue growth on the other side of the film (Kellomäki et al. 2000). Highly porous structures 
often suffer from low mechanical strength. Therefore, different composite structures are widely 
studied for 3D tissue engineering scaffolds for load-bearing applications such as cartilage or bone 
(Chen et al. 2003; Maquet et al. 2004; Navarro et al. 2006; Gentile et al. 2012a; Gentile et al. 
2012b). 
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Hybrids 
A hybrid material is a combination of two or more materials or of material and space so as to allow 
a superposition of their properties. By using hybridisation, it is possible to meet the design require-
ments for the desired construct that is not possible using a single material. Figure 2 shows the four 
scenarios of making a hybrid from two materials. Point A represents the ideal hybrid with the best 
properties of both components: “the best of both” scenario. Point B represents the best that can be 
obtained as an arithmetic average of the properties of the components, i.e., the bulk properties are 
combined: “the rule of mixtures” scenario. In point C, the properties of the hybrid fall below those 
of the rule of mixtures with less spectacular gains, but still somehow useful: “the weaker link domi-
nates” scenario. Point D represents something we do not want: “the worst of both” scenario (Ashby 
& Bréchet 2003). 
 
Figure 2. Hybridisation possibilities.  Four classes of hybrids (A–D) made of two families of mate-
rials (M1 and  M2)  plotted  in  a  chart  with  properties  P1 and  P2 as axes (adapted from Ashby & 
Bréchet 2003). 
Hybrids include fibrous and particulate composites, foams and lattices, sandwich structures and 
almost all natural materials (Ashby & Bréchet 2003). The design variables of hybrids are listed in 
Table 1. The potential of hybrid materials is in the choice of components and their relative volume, 
their configuration and in the way they are connected to each other. The creation of new “materials” 
with specific property profiles is made possible by the new variables expanding the design space 
(Ashby 2013). As scaffolds, hybrids have emerged as a promising alternative for tissue engineering, 
for example, as a combination of a synthetic polymer construct (like sponge or mesh) combined 
with a porous natural polymer matrix (Chen et al. 2004; Chen et al. 2006; Dai et al. 2010; Hokugo 
et al. 2006; Lu et al. 2012).  
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Table 1. The design variables of the hybrid design (Ashby 2013). 
Components The choice of materials to be combined 
Relative volumes The volume fraction of each component 
Configuration The shapes and relative placing of the components 
Connectivity The number of connections between components 
Scale The length-scale of the structural unit 
 
The classification of scaffolds into composites or hybrids is diverse. A composite is a material com-
prised  of  two  or  more  different  components  or  phases  (Hull  &  Clyne  1996).  Therefore,  the  term  
composite includes more or less all the variations of different combinations of two or more materi-
als applied in one system. However, the combination of material and space is not thought to be 
composite but it can be a hybrid. Therefore, some hybrids (but not all) are composites and vice 
versa. The term composite is generally used in this thesis more often since all the studied scaffolds 
in this thesis were composites although some, but not all, were also hybrids. In tissue engineering, 
the hybrids are often thought of as inorganic-organic compounds with a chemical bond, or as a 
combination of natural and synthetic component structures. The hybrids in this thesis are the com-
binations of natural and synthetic materials in one scaffold. 
2.2 Scaffold materials 
2.2.1 Natural bioabsorbable polymers 
Several natural bioabsorbable polymers have been studied as tissue engineering scaffolds (Nair & 
Laurencin 2006; Malafaya et al. 2007; Mano et al. 2007) and they can be considered as the first 
biodegradable biomaterials used clinically (Nair & Laurencin 2007). The use of natural polymers 
often relies on their natural characteristics of being similar to biological macromolecules and, there-
fore, similar to natural ECM (Mano et al. 2007). Being enzymatically degradable polymers, the in 
vivo degradation rate varies significantly with implantation site and depends on the availability and 
the concentration of the enzymes (Nair & Laurencin 2007). Natural polymers can be divided into 
three groups according to their chemical structure: proteins, polysaccharides and polyhydroxyalka-
noates. Natural polymers are mainly extracted from plant and animal sources or from algae. How-
ever, they can also be obtained from the fermentation of microorganisms or produced in vitro by 
enzymatic processes (Mano et al. 2007). Some of the most commonly used natural bioabsorbable 
polymers, their origin and some examples of their use for tissue engineering applications are listed 
in Table 2. Although natural polymers are often the first choice to be used for tissue engineering 
applications because of their ability to highly mimic the natural tissue environment, there are some 
factors that limit their use such as variability from batch to batch, poor mechanical properties, a 
possibility of animal residues and limited processability (Malafaya et al. 2007; Mano et al. 2007; 
Nair & Laurencin 2007).  
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Table 2. Natural bioabsorbable polymers and their origin and applications in tissue engineering 
(Nair & Laurencin 2006; Malafaya et al. 2007; Mano et al. 2007; Nair & Laurencin 2007; Van 
Vlierberghe et al. 2011). 
 Origin TE applications 
Proteins   
Collagen Derived from animal tissues or        produced by recombinant technologies  
Bone, cartilage, skin, vascular, adipose,     
intervertebral disc, cardiovascular, dental, 
urological, liver, neural, pancreas 
Gelatin Derived from collagen 
Bone, cartilage, osteocohdral, skin, vascular, 
adipose, intervertebral disc, liver, neural,   
pancreas 
Elastin Derived from animal tissues or        produced by recombinant technologies Bone, skin, vascular, neural, ocular 
Fibrin Produced from autologously harvested fibrinogen 
Bone, osteochondral, skin, vascular,          
intervertebral disc, cardiovascular, spinal cord, 
peripheral nerve 
Silk fibroin 
Spun into fibres by some lepidoptera 
larvae such as silkworms, spiders,   
scorpions, mites and flies. 
Bone, cartilage, osteochondral, skin, adipose  
Polysaccharides   
Chitosan 
Derived by deacetylation of chitin found 
in exoskeleton of arthropod or cell wall 
of fungi 
Bone, cartilage, osteochondral, skin, vascular, 
peripheral nerve 
Chondroitin sulphate Derived from animal tissues Bone, cartilage, vascular, heart valve, kidney 
Hyaluronic acid Derived from animal tissues or        produced by bacterial fermentation 
Bone, cartilage, osteochondral, skin, vascular, 
adipose, spinal cord 
Starch  Derived from plants Bone, vascular 
Collagen 
Collagen is the most abundant protein in the ECM and is the major component of skin and other 
musculoskeletal tissues. At least 28 different types of collagen have been identified to date (Ram-
shaw et al. 2009; Gordon & Hahn 2010). All collagens have a triple-helical structure where three 
individual chains, each in a left-handed polyproline II-helix, are coiled together to form a right 
handed, super coiled triple helix with a rope-like structure.  In this structure, collagens show a char-
acteristic repeating sequence, glysine-X-Y, where glysine is a small enough amino acid to pack into 
the  centre  of  the  triple-helical  structure.  X and  Y positions  can  be  any  amino acid,  but  X is  often  
proline and Y is frequently hydroxyproline (Ramshaw et al. 2009). Collagens can be divided into 
different groups based on their structure and supramolecular organization. These groups are fibril-
forming collagens, fibril-associated collagens (FACIT), network-forming collagens, anchoring fi-
brils, transmembrane collagens, basement membrane collagens and others, each with a unique func-
tion. The most abundant group of collagens are the fibril-forming collagens with about 90% of the 
total collagen. Collagen type I is the most abundant and the best studied collagen and forms more 
than 90% of the organic mass of bone and is the major collagen in tendons, skin, ligaments, cornea 
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and  many  interstitial  connective  tissues,  with  the  exception  of  only  a  few  tissues  such  as  hyaline  
cartilage, brain and vitreous body. Type II collagen, on the other hand, is the characteristic and pre-
dominant component of hyaline cartilage, but it is also found in the vitreous body, the corneal epi-
thelium, notochord, the nucleus pulposus of intervertebral discs and embryonic epithelial-
mesenchymal transitions (Gelse et al. 2003).  
Collagen possesses high mechanical strength, good biocompatibility, low antigenicity and the abil-
ity to cross-link, which enables the tailoring of the mechanical, degradation and water uptake prop-
erties of collagen. When fabricated into highly porous scaffolds, the cross-linking of collagen is 
necessary to fabricate scaffolds with adequate mechanical properties and degradation rate (Mala-
faya et al. 2007; Mano et al. 2007). Collagen has been extensively studied for use in various medi-
cal applications and a wide range of tissue engineering applications such as bone, cartilage and skin 
tissue engineering. Modifying or combining collagen with other degradable polymers improves the 
potential of collagen as a biomaterial (Ulery et al. 2011). The principal collagen that can be readily 
prepared in a pure form in commercial quantities is type I collagen. It is the most widely used colla-
gen for tissue engineering applications. Collagen scaffolds offer an alternative way to provide bio-
logical information to the growing construct, unlike biodegradable synthetic polymers. While using 
collagen scaffolds, a wide range of cell adhesion and other signals that will enhance the quality of 
the tissue-engineered products is achieved (Ramshaw et al. 2009). Generally, freeze-drying or 
stereolithography methods are used for fabricating porous, collagen-based scaffolds and carbodiim-
ide is often applied for cross-linking. Porous collagen scaffolds are often combined with other com-
ponents such as, bioceramics or synthetic biodegradable polymers (Van Vlierberghe et al. 2011). 
Collagen is already available in a variety of commercial medical products, such as a bioprosthetic 
heart valve or as a wound dressing. The use of collagens can be divided into two different catego-
ries: tissue-based devices where natural, stabilised tissue is used as a device (a bioprosthetic heart 
valve) and purified collagen, where collagen is made soluble through an enzyme digestion step and 
reconstituted into various products (a wound dressing). Recombinant collagens are emerging as the 
most interesting development since they offer a way to produce high purity and disease-free colla-
gens with the possibility to produce all types of collagens, even those with very low abundance in 
natural tissue (Ramshaw et al. 2009). 
Chitosan 
Chitosan is a linear polysaccharide composed of ȕ(1–4) linked glucosamine with randomly located 
N-acetyl-glucosamine groups, depending on the degree of deacetylation of the polymer. Chitosan is 
a deacetylated form of chitin, the second most abundant natural biopolymer. Chitin is a fully acety-
lated polymer extracted from the exoskeletons of arthropods and also from cell walls and the ECM 
of most fungi. The degree of deacetylation of chitosan can vary from 30% to 95% (Di Martino et al. 
2005; Domard & Domard 2001) and molecular weight from 300 to over 1000 kD (Di Martino et al. 
2005). Chitosan, unlike chitin, is soluble in dilute acids (pH<6.0) when the protonated free amino 
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groups on glucosamine facilitate the solubility of the molecule. The degree of deacetylation and the 
molecular weight of chitosan can vary greatly, depending on the source and the preparation proce-
dure of the polymer. Chitin and chitosan in their polymeric form are completely absent in numerous 
animals including mammals. However, the N-acetyl-glucosamine unit is widely found in the chemi-
cal structure of other glycosaminoglycans (GAGs) and in glycoconjucates such as glycoproteins and 
glycolipids (Domard & Domard 2001). Chitosan is primary degraded by lysozyme enzyme in vivo 
through hydrolysis of acetylated residues. The degree of deacetylation is related to its degradation 
rate and, as a consequence, highly deacetylated chitosan degrades more slowly in vivo (Di Martino 
et al. 2005).  
Chitosan is often processed for tissue engineering scaffolds by freeze-drying, supercritical fluid 
technology or stereolithography (Van Vlierberghe et al. 2011). The glass transition and the melting 
temperatures of dry, solid chitosan are both higher than its temperature of thermal decomposition. 
Therefore, it is necessary to process chitosan from solutions (Domard & Domard 2001). The quali-
ties that make chitosan a versatile polymer for tissue engineering applications are its good biocom-
patibility, its ability to be processed into various forms, its antibacterial activity and its ability to 
bind anionic molecules such as the growth factors, GAGs and DNA. Chitosan has cationic nature 
which enables electrostatic interactions with GAGs, proteoglycans and other negatively charged 
molecules (Di Martino et al. 2005). Chitosan has been used, for example, in bone, cartilage and skin 
tissue engineering in various forms and it is also often combined with other natural polymers such 
as collagen, with ceramics, or with synthetic polymers (Van Vlierberghe et al. 2011; Di Martino et 
al. 2005; Muzzarelli 2009). Especially, as a positive aspect for cartilage tissue engineering, chitosan 
has been found to maintain the round morphology of chondrocytes. This is a normal phenotypic 
characteristic of chondrocytes and preserves their capacity to synthesize cell-specific ECM (Muzza-
relli 2009). 
2.2.2 Synthetic bioabsorbable polymers 
Synthetic bioabsorbable polymers are widely studied as tissue engineering scaffolds (Jagur-
Grodzinski 2006; Nair & Laurencin 2006; Nair & Laurencin 2007; Gunatillake et al. 2003; Ulery et 
al. 2011). Their controllable chemistry and properties as well as their characteristic of being easily 
reproducible have exceeded their use as scaffold materials. Synthetic bioabsorbable polymers can 
be divided into various subgroups such as esters, orthoesters, anhydrides, carbonates and amides, 
depending on their functional group’s susceptibility to hydrolysis. In particular, polyesters have 
been used in a number of clinical applications because of their ease of degradation by hydrolysis of 
ester linkage. Also, their degradation products are in some cases resorbed through the metabolic 
pathways, and they possess the potential to alter their degradation rates by tailoring their structures. 
For these reasons, polyesters are also studied for tissue engineering applications (Gunatillake et al. 
2003). Some of the most widely and earliest studied synthetic bioabsorbable polymers used in tissue 
engineering are polyĮ-esters). Their synthetisation methods and applications in the field of tissue 
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engineering are listed in Table 3. The uniqueness of poly(Į-esters) lies in their vast diversity and 
synthetic versatility. In the class of poly(ɲ-esters), the poly(Į-hydroxy acid)s, which include poly-
glycolide  (PGA)  and  the  stereoisomeric  forms  of  polylactide  (PLA),  are  the  most  widely  studied  
polymers. Although many groups of bioabsorbable polymers have been studied for biomaterial ap-
plications, only a few of them are generally used for tissue engineering scaffolds. The main reasons 
for this are that many of them cannot be used in load bearing applications because their degradabil-
ity is too fast or too slow, or they cannot be processed into 3D structures. This is why copolymeri-
zation is often used to overcome these limitations (Nair 2007). 
Table 3. Poly(Į-esters), their synthetisation method and applications in tissue engineering scaffolds 
(Jagur-Grodzinski 2006; Nair & Laurencin 2006; Nair & Laurencin 2007; Gunatillake et al. 2003; 
Ulery et al. 2011). 
 Synthetisation method TE applications 
Poly(Į-esters)   
Polyglycolide  
(PGA) 
Ring-opening polymerization of      
glycolide, the cyclic dimer of glycolic 
acid, with solution or melt               
polymerization 
Bone, cartilage, dental, tendon,   
vaginal, intestinal, lymphatic, spinal 
regeneration 
Polylactide  
(PLA) 
Condensation polymerization of lactic 
acid [poly(lactic acid)] or ring-opening 
polymerization of lactide [poly(lactide)] 
Bone, cartilage, vascular, neural, 
tendon 
Poly(lactide-co-glycolide) 
(PLGA) 
Copolymerization of lactic and glycolic 
acid 
Bone, cartilage, skin, liver, neural, 
tendon 
Polycaprolactone  
(PCL) 
Ring-opening polymerization of the 
cyclic monomer İ-caprolactone 
Bone, cartilage, skin, vascular, neural, 
ligament 
 
Polylactides 
PLAs are thermoplastic, biodegradable polymers produced either by condensation polymerization 
from lactic acid, derived from the fermentation of sugars from carbohydrate sources such as corn, 
sugarcane and tapioca or by ring-opening polymerization from lactide, the cyclic dimer of lactic 
acid. Because of its chiral carbon atom, lactic acid exists in two enantiomeric forms referred to as 
L-lactic acid (S), which occurs in the metabolism of all animals and microorganisms, and D-lactic 
acid  (R).  With  condensation  polymerization,  only  low molecular  weight  PLA is  usually  obtained.  
High molecular weight PLA can be obtained by ring-opening polymerization in which the polycon-
densation of lactic acid is followed by depolymerisation into the dehydrated cyclic dimer, lactide. 
The optically active lactide can be found either as D-lactide, L-lactide or as meso-lactide (D,L-
lactide). In addition to the three diastereomeric structures, racemic lactide, a racemic mixture of D-
lactide and L-lactide also exists (Södergård & Stolt 2002; Groot et al. 2010). 
The structure and composition of the polymer chains, and in particular the ratio of the L- to the D-
isomer of lactic acid, affect the processing, crystallization and degradation behaviour of PLA. By 
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using copolymerization of L-lactide and meso-, D- or racemic lactide, high molecular weight amor-
phous or semicrystalline polymers with a melting point from 130 to 185 °C can be obtained. 
Poly(L-lactide) (PLLA), a homopolymer comprising only L-lactide, is a semicrystalline and has the 
highest melting point, whereas PLA copolymers with higher D-isomer content exhibits lower melt-
ing points and dramatically lower crystallization behaviour, becoming amorphous at D-contents 
higher than 12–15% (Groot et al. 2010).  
PLA is an aliphatic polyester and is, therefore, susceptible to hydrolytic degradation because of the 
ester groups present in its structure. The hydrolytic degradation behaviour, rate and mechanism are 
controllable by varying the molecular and higher order structures and by medium factors such as 
temperature, pH and the catalytic species (for example alkali and enzyme) of PLA. The in vivo hy-
drolytic degradation rate is comparable to in vitro degradation and, therefore, the in vivo degrada-
tion can be predicted to a certain extent from in vitro degradation behaviour and rate (Tsuji 2010). 
PLA does not require the presence of enzymes to catalyse the hydrolysis. Lactic acid occurs in the 
metabolism of living organisms and, as a result, the degradation products of PLA are non-toxic 
(Gupta & Kumar 2007). The hydrolysis of aliphatic polyesters starts with a water uptake into the 
matrix that is followed by the hydrolytic splitting of the ester bonds. The initial degree of crystallin-
ity affects the hydrolytic degradation rate as the amorphous parts have the higher rate of water up-
take and the crystal segments reduce the water permeation in the matrix (Södergård & Stolt 2002). 
Also, the autocatalytic effect of a PLA specimen has been reported. The autocatalysis is due to the 
increasing number of compounds containing carboxylic end groups in the centre of a specimen 
when low molar mass compounds cannot permeate the outer shell where the degradation products 
dissolve in the surrounding solution (Gupta & Kumar 2007; Li et al. 1990). 
PLAs can be processed into various forms due to their thermoplastic nature. Melt processing is the 
most widely used method for PLA. In addition, injection moulding and extrusion are widely used 
methods to fabricate PLA films and fibres for different nonwovens or textiles. Also, the electro-
spinning of PLA is used for medical applications to produce thin fibres that can be used as medical 
tissue scaffolds, wound dressings, carriers for drugs, protective fabrics and nanocomposite materials 
(Lim et al. 2010). The wide range of medical applications of PLAs includes orthopaedic screws, 
tissue engineering scaffolds, sutures, protein encapsulation and delivery, microspheres and drug 
delivery systems (Gupta & Kumar 2007). PLLA is a slow-degrading polymer (between 2 to over 5 
years for total resorption in vivo) with good tensile strength, low extension and high modulus. That 
is why PLLA is considered to be ideal for load bearing applications such as orthopaedic fixation 
devices. PDLLA, on the other hand, degrades faster and loses its strength within 1–2 months and, 
when hydrolysed, undergoes a loss in mass within 12–16 months. It also has lower tensile strength 
compared with PLLA. For that reason, PDLLA is preferred as drug delivery vehicles and as a low 
strength scaffold material for tissue engineering (Nair & Laurencin 2007; Ulery et al. 2011). At the 
moment, PLLA (semi crystalline), PLDLA (amorphous), P(L/DL)LA 70/30 (amorphous) and 
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P(L/D)LA 96/4 (semi crystalline) are the most commonly used PLA polymers in the medical indus-
try (Ellä 2012). 
Polylactide-based co-polymers 
One of the oldest and most successful approaches to vary the properties of a polymer is copolymeri-
zation with suitable comonomers. The stereocopolymers of D- and L-lactide are a special case for 
PLA copolymers, but other copolymers with PLAs are extensively studied as well. In the case of 
PLAs,  the  most  widely  used  comonomers  of  L-  or  DL-lactide  are  glycolide  (GA)  and  İ-
caprolactone (CL). The GA enhances the rate of degradation of the polymer, and hence 
poly(lactide-co-glycolide) (PLGA) is often designed for pharmaceutical  applications such as con-
trolled drug release. In the case of poly(lactide-co-İ-caprolactone) (PLCL), the incorporation of CL 
reduces the rate of hydrolytic degradation and lowers the glass transition temperature and thus en-
hance the flexibility of the end product (Kricheldorf 2001). 
PLGA is the most studied degradable polymer for biomedical applications. Because PLA and PGA 
have  significantly  different  properties,  different  copolymer  compositions  allow  PLGA  to  be  opti-
mized for different applications. With 25–75% lactide composition, PLGA forms amorphous poly-
mers that are very hydrolytically unstable compared with the more stable homopolymers. A number 
of different processing techniques have been used for PLGA scaffold manufacturing such as gas 
foaming, microsphere sintering, porogen leaching, electrospinning and polymer printing. Because 
of the rapid degradation of PLGA compared with other polyesters, PLGA has been especially used 
as sutures and drug delivery devices. PLGA has also been fabricated into tissue engineering scaf-
folds since it demonstrates great cell adhesion and proliferation properties (Nair & Laurencin 2007; 
Ulery et al. 2011). 
2.3 Fabrication methods of porous scaffolds 
The fabrication parameters of a tissue-engineered scaffold depend mostly on the geometry and the 
mechanical properties of the tissue to be replaced. The scaffold should mimic the natural ECM en-
vironment. This is essential if the cells are to function in the simulated environment as they would 
in vivo. The material to be processed may present some processing limitations because not all bio-
degradable polymers are suitable for processing into 3D matrices or at least not in all processing 
methods (Lee et al. 2008). For this reason, it is important to know the limitations and advantages of 
the fabrication method to be used in order to process applicable scaffolds for the required applica-
tion. Fabrication methods can be divided into different categories based on the process feature used, 
for example, under high temperatures or through the use of solvents or gases during processing. The 
used process feature can also be an advantage or disadvantage as not all materials can be processed 
in all conditions. Tissue engineering requires highly porous 3D scaffolds. Table 4 summarizes some 
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of the most commonly applied fabrication methods for porous polymeric tissue engineering scaf-
folds.  
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Each of the fabrication processes has its own unique advantages in the manufacturing of tissue en-
gineering constructs. No standard fabrication method is superior to any other method and, therefore, 
new methods are being researched (Lee et al. 2008). The future of the fabrication of tissue engineer-
ing scaffolds could rely on combining multiple processing methods to achieve the best scaffold 
structure for each tissue engineering application (Mikos & Temenoff 2000; Weigel et al. 2006). 
Though new fabrication methods are being introduced, the potential for the future development of 
scaffolds could also rely on the advancement and adaptation of conventional fabrication methods or 
their combination (Weigel et al. 2006). 
2.3.1 Freeze-drying 
Freeze-drying, also known as lyophilisation, has been used in the food and pharmaceutical industry 
because of its favourable property of being a low-temperature drying method (Franks 1998). 
Freeze-drying is nowadays also widely used for the fabrication of tissue engineering scaffolds. It is, 
therefore, known as one of the conventional methods for fabricating biomaterials into scaffolds (Liu 
et al. 2007). Freeze-drying is a processing method based on the sublimation phenomenon. Sublima-
tion of the solvent, the formed ice crystals, produces a highly porous scaffold as an anhydrous or 
almost anhydrous state (Franks 1998). Unlike other drying methods, freeze-drying is a process 
where the material is solidified prior to drying and the removal of the major amount of water occurs 
through direct conversion of water from the solid state to the vapour state (Flink & Knudsen 1983).  
Freeze-drying is a three-step process divided into freezing, primary drying and secondary drying 
periods.  First (step 1), the liquid material is cooled into its solid form in the freezing period. Then 
(step 2), the frozen liquid, ice, is subsequently dried under vacuum in a freeze-dryer. Finally (step 3), 
the strongly bound water is removed from the product (secondary drying). The last two steps occur 
simultaneously in a freeze-dryer at different locations in the sample (Flink & Knudsen 1983). The 
properties of the dried sample can only be affected by the three different process parameters in the 
freeze-dryer that can be directly controlled: condenser temperature, chamber pressure and freeze-
drying time. In addition to the freeze-dryer properties, the properties of the sample can also be af-
fected by the material properties prior to freeze-drying as well as by the freezing temperature. The 
composition/formulation/concentration of the used material, the solid content and the fill volume all 
affect the properties of the sample (Franks 1998). In brief, the higher the freezing temperature or the 
slower the freezing results in a smaller number of larger ice crystals and also a more oriented struc-
ture into the sample. On the other hand, rapid freezing or a lower freezing temperature results in a 
large number of small ice crystals not oriented in one direction (Flink & Knudsen 1983). 
To date, various polymers and various kinds of scaffolds have been fabricated by freeze-drying, and 
it  is  still  one  of  the  most  commonly  used  methods  to  fabricate  highly  porous  scaffolds  for  tissue  
engineering. By freeze-drying, it is possible to manufacture many kinds of polymers, natural and 
synthetic, and different kinds of composite structures are also possible. From natural polymers col-
lagen (Pieper et al. 2002; Pieper et al. 1999; Park et al. 2002; Schoof et al. 2001; Von Heimburg et 
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al. 2001; Powell & Boyce 2006; Harley et al. 2007) and chitosan (Madihally & Matthew 1999; 
Francis Suh & Matthew 2000b; Ma et al. 2001; Nettles et al. 2002; Xia et al. 2004), for example, 
are widely studied as scaffold materials for freeze-drying. From synthetic polymers, the most used 
polymers are polyesters such as polylactide-based polymers. Also, different kinds of polymer 
blends such as collagen-chitosan blends (Ma et al. 2003; Wang et al. 2003; Wu et al. 2007; Zhu et al. 
2009a; Zhu et al. 2009b; Arpornmaeklong et al. 2008; Wang et al. 2011), as well as different com-
posite structures or hybrid structures with natural and synthetic components (Chen et al. 2003; Chen 
et al. 2004; Dai et al. 2010; Sato et al. 2001; Lee et al. 2006; Lee et al. 2004; Hiraoka et al. 2003; 
Lin et al. 2009; Ficai et al. 2010; Sionkowska & Kozáowska 2010; Akkouch et al. 2011; Xu et al. 
2011) have been studied.  
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3 Cartilage and bone tissue engineering 
3.1 Physiology and function of cartilage and bone 
Because of the high variation between cartilage and bone tissue compositions and structures, it is 
very important to find the optimum tissue engineering construct to be used in osteochondral lesions. 
Cartilage is categorized as soft tissue. On the other hand, bone is categorized as hard tissue and, 
therefore, many approaches for osteochondral tissue engineering have concentrated on the different 
compositions and mechanical properties of each of the tissues (Martin et al. 2007; Castro et al. 
2012). There are two distinct approaches for interfacial tissue engineering: by bridging two tissues 
as an independent interface or by transitioning from one tissue to another with a specific “tissue unit” 
as one component.  The use of an autologous tissue transplant is  an example of the latter approach 
that includes both cartilage and subchondral bone components (Castro et al. 2012). 
3.1.1 Cartilage 
Cartilage exists in various places in the body such as the articular surface of long bones, the trachea, 
ears, nose and intervertebral discs. Three types of cartilage exist: hyaline cartilage, elastic cartilage 
and fibrocartilage. Hyaline cartilage is the most abundant type of cartilage present in the human 
body. Hyaline cartilage exists, for example, on the articular surface of bones and in the trachea; 
whereas, elastic cartilage can be found in the ears and in fibrocartilage in the intervertebral discs 
(Meyer & Wiesmann 2006). The articular cartilage (hyaline cartilage) in the ends of bones is nor-
mally only ~3 mm thick, and it permits a smooth motion and minimal friction between the bones 
forming the joint (Kinner et al. 2005; Chiang & Jiang 2009). Loss of cartilage and especially articu-
lar cartilage is a problem from which millions of people suffer worldwide. The failure of articular 
cartilage may be caused by injury or disease and is a major problem as it may lead to severe pain 
and disability of the joint. (Kinner et al. 2005; Temenoff & Mikos 2000) Many joint diseases can 
cause these lesions, but the primary cause of losing articular cartilage is osteoarthritis (OA) (Te-
menoff & Mikos 2000; Hunziker 2002; Risbud & Sittinger 2002). Therefore, the regeneration of 
articular cartilage by therapeutic approaches would improve the quality of life for many people. 
This is why several approaches have been made in order to improve the outcome of the loss of ar-
ticular cartilage. However, there is still no optimal way of regenerating fully functional articular 
cartilage (Kinner et al. 2005; Iwasa et al. 2009; Vinatier et al. 2009). 
Cartilage tissue possesses only limited or almost no regenerative properties on its own. This is 
mainly  due  to  its  avascular,  aneural  and  alymphatic  nature  and  because  cartilage  contains  a  rela-
tively  low  number  of  cells,  mainly  chondrocytes,  in  its  structure.  The  chondrocytes  are  placed  in  
lacunas and are therefore surrounded by dense ECM and not by other cells as in many other tissues. 
Cartilage ECM is mainly composed of collagen type II and proteoglycans that give the tissue its 
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unique mechanical properties. The articular cartilage comprises three distinct layers: the superficial, 
the middle and the deep zone. Each layer varies in structure and function and responds to different 
stimuli and secretes different proteins. For example, with increased depth, an increase in collagen is 
observed, and superior mechanical properties in the deep zone compared with the superficial zone 
are provided. (Chung & Burdick 2008)  
Because of the low healing capability of articular cartilage, many attempts have been made in order 
to produce proper cartilage tissue. The most used so-called conventional cartilage repairing tech-
niques are the microfracture technique, mosaicplasty, osteochondral autologous grafts and autolo-
gous chondrocyte implantation. However, these techniques can lead to fibrocartilage repair tissue, 
the morbidity of the donor site is a concern and the surgical procedures are complex (Iwasa et al. 
2009). Nowadays, the tissue engineering approach has been found to posses the best abilities for 
cartilage regeneration. For example, to further improve the quality of autologous chondrocyte im-
plantation by also using appropriate scaffolds (Iwasa et al. 2009; Chung & Burdick 2008). Even 
though cartilage tissue is an anisotropic tissue composed of different layers, the use of homogenous 
constructs has been the most used method for cartilage tissue engineering (Chung & Burdick 2008). 
3.1.2 Bone 
Bone serves as a mineral reservoir in the body and, more importantly, it provides the mechanical 
stability that is needed by the skeleton for load bearing, locomotion and also for the protection of 
internal  organs.  (Kneser  et  al.  2006)  In  general,  bone  possesses  the  intrinsic  ability  to  self-repair  
itself as a response to injury or during skeletal development, or continuous remodelling to maintain 
mechanical integrity and to respond to the changing demands of the body. Trauma, infection, tu-
mour resection or skeletal abnormalities may, however, need assisted bone regeneration in load 
bearing and non-load bearing skeletal sites. Also, the normal regenerative process of bone might be 
compromised, for example, by avascular necrosis, osteoporosis or rheumatoid arthritis. (Dimitriou 
et al. 2011; Holland & Mikos 2006)  
The structure of bone is highly vascularized and it has the ability to regenerate itself without form-
ing  scar  tissue.  An adult  skeleton  contains  two types  of  bone:  trabecular  (cancellous)  and  cortical  
(compact) bone. Cortical bone, 80% of all bones, is arranged in a compact pattern with almost solid, 
less than 10% porosity and is generally present in long, short and flat bones. Trabecular bone, 20% 
of all bones, is arranged in a porous sponge-like pattern (up to 50–90% porous) and it can be found 
in a large part of the bone marrow and is essentially present in the methaphysis of long bones, the 
iliac crest and the vertebral bodies. Bone tissue is mainly composed of three different cell types: 
osteoblasts, osteocytes and osteoclasts. (Kneser et al. 2006; Mistry & Mikos 2005) Osteoblasts are 
derived from mesenchymal stem cells (MSCs) and they secrete collagenous proteins that form the 
organic matrix of bone, the osteoid. When surrounded by osteoid, the mature osteoblasts stop se-
creting matrix and become osteocytes. Osteoclasts, derived from hematopoietic cells of the marrow, 
secrete acids and proteolytic enzymes that dissolve mineral salts and digest the organic matrix of 
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bone. The inorganic-organic structure of bone is composed of roughly 60% inorganic mineral, 30% 
organic material and 10% water (Mistry & Mikos 2005). The inorganic phase is composed of cal-
cium phosphate, mainly hydroxyapatite (HAp), while the organic phase is mainly composed of col-
lagens but also glycoproteins, proteoglycans and sialoproteins. (Mistry & Mikos 2005; Kneser et al. 
2006) HAp crystals provide compressive strength to the inorganic-organic composite structure, 
while collagen fibres give tensile properties to the structure  (Mistry & Mikos 2005).  
Current treatments in bone repair are based on bone grafts, mainly autologous grafts, and allografts 
or metal or ceramic-based constructs. However, autologous grafts are limited due to their number 
and donor site morbidity. Allografts carry the risk of immune reactions. Metals exhibit poor overall 
integration and may also cause infections. Ceramics have very low tensile strength and are brittle. 
As a result, several clinical conditions still require enhancement of bone regeneration and various 
methods are used for this purpose. Nevertheless, more work is still needed to find the optimised 
outcome for bone tissue regeneration for the required purposes (Dimitriou et al. 2011). 
3.2 Scaffolds for cartilage and bone tissue engineering 
3.2.1 Cartilage tissue engineering scaffolds 
The unique structure of cartilage has set many limitations on cartilage tissue engineering. The ideal 
materials used for cartilage tissue engineering could be the major components in cartilage tissue, 
collagen and proteoglycans. Collagen type II makes up the majority in articular cartilage (90–95% 
of the collagen in the matrix) but other collagens V, VI, IX and XI are also present. Proteoglycans, 
composed of about 95% polysaccharide and about 5% protein are not chemically bound between 
collagen fibres in the cartilage ECM, but aggregation prevents the diffusion of the proteoglycans 
out of the matrix during loading of the joint. (Temenoff & Mikos 2000) The collagen fibre structure 
gives the cartilage ECM its ability to withstand tensile stresses and proteoglycans withstand com-
pressive loads and have the ability to contain water and, therefore, swell again after the load is re-
leased (Kinner et al. 2005). However, tissue engineering scaffolds fabricated from collagen and/or 
proteoglycans often lack the mechanical properties necessary to properly mimic the cartilage ECM. 
Therefore, several scaffold constructions have been studied to date, and many are under investiga-
tion for optimal cartilage tissue engineering (Iwasa et al. 2009; Chung & Burdick 2008). Articular 
cartilage  has  relatively  high  water  content  60–80%  of  the  wet  weight  of  the  tissue  (Kinner  et  al.  
2005). The scaffold should maintain its structure during the mechanical loading-unloading phe-
nomenon and also be able to reabsorb the lost liquid into the scaffold in situ. This is important be-
cause the main exchange of nutrients and oxygen happens in cartilage ECM during this phenome-
non (Temenoff & Mikos 2000; Ge et al. 2012). Furthermore, the mechanical stimulus of a tissue 
engineered scaffold during cell culturing affects the outcome of the newly formed tissue (Kinner et 
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al. 2005; Vinatier et al. 2009). As pointed out here, there are still many things to be studied before 
an ideal cartilage tissue engineering construct is discovered.  
3.2.2 Bone tissue engineering scaffolds 
The optimal materials to be used for bone tissue engineering should preferably be osteoinductive, 
capable of promoting the differentiation of progenitor cells down an osteoblastic lineage, osteocon-
ductive, supports bone growth and encourages the ingrowth of surrounding bone, and capable of 
osseointegration, integrates into surrounding bone (Stevens et al. 2008). Several materials such as 
metals, ceramics and biodegradable polymers, both synthetic and natural, have been studied for 
bone tissue engineering. Metals and most of the ceramics are not biodegradable. Therefore, the 
most suitable materials to be studied for the application rely on biodegradable polymers and a small 
number of ceramics (Salgado et al. 2004). Collagen and especially type I collagen is a widely used 
material for bone tissue engineering because it is one of the major organic components in bone 
ECM. Also, osteogenic differentiation and mineralization have been shown to be provoked in type I 
collagen matrices (Ignatius et al. 2005; Ferreira et al. 2012). However, collagen scaffolds lack the 
mechanical properties essential for bone tissue engineering, and, therefore, they are not the best 
choice for the application on their own. Synthetic biodegradable polyesters, poly(Į-hydroxy acids), 
and especially polylactide copolymers (PLAs), are widely used and well studied polymers for nu-
merous biomedical applications and also for bone tissue engineering. More and more bone tissue 
engineering applications are using PLAs together with inorganic components, as they enhance the 
mechanical and degradation properties and can modify the biological behaviour of the scaffold. 
Because the structure of the native ECM of bone is a composite, many kinds of composite scaffolds 
are studied for bone tissue engineering (Navarro et al. 2006). Scaffolds composed of bioactive ce-
ramics,  bioactive  glasses,  natural  or  synthetic  polymers  or  composites  of  the  above  are  the  most  
studied components for bone tissue engineering (Stevens et al. 2008). The pore size and porosity of 
a bone tissue engineering scaffold are crucial factors for proper scaffold geometry. A bone tissue 
engineering scaffold needs a highly porous structure with relatively large pores (diameter preferably 
over 100 µm). The high porosity is needed because the scaffold needs relatively fast cell migration 
into the scaffold and also vascularisation throughout the scaffold with high oxygenation. However, 
the porosity of the scaffold should not exceed the limit of the mechanical properties of the scaffold 
material or the scaffold construct. Also, the degradation of the scaffold should be taken into account. 
The scaffold should not be too porous when rapidly degrading materials are used, especially if the 
scaffold is used in load-bearing applications (Karageorgiou & Kaplan 2005). 
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4 Approaches for osteochondral tissue engineering 
Since osteochondral tissue engineering requires the repair of both the cartilage and subchondral 
bone, the approach towards osteochondral scaffolds can vary in several ways. To repair an osteo-
chondral defect, one must take into account all of the three variables: cartilage, bone and the carti-
lage-bone interface. A scaffold used for osteochondral tissue engineering may be composed of one, 
two or even more components, depending on the used materials and their compositions. Osteo-
chondral scaffolds can be either single phase, layered or graded structures (Nukavarapu & Dorce-
mus 2013).  
The major limitation in osteochondral tissue engineering is that it relies on the regeneration of the 
complex structure of the interface between cartilage and bone. Many different approaches including 
different scaffold materials, scaffold fabrication methods and the used cell types and compositions 
have been studied for osteochondral tissue engineering (Panseri et al. 2012; Martin et al. 2007; Cas-
tro et al. 2012).  
4.1 Cartilage defects 
If the cartilage defect affects the underlying subchondral bone, the defect is said to be an osteo-
chondral defect. The osteochondral lesions may heal to some extent as the mesenchymal chondro-
progenitor cells can penetrate through the vascularised subchondral bone into the lesion and form 
cartilage. However, the formed cartilage is mainly fibrous tissue without the functional properties of 
native hyaline cartilage (Panseri et al. 2012; Puppi et al. 2010). Osteochondral defects are typically 
formed by trauma or OA leading to structural and functional failures of the bone-cartilage interface 
which, in turn, leads to severe pain and reduced joint motion (Martin et al. 2007; Castro et al. 2012). 
As a result, osteochondral defects typically require surgical methods to heal. Currently, defects over 
the size of 2.5 cm2 are difficult to heal with the commonly used methods such as joint debridement, 
microfracture and mosaicplasty. The above-mentioned methods have limited success in, for exam-
ple, long-term repair. Therefore, tissue engineering, or more precisely interfacial tissue engineering 
(Castro et al. 2012), would give the best outcome for osteochondral defect repair (Panseri et al. 
2012). 
The classification of cartilage defects using the most popular system, the Outerbridge Classification 
System, is represented in Figure 3. The Outerbridge Classification System ranks the different carti-
lage lesion types into five different grades, where the Grade 0 is normal cartilage, from which point 
Grade I lesions (not shown in Figure 3) denote swelling and softening of the cartilage. Grade II is a 
partial thickness chondral defect, the type most often seen clinically, that has a defect diameter of 
less  than  1.5  cm.  A Grade  III  defect  is  a  full  thickness  chondral  defect  that  has  a  diameter  larger  
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than 1.5 cm. A Grade IV defect is an osteochondral defect, where the subchondral bone is exposed 
(Nukavarapu & Dorcemus 2013). 
 
Figure 3. Representative graphs of different classifications of osteochondral defects: the Outer-
bridge Classification System. Grade 0: normal cartilage, Grade II: partial thickness defect (with a 
diameter less than 1.5 cm), Grade III: full thickness defect (with a diameter larger than 1.5 cm), and 
Grade IV: osteochondral defect (adapted from Nukavarapu & Dorcemus 2013). 
4.2 Different scaffold strategies for osteochondral tissue engineering 
Some of the possible scaffold strategies for osteochondral tissue engineering are represented in Fig-
ure 4. The scaffold can contain an independent bone scaffold combined with a cartilage scaffold (4 
and 5 in Figure 4), a so-called bi-layered scaffold. The scaffold can be a combination of both parts 
(1 and 3 in Figure 4), with only one scaffold that can be either homogeneous or heterogeneous. Also, 
only one scaffold may be used for only one part, for example, for bone (2 in Figure 4) (Nooeaid et 
al. 2012). In addition, the used materials can vary for different components and the scaffold may 
contain  only  one  material  with  one  or  more  compositions.  The  different  layers  of  combined  bone  
and cartilage scaffolds may also be attached to each other prior to implantation or at the time of 
implantation (Martin et al. 2007).  
 1 2 3 4 5 
 One scaffold for 
both cartilage and 
bone 
Scaffold for 
bone, no scaf-
fold for cartilage 
One scaffold for 
both cartilage and 
bone, the geome-
try changes for 
different applica-
tions 
Two different 
scaffolds for 
cartilage and 
bone 
Two different 
scaffolds for carti-
lage and bone 
combined, no 
clear interface 
between the two 
Figure 4. Schematic representations of different scaffold strategies for osteochondral tissue engi-
neering. 
Cartilage 
Bone 
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In  addition  to  the  different  scaffold  strategies  for  osteochondral  tissue  engineering,  there  are  also  
different strategies for loading cells into the scaffold. The scaffolds may be loaded with a single cell 
source that has chondrogenic capacity, with two cell sources that have either chondrogenic or os-
teochenic capacity, with a single cell source that have both chondrogenic and osteochenic differen-
tiation capacity or with no cells (cell-free approach). Furthermore, different cell types such as ar-
ticular chondrocytes, chondrocytes obtained from non-articular cartilage tissues or mesenchymal 
progenitor cells can be applied (Martin et al. 2007). 
4.3 Current approaches to osteochondral tissue engineering 
Though considerable progress has been made, several challenges still remain and so far only a few 
of the approaches developed have effectively found their way into the clinic. For example, the vari-
able geometry of the 3D articular surface should be changeable in the scaffolds, the proportions 
between bone and cartilage thickness should be considered, the micro and nanoscale arrangement of 
cells and ECM should be considered within the tissue and the micromotion at the graft-tissue inter-
face should also be avoided (Panseri et al. 2012). 
Since the possibilities for osteochondral tissue engineering includes either cartilage and bone com-
ponents or a combination of the two, the focus in planning a suitable osteochondral scaffold com-
prises both tissue type scaffolds as well as combined scaffolds, i.e., osteochondral scaffolds. In the 
beginning, single-phase scaffolds served as the standard. Since then, bi-layered, also called biphasic 
scaffolds, have been developed to promote cartilage and bone growth in the individual layers. In 
addition, the importance of an intermediate layer between the cartilage and bone layers has been 
realized, and so-called triphasic scaffolds have been developed as a result. However, it has not been 
demonstrated that the triphasic scaffolds are superior to biphasic scaffolds and, therefore, need fur-
ther investigation (Shimomura et al. 2014). Current osteochondral tissue engineering strategies are 
heading in the direction of gradient scaffold development because such a structure would be similar 
to osteochondral tissue and would establish osteochondral interface formation. However, the opti-
mal fabrication process for graded osteochondral scaffolds has not yet been established and the 
challenge is how to achieve optimal osteochondral interface formation into the scaffold. When it 
comes to product development, a scaffold alone strategy (scaffold with no cells or growth factors) is 
currently being given priority because of regulatory challenges and difficulties (Nukavarapu & 
Dorcemus 2013). 
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4.4 Freeze-dried composites for cartilage, bone and osteochondral ap-
plications 
As the main processing technique discussed in this thesis is freeze-drying, examples of different 
approaches such as cartilage tissue engineering scaffolds, bone tissue engineering scaffolds and 
osteochondral tissue engineering scaffolds manufactured with freeze-drying are subsequently re-
viewed in the next chapters. The focus of these freeze-dried scaffolds is on composite structures as 
many of  the  studied  scaffolds  are  a  combination  of  two or  more  components  because  many times  
the use of only one component structure does not contain all the needed properties such as mechani-
cal strength, optimal scaffold geometry, biomimetic properties, optimal resorption rate or bioactiv-
ity for the studied applications. 
4.4.1 Freeze-dried composites for cartilage tissue engineering 
Cartilage tissue engineering relies mostly on the natural components of the native tissue such as 
collagen and some naturally occurring glycosaminoglycans (GAGs) such as hyaluronic acid (HA) 
or chondroitin sulphate. Also, another natural polymer, chitosan, is used because of its natural 
GAG-like properties (Iwasa et al. 2009). Since many of the freeze-dried scaffolds do not have the 
ability to be used as only one component or one material structure, or without any reinforcement, 
Table 5 summarizes the freeze-dried composite scaffolds for cartilage tissue engineering. As can be 
seen in Table 5, natural polymers, such as collagen, are often combined with synthetic polymer 
components to achieve better mechanical strength for the freeze-dried scaffold. In the case of 
freeze-dried composite systems for cartilage tissue engineering, the constructs are often achieved by 
combining a so-called synthetic polymer skeleton with natural components. The skeleton of syn-
thetic polymer is in these cases often some kind of embedded fibres, textile or embedded solid 
structures (Moutos & Guilak 2008). 
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Table 5. Freeze-dried composite scaffolds for cartilage tissue engineering.  
Used materials Filler Processing method Ref. 
Collagen I + 
PLGAa 
PLGA knitted mesh 
(Vicryl) PLGA knitted mesh and freeze-dried collagen 
(Chen et al. 2003; Chen 
et al. 2004; Dai et al. 
2010) 
Collagen I + 
PLGA PLGA sponge 
Collagen freeze-dried into NaCl-particle leached 
PLGA sponge 
(Chen et al. 2004; Sato 
et al. 2001) 
Collagen I + 
PLGA 
PLGA microbeads 
(Loaded with 
 insulin) 
Freeze-drying of collagen solution with PLGA 
microbeads and ice particulates (as porogen  
material) 
(Nanda et al. 2014) 
Collagen I + 
PLLAb PLLA nanoparticles 
Frreze-drying of collagen solution with PLLA 
nanoparticles 
(Xu et al. 2012; Bian et 
al. 2014) 
Collagen I + 
HAc + chitosan  Freeze-drying of collagen + HA + chitosan solution (Lin et al. 2009) 
Collagen I + HA  Freeze-drying of collagen + HA solution (Tang et al. 2007) 
Collagen II + 
chondroitin 
sulphate + HA 
 
Freeze-drying of collagen solution and  
subsequent immersion of collagen scaffolds into 
chondroitin sulphate and HA solutions with  
cross-linker 
(Ko et al. 2009) 
Collagen II + 
chondroitin 
sulphate 
 Freeze-drying of collagen + chondroitin sulphate solution (Tamaddon et al. 2013) 
Recombinant 
collagen + 
HApd 
Nano-HAp Freeze-drying of collagen + HAp solution (Jia et al. 2013) 
PCLe + HA / 
chitosan 
PCL rapid  
prototyped porous 
structure 
Freeze-drying of HA or chitosan into the PCL 
structure  
(Schagemann et al. 
2010) 
PVAf + PCL + 
gelatin  
Freeze-drying of a foam-like mixture (formed with 
high-speed mixing) of PVA + PCL + gelatine  
solution 
(Karkhaneh et al. 2014) 
PGAg + HA  
PGA scaffolds (BioTissue AG, Zurich,  
Switzerland) immersed with HA and subsequently 
freeze-dried 
(Patrascu et al. 2013) 
Poly(L-glutamic 
acid) + chitosan  
Freeze-drying of poly(L-glutamic acid) + chitosan 
solution (Zhang et al. 2013) 
Silk fibroin + 
collagen /  
gelatin 
 Freeze-drying of silk fibroin, silk-fibroin + collagen or silk-fibroin + gelatin solutions 
(Chomchalao et al. 
2013) 
aPLGA = poly(lactide-co-clycolide), bPLLA = poly(L-lactic acid), cHA = hyaluronic acid, dHAp = hydroxyapatite ePCL = polycaprolactone, fPVA = 
poly(vinyl alcohol), gPGA = polyglycolide 
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4.4.2 Freeze-dried composites for bone tissue engineering 
In bone tissue engineering composites, bioabsorbable and bioactive materials are often combined. 
The combination of bioabsorbable polymers and bioactive ceramics is often applied. As can be seen 
in Table 6, there have been several studies about bone tissue engineering composite scaffolds fabri-
cated by freeze-drying. The mostly studied components for these studied scaffolds are natural 
polymers such as collagen (especially type I, the most common collagen type in bone), chitosan or 
gelatine, together with some bioactive components such as calcium phosphates (CaP), for example, 
HAp or tricalcium phosphate (TCP). Because widely used natural polymers such as collagen and 
chitosan lack the mechanical strength required for load-bearing applications, natural polymer com-
posites with other more mechanically stable components such as CaP or synthetic bioabsorbable 
polymer components are often used for load-bearing applications (Puppi et al. 2010). As can be 
seen in Table 6, the used filler for freeze-dried bone tissue engineering composite scaffolds is most 
often in the form of small particles, powders such as nanoscale HAp or other small particles (< 40 
µm). Synthetic matrices, for example PLA and PLGA, are also combined with BaGs for bone tissue 
engineering. BaGs are thought to buffer the acidic degradation products of the polyesters and pre-
vent catalytic action on the degradation and also the development of adverse tissue reaction. Since 
the hydroxyl carbonate apatite phase on the bioactive ceramic implant is chemically and structurally 
equal to the mineral phase of bone, it provides the interfacial bonding between the implant and the 
surrounding tissue. CaPs such as HAp or TCP and BaGs are considered to be bone bioactive ceram-
ics as they bind the surrounding osseous tissue and enhance bone tissue formation. However, the 
poor mechanical properties of BaGs, low fracture toughness and mechanical strength, especially in 
the case of porous structures, limit their use in load-bearing applications (Puppi et al. 2010).  
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Table 6. Freeze-dried composite scaffolds for bone tissue engineering.  
Used materials Filler Processing method Ref. 
Collagen I + 
HApa 
HAp (nanoparticles 
/ particles or  
powder / whiskers / 
in situ formed 
HAp) 
Freeze-drying of collagen solution and with HAp / 
in situ precipitation of HAp after freeze-drying of 
collagen / freeze-drying of collagen and  
subsequent immersion of the collagen scaffolds into 
HAp solution (and freeze-drying again) 
(Sionkowska & 
Kozáowska 2010;  
Al-Munajjed et al. 2009; 
Ciardelli et al. 2010; 
Cunniffe et al. 2010; 
Shen et al. 2011;  
Hoyer et al. 2012;  
Kane & Roeder 2012) 
Collagen I + 
chitosan / PVAb 
+ HAp 
HAp Freeze-drying of  collagen + chitosan / polyvinyl alcohol solution with HAp (Nitzsche et al. 2010) 
Collagen I + 
PLCLc + HAp HAp 
Freeze-drying of the collagen + PLCL solution with 
HAp and NaCl particles followed by porogen  
leaching 
(Akkouch et al. 2011) 
Collagen I + 
CaPd 
CaP (sodium  
ammonium  
hydrogen  
phosphate: 
NaNH4HPO4 and 
calcium chloride: 
CaCl2) 
Freeze-drying of collagen solution and subsequent 
immersion of the collagen scaffolds into 
NaNH4HPO4 and CaCl2 solutions to form CaP  
coating 
(Al-Munajjed &  
O'Brien 2009) 
Collagen I +  
BaGe (+ PSf)  / 
TCPg 
BaG  / TCP Freeze-drying of collagen (+PS) solution with BaG / TCP (Oprita et al. 2008) 
Collagen I / 
PGAh PGA non-woven 
Freeze-drying of collagen solution into PGA  
non-woven 
(Hosseinkhani et al. 
2006) 
Collagen I + 
BPCi + HCA j 
BCP (HAp and 
TCP particles) 
Sintered BCP scaffold immersed in collagen  
solution and freeze-dried. Subsequently the  
scaffolds were biomineralized in vitro with  
supersaturated calsification solution (SCS) 
(Yang et al. 2005) 
Collagen I + 
HAk + PS + 
BaG 
BaG Freeze-drying of collagen + HA + PS solution with BaG particles 
(Wang et al. 2006;  
Xie et al. 2008) 
Chitosan + HAp 
(+ nano-silver) HAp 
Freeze-drying of chitosan solution with HAp (and 
subsequently soaking the scaffolds in aqueous silver 
nitrate solution to enrich the scaffold surface with 
silver) 
(Zhang et al. 2012) 
Chitosan + 
CMCl / collagen 
+ HAp 
HAp Freeze-drying of chitosan + CMC /collagen solution with HAp 
(Jiang et al. 2008; 
Liuyun et al. 2009)  
Chitosan + 
carbon nanotube 
(+ HAp) 
Carbonnanotubes 
(+ HAp) 
Freeze-drying of chitosan solution with carbon 
nanotubes (+HAp) (Venkatesan et al. 2012) 
Chitosan + HAp 
+ nano-copper-
zinc /  
amylopectin / 
chondroitin 
sulphate 
HAp + Cu-Zn alloy 
nanoparticles / 
amylopectin / 
chondroitin  
sulphate 
Freeze-drying of chitosan solution with HAp + 
nano-copper-sinc / amylopectin / chondroitin  
sulphate 
(Tripathi et al. 2012) 
Chitosan + 
alginate + HAp  
Freeze-drying of chitosan + alginate solution and in 
situ co-precipitation of HAp (with H3PO4 and 
Ca(OH) 2) 
(Jin et al. 2012) 
Chitosan  
(+ gelatine) + 
BaG / TCP 
BaG  / TCP Freeze-drying of chitosan (+gelatine) solution with BaG  / TCP particles (Zhang & Zhang 2001) 
Chitosan + CaP HAp+TCP  macroporous block 
Freeze-drying of chitosan solution inside the 
macroporous CaP block 
(Zhang & Zhang 2002; 
Zhang et al. 2003) 
Chitosan + 
silica + zirconia 
Silicon dioxide and 
zirconia 
Freeze-drying of chitosan solution with silicon 
dioxide and zirconia powders (Pattnaik et al. 2011) 
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Table 6 continues.   
Used materials Filler Processing method Ref. 
Chitosan + CaP CaP Freeze-drying of chitosan solution with CaP  precursor (CaCl2 and NaH2PO4) 
(Tanase et al. 2011) 
Chitosan + 
carbonate  
apatite 
Carbonate apatite 
particles 
Freeze-drying of chitosan solution with carbonate 
apatite particles after thermal drying (Shen et al. 2007) 
Chitosan + 
PLGA + HAp HAp powder 
Freeze-drying of chitosan + HAp solution and  
subsequently adding PLGA on the scaffolds and 
freeze-dried 
(Endogan Tanir et al. 
2014) 
Chitosan + 
collagen + PVA 
+ BaG 
PVA + BaG  
composite powder 
Freeze-thawing + freeze-drying of chitosan +  
collagen solution with PVA + BaG composite  
powder 
(Pon-On et al. 2014) 
Chitin +  
gelatine + HAp HAp 
Freeze-drying of carboxymethyl chitin + gelatine 
solution with nano-HAp (Sagar et al. 2012) 
Chitin +  
chitosan + 
TiO2m 
TiO2 nanoneedles 
Freeze-drying of chitin + chitosan solution with 
TiO2-nanoneedles 
(Jayakumar et al. 2011) 
Chitin + HAp HAp Freeze-drying of chitin solution with HAp (Kumar et al. 2011) 
Gelatin (+  gel-
lan gum)  + 
HAp 
HAp Freeze-drying of gelatine (+ gellan gum) solution with HAp (Kim et al. 2005) 
Gelatin + TCP / 
HAp + fibrin + 
rhBMP-2n / 
montmorillonite 
+ cellulose 
TCP / HAp + 
rhBMP-2 +  
fibrin glue /  
montmorillonite 
Freeze-drying of gelatine solution with TCP / HAp 
+ rhBMP-2 + fibrin / montmorillonite particles (Panzavolta et al. 2009) 
Gelatin + HAp HAp Freeze-drying of gelatine + HAp solution (Panzavolta et al. 2013) 
Gelatin + HA + 
alginate  Freeze-drying of gelatine + HA + alginate solution (Singh et al. 2014) 
CaP + silk CaP + silk Freeze-drying of silk water solution with CaP + silk powder (Zhang et al. 2010) 
Carboxy methyl 
cellulose + HAp HAp powder 
Freeze-drying of carboxy methyl cellulose,  
immersing of scaffolds into HAp solution and 
freeze-drying 
(Pasqui et al. 2014) 
PLGAo + HAp HAp Freeze-drying of PLGA solution with HAp and salt particles followed by dissolution of the salt particles 
(Aboudzadeh et al. 
2010) 
PLGA + HAp + 
rhBMP-2 / 
PDLLAp + BaG 
/ pHEMAq + 
HAp / PLGA + 
BaG / PHBVr + 
HAp 
HAp / BaG, 
rhBMP-2 
Freeze-drying of polymer solution with HAp / BaG 
(and rhBMP-2) (Miki et al. 2000) 
aHAp = hydroxyapatite, bPVA = polyvinyl alcohol, cPLCL =  poly(lactide-co-caprolactone), dCaP = calsium phosphate, eBaG = bioactive glass, fPS = 
phosphatidylserine gTCP = tricalcium phosphate, hPGA = polyglycolide, iBPC = biphasic calcium phosphate, jHCA = hydroxyl-carbonate-apatite, 
kHA = hyaluronic acid, lCMC = carboxymethyl cellulose, mTiO2 = titanium oxide nrhBMP-2 = recombinant human bone morphogenetic protein, 
oPLGA = poly(lactide-co-clycolide), pPDLLA = poly(D,L)lactide, qpHEMA = poly(2-hydroxyethyl methacrylate), rPHBV = poly(hydroxybutyrate-
co-hydroxyvalerate)
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4.4.3 Freeze-dried composites for osteochondral tissue engineering 
The complexity of osteochondral lesions also affects the osteochondral tissue engineering scaffold 
geometry. The unique structure of the combined tissues, bone and cartilage, as well as the propor-
tions of bone and cartilage thickness makes it difficult to define the optimal osteochondral scaffold 
geometry (Panseri et al. 2012). Different freeze-dried composite scaffolds studied for osteochondral 
tissue engineering are listed in Table 7. The scaffolds used for osteochondral tissue engineering can 
roughly be divided into two categories: one component scaffold for both regions and two different 
components for cartilage and bone tissues. The one component scaffolds can also be divided into 
scaffolds with homogenous regions and scaffolds with heterogeneous regions (Martin et al. 2007). 
As Table 7 indicates, a variety of different freeze-dried scaffolds have been studied for osteo-
chondral tissue engineering as the components used and the scaffold geometry vary a lot. Even 
though, no clear trend in Table 7 exists for manufacturing the different layers for osteochondral 
scaffolds, collagen, the main component in both tissues, seems to be the most studied material for 
the application. However, the trend in osteochondral tissue engineering seems to be towards bi-
layered scaffolds and a gradient scaffold structure. More and more freeze-dried osteochondral com-
posite scaffolds have been developed during the past few years. Therefore, it can be concluded that 
freeze-drying has been found to be an applicable way to produce different kinds of multilayered 
scaffolds for tissue engineering of osteochondral lesions. 
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Table 7. Freeze-dried composite scaffolds for osteochondral tissue engineering.  
Used materials Filler Processing method Ref. 
Collagen I + 
GAGa  
(chondroitin 
sulfate) 
Calsium salts (CaP, 
calciumhydroxide)  
Freeze-drying of collagen + GAG-solution with 
calcium salts in a solution of phosphoric acid (Harley et al. 2010b) 
Collagen I / 
collagen II + 
GAG  
(chondroitin 
sulfate) 
Different collagen 
type I or II + GAG 
solutions in different 
layers 
Freeze-drying of collagen type I + GAG and  
collagen type II + GAG-solutions sequentially in 
one mould 
(Harley et al. 2010a) 
Collagen I + 
HApb 
Different blend ratios 
of collagen + HAp in 
different layers 
Combining the different blend layers on top of a 
Mylar sheet and finally freeze-drying (Kon et al. 2010) 
Collagen I + 
HAp HAp paste 
Freeze-drying of collagen or collagen + HAp 
solutions for two different scaffolds to be combined 
for two layered scaffold 
(Zhou et al. 2011) 
Collagen I + 
collagen II + 
HAp + HAc 
HAp powder 
Combining of different layers with step-by-step 
freeze-drying. Bone layer: Collagen I + HAp.  
Intermediate layer: Collagen I + collagen II + HAp. 
Cartilage layer: Collagen I + collagen II + HA 
(Levingstone et al. 
2014) 
Collagen I + 
PLGAd 
PLGA knitted mesh 
(Vicryl) PLGA knitted mesh and freeze-dried collagen (Chen et al. 2006) 
Collagen + CaPe 
Calsium phosphate 
formation onto the 
collagen matrix 
Freeze-dried collagen soaked in calcium solution 
for CaP crystallisation onto the collagen matrix 
(Yaylaoglu et al. 
1999) 
Collagen II + 
chitosan + PCLf  
Layered scaffolds with different ratios of  
components in layers. Chitosan-PCL copolymers 
blended with collagen II manufactured with  
combinatorial processing of adjustable temperature 
gradients, collimated photothermal heating and 
freeze-drying 
(Zhu et al. 2014) 
Chitosan + 
gelatine / 
chitosan +  
gelatine + HAp 
HAp powder, TGF-ɴg 
and BMP-2h 
Freeze-drying of chitosan + gelatine solution and 
subsequently loaded with TGF-ȕ for cartilage layer. 
Freeze-drying of chitosan + gelatine + HAp and 
subsequently loaded with BMP-2 for bone layer 
(Chen et al. 2011) 
BaGi + chitosan 
/ alginate / gela-
tine or sucrose 
Electrospun chitosan 
membranes, BaG 
(Bioglass®)-based 
substrate  
Bottom layer: BaG substrate fabricated by foam 
replica dipped into chitosan or alginate or gelatine 
or sucrose and freeze-dried. Top layer: electrospun 
chitosan 
(Liverani et al. 2012) 
BaG + chitosan 
+ PCL 
BaG (Bioglass®) 
scaffold manufac-
tured by foam-
replication method 
Porous BaG scaffolds immersed into chitosan + 
PCL solution and freeze-dried. Second layer  
manufactured by applying chitosan + PCL solution 
on top of BaG scaffold and freeze-dried  
(Yao et al. 2014) 
Gelatin + BaG 
BaG (bioresorbable 
phosphate glass) 
particles 
Freeze-drying of gelatine solution with BaG  
particles (Gentile et al. 2012b) 
PLLAj + ACPk ACP powder  (+ bFGFl) 
Freeze-drying of PLLA solution with ACP powder 
and subsequently impregnating the scaffolds in 
PBS+bFGF  
(Huang et al. 2007) 
aGAG = glycosaminoglycan, bHAp= hydroxyapatite, cHA = hyaluronic acid, dPLGA = poly(lactide-co-clycolide), eCaP = calsium phosphate, fPCL = 
polycaprolactone, gTGF-ȕ = transforming growth factor- ȕ hBMP-2 = bone morphogenic protein-2 iBaG =  bioactive glass, jPLLA = poly(L-lactic 
acid), kACP = amorphous calcium phosphate, lbFGF = fibroblast growth factor
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5 Aims of the study 
The primary aim of this thesis was to find optimal ways to manufacture cartilage and osteochondral 
tissue engineering scaffolds using freeze-drying. To overcome the high demands of osteochondral 
lesions, two types of scaffolds are studied based to the origin of the polymer applied. The studied 
natural polymer-based scaffolds are aimed for cartilage tissue engineering and synthetic polymer-
based scaffolds for bone or osteochondral tissue engineering. Therefore, the more detailed aims of 
the current study are divided into two categories: aims of the natural polymer-based scaffolds and 
aims of the synthetic polymer-based scaffolds.  
The aims of the thesis were to find answers to the following questions:  
 
Natural polymer-based scaffolds for cartilage tissue engineering: 
1. How to manufacture freeze-dried collagen scaffolds and what is the best way to cross-link 
freeze-dried collagen scaffolds? (Publication I) 
2. Does the blending of collagen with chitosan improve the properties of freeze-dried collagen 
scaffolds? (Publication IV) 
3. Does PLA fibre-reinforcement improve the properties of freeze-dried natural polymer-based 
scaffolds? (Publication IV) 
4. Are the manufactured natural polymer-based scaffolds suitable for cell seeding? (Publication 
IV) 
 
Synthetic polymer-based scaffolds for bone or osteochondral tissue engineering: 
1. How to manufacture freeze-dried synthetic polymer-based scaffolds? (Publications II, III, V) 
2. Is there a difference between the used filler particles, TCPp and BGp, or between the filler 
particle concentrations in PLA70 composites? (Publications II, III) 
3. Do BG fibres improve the properties of PLGA scaffolds? (Publication V) 
4. Are the manufactured synthetic polymer-based composite scaffolds suitable for cell seeding? 
(Publication II) 
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6 Materials and methods 
6.1 Materials 
The materials, reagents and their suppliers used in this work are presented in Table 8. The used col-
lagens (COLI) were pepsin-solubilized bovine dermal collagens dissolved in 0.01 M HCl with col-
lagen concentration of 3.0 mg/ml. The collagen supplier and the product name of the used collagen 
changed by the time the second batch of collagen was purchased, although the product remained the 
same. The commercial synthetic polymers Poly(L/D,L)lactide 70/30 (PLA 70) and Poly(L/D)lactide 
96/4 (PLA 96) were both medical grade, highly purified polymers with a residual monomer content 
of <0.5%. The Poly(D,L-lactide-co-glycolide) 70/30 (PLGA1 and PLGA2) with a rac-lactide-to-
glycolide ratio of 70:30 were synthesized by ring-opening polymerization. The bioactive glass fi-
bres (BGf1 and BGf2 in Table 8) were glass fibres coated with polycaprolactone (PCL). 
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Table 8. The used materials and reagents, and their suppliers. 
Material/Reagent Supplier Publication 
Natural polymers   
Bovine dermal Collagen type I* (COLI) 
VITROGEN® (3.0 mg/ml in 0.01 M HCl) 
Nutagon B V, The Netherlands I 
Bovine dermal Collagen type I* (COLI) 
PureCol™ (3.0 mg/ml in 0.01 M HCl) 
Nutagon B V, The Netherlands I, IV 
Medical grade chitosan (CHI) 
Protasan UP B 90/500 (deasetylation degree of 90%,  
molecular weight of 460,000 g/mol) 
FMC Biopolymer d/b/a      
NovaMatrix, Norway 
IV 
Synthetic polymers   
Poly(L/D,L)lactide 70/30 (PLA 70) 
(inherent viscosity of 3.1 dl/g) 
PURAC Biochem B V, The 
Netherlands 
II, III 
Poly(L/D)lactide 96/4 (PLA 96) 
(inherent viscosity of 2.2 dl/g) 
PURAC Biochem B V, The 
Netherlands 
IV 
Poly(D,L-lactide-co-glycolide) 70/30 (PLGA1) 
(molecular weight of 76 300 g/mol) 
Åbo Akademi, Finland V 
Poly(D,L-lactide-co-glycolide) 70/30 (PLGA2) 
(molecular weight of 48 300 g/mol) 
Åbo Akademi, Finland V 
Bioceramics and bioactive glasses   
ȕ-TCP (TCP) 
Beta Whitlockite  (porous particles size of 75–106 µm) 
Plasma Biotal Ltd, UK III 
Bioactive glass (BG) 
BaG0127 (5%  Na2O, 7.5% K2O, 3% MgO, 25% CaO and  
59.5% SiO2, particle size of 75–125 µm) 
Åbo Akademi, Finland II 
Bioactive glass (BGf1) 
(11.9% Na2O, 13.3% CaO, 4.4% MgO, 0.3% Al2O3, 0.9% B2O3,  
0.6% P2O5 and 68.7% SiO2, fibre diameter of 13 µm) 
Vivoxid Ltd., Finland V 
Bioactive glass (BGf2) 
(12.5% Na2O, 9.3% CaO, 7.2% MgO, 1.8% B2O3, 0.6% P2O5  
and 68.6% SiO2, fibre diameter of 13 µm) 
Vivoxid Ltd., Finland V 
Reagents   
1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride 
(EDC) 
Sigma-Aldrich, Finland I 
N-Hydroxysuccinimide (NHS) Sigma-Aldrich, Finland IV 
1,4-dioxane Sigma-Aldrich, Finland II, III 
* Same product, the supplier and the name of the product had changed when purchasing the second batch 
6.2 Methods 
6.2.1 Fabrication of freeze-dried scaffolds 
Fabrication of plain and blend solutions of natural polymers (I, IV) 
Collagen fibril formation was carried out using the method previously described by Williams et al. 
1978 (Williams et al. 1978) with some modifications. The collagen-HCl solution was mixed with 
fibrillogenesis buffer (0.2M NaH2PO4, pH 11.2) at a ratio of 1:10. The pH of the solution was ad-
justed to 7.20 and the solution was incubated at room temperature (RT) for 6 h. The cross-linker, 
EDC, was added into the solution, if used prior to freeze-drying. This was followed by incubation 
of the collagen solution at RT overnight. The collagen solution manufactured had an initial concen-
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tration of 0.3 wt%. Higher collagen concentrations were achieved by centrifuging and then concen-
trating the solution. Using this method, concentrations from 0.5 to 2.0 wt% were achieved. The chi-
tosan solution was manufactured by dissolving the chitosan in an acetic acid solution at a ratio of 
1:1 (w/v) with chitosan concentrations of 0.5 or 1.0 wt%. For collagen-chitosan blends, the initial 
collagen and chitosan solutions were mixed at ratios of 1:1 or 2:1 (v/v), respectively. 
Fabrication of synthetic polymer solutions (II, III, V) 
PLA solutions were manufactured by dissolving the polymer in 1,4-dioxane. The solutions were 
stirred vigorously overnight to form a uniform slurry. The used polymer concentrations were 2.0 or 
3.0 wt%, for PLA70 and 3.0 or 5.0 wt% for PLGA1 and PLGA2. 
Fabrication of polylactide and bioactive glass mesh (IV, V) 
The PLA96 was melt-spun into multi-filament fibres (16-ply, with the average diameter of a single 
fibre ~20 µm) using a Gimac microextruder (Gimac, Gastronno, Italy) with a screw diameter of 12 
mm.  The  bioactive  glass  fibres,  BGf1  and  BGf2  (with  a  diameter  of  a  single  fibre  13  µm),  were  
used as received. To manufacture the carded mesh, PLA96, BGf1 or BGf2 fibres were cut into sta-
ple fibres at a length of ~10 cm and carded into mesh manually by feeding a standard number of 
fibres to the drum carder (Louët Elite Drum Carder, Louët, The Netherlands). 
Fabrication of different scaffold types (I-V) 
The abbreviations used for the different scaffold types, the materials used (matrix and filler) and the 
number of components, possible cross-linking method and the related publications are listed in the 
table presented in Abbreviations. A more detailed table with the different scaffold types, the materi-
als used (matrix and filler) and the number of components, cross-linking method, the type of mould 
used in the processing (the material used for the mould and the size of the mould), possible steriliza-
tion method, abbreviations for the different scaffold types, as well as the related publications are 
presented in Appendix I.  
All of the scaffolds were manufactured by freeze-drying the manufactured solutions by freezing at 
-30 °C for 24 h prior to freeze-drying for 24 h. Schematic diagrams of the fabrication process of 
natural polymer-based scaffolds as well as the synthetic polymer-based scaffolds are presented in 
Appendix II.  
For scaffolds containing collagen (Publications I and IV), EDC or EDC+NHS cross-linking was 
performed to  improve  the  stability  of  the  scaffolds.  When cross-linked  with  EDC prior  to  freeze-
drying, the cross-linker was added into the collagen solution after the first incubation at RT for 6 h 
and followed by incubation at RT overnight. When cross-linked post freeze-drying, the freeze-dried 
scaffolds  were  immersed  in  95% ethanol  either  with  1  mM or  10  mM EDC,  or  14  mM EDC + 6  
mM NHS in the solution. In the case of the 1 mM or 10 mM EDC solution, the incubation time for 
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cross-linking was 24 h at RT. With the 14 mM EDC + 6 mM NHS solution, the incubation time was 
4 h at RT. After cross-linking, the scaffolds were withdrawn from the cross-linking solution and 
carefully washed several times with deionized water and freeze-dried again using the same freezing 
method at -30 °C for 24 h prior to freeze-drying for 24 h. 
To stabilize the structure of the plain chitosan scaffolds (Publication IV), the freeze-dried scaffolds 
were neutralized with 99.5% and 70% ethanol steps for 30 minutes in each. After that, the chitosan 
scaffolds were washed several times with deionized water and freeze-dried again, as described ear-
lier.  
All of the manufactured scaffolds were held under vacuum at RT for a minimum of 48 h prior to 
any characterization or sterilization of the synthetic polymer-based scaffolds with 25 kGy gamma 
irradiation.  
The structure of the natural polymer-based hybrids, collagen+PLA96, chitosan+PLA96 and colla-
gen+chitosan+PLA96 (Publication IV) was a so-called sandwich structure with the PLA96 fibrous 
mesh laid at the bottom and at the top of the scaffold. In the PLA70+TCP or PLA70+BG compos-
ites (Publications II and III), the structure of the scaffolds was heterogeneous with the filler particles 
at the bottom of the scaffold structure. The structure in the PLGA1/BGf1 and PLGA2/BGf2 com-
posites (Publication V) was homogenous with BG fibrous mesh acting as a skeleton inside the 
polymer matrix.   
6.2.2 Scaffold microstructure analysis (I-V) 
Scanning electron microscopy (SEM) was used to characterize the microstructure of the scaffolds. 
SEM imaging with a JEOL T100 scanning electron microscope (JEOL Ltd, Tokyo, Japan) was per-
formed for scaffolds sputtered with gold prior to analysis (Publications I and V). SEM imaging with 
an FEI Quanta 250 Field Emission Gun (Electron Microscope Unit, Institute of Biotechnology, Hel-
sinki, Finland) was performed for platinum coated scaffolds (Publication IV). An environmental 
scanning electron microscopy (ESEM; Philips XL30 ESEM-TMP, Amsterdam, The Netherlands) 
was used to study the microstructure of the scaffolds in wet conditions (Publications II and III) as 
well as the cell morphology (Publication II). Pore sizes were determined from the SEM images us-
ing Image J software. 
MicroCT  analysis  to  study  the  microstructure  of  the  scaffolds  was  carried  out  with  two  different  
pieces  of  equipment:  a  MicroCT  scanner  (SkyScan  1172,  SkyScan,  Kontich,  Belgium)  with  tube  
voltage and voxel size of 40 kV and 30.2 × 30.2 × 30.2 µm3, respectively (Publication IV), or with 
MicroXCT-400 (Carl Zeiss X-ray Microscopy, Inc., Pleasanton, USA) with tube voltage and voxel 
size of 40 kV and 2.2 × 2.2 × 2.2 µm3, respectively (Publication V). A Fiji (Schindelin et al. 2012) 
with a BoneJ (Doube et al. 2010) plugin was used to determine the pore structure of the scaffolds 
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(porosity, pore size, material thickness and pore size distribution). No filters were used in the mi-
croCT analyses. 
6.2.3 Contact angle measurements (V) 
The contact angle (CA) of the dry scaffolds was examined with a Theta optical tensiometer (Biolin 
Scientific, Västra Frölunda, Sweden) device (Publication V). The measurements were done with 
deionized water, phosphate buffered saline solution (PBS) and with bovine blood (commercially 
available) (n=6).  
6.2.4 In vitro studies (III, V) 
In vitro hydrolytic degradation of synthetic polymer-based scaffolds was conducted in PBS, pre-
pared as described by Shah et al. 1992 (Shah et al. 1992), with standard volume (according to Inter-
national Standard, ISO 15814, 1999 (Implants for surgery - copolymers and blends based on poly-
lactide - in vitro degradation testing 1999)) of 10 ml. The pH of the hydrolysis solution was meas-
ured weekly using a Mettler Toledo MP225 pH meter (Mettler-Toledo GmbH, Schwerzenbach, 
Switzerland). The buffer solution was changed fortnightly or weekly if its pH exceeded the given 
limits (7.35–7.45). The degradation studies were timed at weeks 0, 2, 4, 8, 16 and 26 for plain 
PLA70 and PLA70+TCP scaffolds (Publication III), and at weeks 0, 2, 4, 6, 8 and 10 for plain 
PLGA and PLGA+BGf scaffolds (Publication V). Samples each half the size of the original freeze-
dried scaffolds were used (n=6) with an initial sample weight of approximately 5 mg or 15 mg for 
PLA70 and PLGA-based samples, respectively. 
6.2.5 Weight change (I, III, IV, V) 
The weight  change  of  scaffolds  during  hydrolysis  (Publications  III  and  V)  was  determined  by  the  
following Equation 1: 
Weight change (%) = [(We–Wb)/Wb] × 100%,     (1) 
where We is the measured weight after immersion in PBS (wet or dry, depending if measuring the 
water intake or the overall weight change) and Wb is  the  initial  dry  weight  of  the  scaffold.  When 
determining the weight change during hydrolysis, the scaffolds were rinsed with deionized water 
and gently dried with tissue paper, dried in a fume hood for 2 days, and then one week in a vacuum 
at RT before the dry weighing. 
The ability of the natural polymer-based scaffolds to bind water was determined by using the same 
equation of weight change. The scaffolds were immersed in PBS in a volume of 3 ml for 1 h at RT 
(Publication I, n=2) or in 5 ml for 24 h at 37 °C (Publication IV, n=6).  The overall ability of the 
scaffold to bind water (the material itself with the pore system) was measured by removing the scaf-
fold from the PBS without dripping (Publications I and IV). Also, the ability of the scaffold itself 
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(no excess water inside the pore system) to bind water was measured after drying the scaffolds be-
tween filter papers to remove the water inside the pore system of the scaffold (Publication IV).  
6.2.6 Thermal properties (I, III, V) 
A differential scanning calorimeter (DSC, Q1000, TA Instruments, New Castle, DE, USA) was 
used to determine the collagen denaturation temperatures (Td) in order to evaluate the efficiency and 
extent of collagen (Publication I). The Td values were evaluated as a maximum value of an endo-
thermic peak, while heating the sample from 5 to 140 °C with a heating rate of 20 °C/min. The sam-
ple size used was approximately 1–2 mg. For synthetic polymer-based scaffolds, a DSC was used to 
determine the glass transition temperature (Tg) (Publication V). The results are from the second 
heating scan using the following procedure: heat to 200 °C, 20 °C/min, cool to 0 °C, 50 °C/min, and 
heat to 200 °C, 20 °C/min. The sample size used was approximately 5 mg. All samples were meas-
ured in standard aluminium pans under a dry N2 atmosphere (n=2). 
Thermogravimetric  analysis  (TGA) with  a  Q500 (TA Instruments,  New Castle,  DE,  USA)  device  
was used for analytic measurement of the component ratios of synthetic polymer and inorganic 
filler in the composite scaffolds. The method used was Hi-Res-Dynamic and samples were heated 
to 640 °C (Publication III) or to 800 °C (Publication V). The sample size was approximately 2 mg 
(Publication III) or 10 mg (Publication V) (n=2). 
6.2.7 Inherent viscosity measurements (III) 
The inherent viscosity (i.v.) of the synthetic polymer-based scaffolds was measured with a Lauda 
PVS viscometer (Lauda DR. R. Wobster GmbH, KG, Königshofen, Germany) (Publication III). 
Samples were prepared by dissolving the polymer in 1 mg/ml chloroform. An Ubbelohde capillary 
viscometer type 0c (Schott-Geräte, Mainz, Germany) was used to determine the viscosity. Viscosity 
measurements were run for plain polymer scaffolds (n=2). 
6.2.8 Gel permeation chromatography (V) 
The determination of the molecular weight of the polymer component in synthetic polymer-based 
scaffolds (Publication V) was performed using gel permeation chromatography (GPC). The meas-
urements were carried out with an LC-10ATVP HPLC-pump (Shimadzu Corporation, Kyoto, Ja-
pan),  an  AM GPC Gel  10  µm Linear  colon  (Mentor,  Ohio,  USA)  and  a  Sedex  85  light  scattering  
detector (Sedere SA, Alfortville, France) at 40 °C at a flow rate of 1 ml/min using tetrahydrofuran 
as a solvent. Polystyrene standards from Polymer Standard Service were used for calibration. The 
samples were filtered with 0.22 µm polytetrafluoroethylene (PTFE) filters before analysis. The 
GPC analysis was conducted as an average of parallel samples, as the remaining average mass of 
the studied scaffolds was too low for individual parallel measurements.  
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6.2.9 Compression testing (IV) 
Compression tests for dry and wet natural polymer-based scaffolds (Publication IV) were done with 
Loyd LR30K mechanical tester (Loyd Instruments Ltd, Hampshire, UK). To test wet scaffolds, the 
scaffolds were immersed in PBS for 24 h at 37 °C. Scaffolds were compressed at a rate of 0.5 
mm/min and a cell load of 1 kN. The corresponding compressive modulus was determined from the 
linear  elastic  region  (from  7  to  9%  strain),  and  the  compressive  stiffness  values  were  determined  
(n=6). 
6.2.10 Cell studies (II, IV) 
The viability, distribution, proliferation, and osteogenic differentiation of adipose stem cells (ASCs) 
were studied with synthetic polymer-based scaffolds (Publication II). The study was conducted in 
collaboration with Regea Institute for Regenerative Medicine (currently Regea Cell and Tissue Cen-
ter, University of Tampere / BioMediTech, Tampere, Finland) in accordance with the Ethics Com-
mittee of the Pirkanmaa Hospital District, Tampere, Finland. The ASCs were isolated from adipose 
tissue  samples  taken  from  six  donors  (mean  age  =  44  ±  7  years)  and  the  tissue  samples  were  re-
ceived from the Department of Gastroenterology and Alimentary Tract Surgery, Tampere Univer-
sity Hospital. The adipose tissue was digested with collagenase type I (1.5 mg/ml; Invitrogen, Pais-
ley, UK), and the ASCs were expanded in T-75 polystyrene flasks. After the primary culture in T-
75 flasks, the ASCs were harvested and analyzed by a fluorescence-activated cell sorter (FACSAria; 
BD Biosciences, Erembodegem, Belgium). Three to four patient samples were pooled together for 
each experiment to yield enough cells. The scaffolds were pretreated with maintenance medium for 
48 h at 37 °C.  The bottom surface of the scaffolds was seeded with 350 000 cells in a 0.175 ml 
drop,  and  the  cells  were  allowed to  attach  to  the  scaffolds  for  3  h  at  37  °C in 5% carbon dioxide 
before additional medium was added. Cell seeding for up to two weeks was performed. Cell at-
tachment and viability were studied by Live/Dead staining. Cell morphology was evaluated with 
ESEM, and cell proliferation and quantitative analysis of alkaline phosphatase (ALP) activity was 
measured.  Statistical  analysis  was  performed  with  SPSS,  version  13.  The  experiments  were  re-
peated three times. 
The viability and attachment of adult bovine chondrocytes were studied with the natural polymer-
based scaffolds (Publication IV). These cell studies were conducted in collaboration with the De-
partment of Orthopaedics and Traumatology, University of Helsinki and Helsinki University Cen-
tral Hospital, Helsinki, Finland. One million adult bovine primary chondrocytes isolated from the 
femoral condyle of the knee of 5–6 month-old male cows (Bos Taurus) were seeded into the 0.5 
cm2 scaffold by pipetting. First, 50 µl of cell culture medium containing 500 000 cells were pipetted 
on top of the scaffold. After 5 min of incubation at RT, the scaffolds were turned around and anoth-
er 50 µl of cell culture medium containing 500 000 cells were pipetted on the other side of the scaf-
fold. The scaffolds were cultured in the common proliferation medium DMEM/F12 (21331-020 
Gibco, Invitrogen, USA) at 37 °C in 5% CO2 for up to one week. The chondrocytes were fixed and 
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imaged at the Light Microscope Unit, Institute of Biotechnology, Helsinki with a Leica TCS SP5II 
HCS A confocal microscope using 10x or 20x air objectives. For the imaging of the cross-section, 
the  scaffolds  were  cut  in  half  with  a  scalpel  and  the  cross-section  was  imaged  at  an  approximate  
depth of 150 µm.  
6.2.11 Statistical analysis (II, V) 
Majority of the data are presented as mean ± standard deviation. In Publication II, the effects on the 
DNA content and ALP activity between the TCP and BG composite material were compared using 
a one-way ANOVA, after checking for normal distribution and homogeneity of variance. Post hoc 
tests were performed to detect significant differences between groups. The significance level of p < 
0.05 was considered significant. In Publication V the contact angle data was analysed with the 
Mann-Whitney test. The significance level of p 0.05 was used. 
Table 9 lists all the characterization methods for different freeze-dried natural and synthetic poly-
mer-based scaffolds as well as the related publications.  
Table 9. Characterization methods applied for different freeze-dried natural and synthetic polymer-
based scaffolds. 
Scaffold 
Characterization method 
Publication SEM/ 
ESEM/ 
µCT 
CA In vitro 
Weight 
change 
DSC/ 
TGA i.v. GPC 
Compression 
testing 
Cell 
studies 
Natural polymer-based scaffolds 
Col0.3NoE SEM - - Yes DSC - - - - I 
Col0.3(E) SEM - - Yes DSC - - - - I 
Col0.3E SEM - - Yes DSC - - - - I 
Col0.5NoE SEM - - Yes DSC - - - - I 
Col0.5(E) SEM - - Yes DSC - - - - I 
Col0.5E SEM - - Yes DSC - - - - I 
Col1.0NoE SEM/µCT - - Yes DSC - - Yes Yes I 
Col1.0(E) SEM - - Yes DSC - - - - I 
Col1.0E SEM - - Yes DSC - - - - I 
Col SEM/µCT - - Yes - - - Yes Yes IV 
Col2.0NoE SEM - - Yes DSC - - - - I 
Col2.0(E) SEM - - Yes DSC - - - - I 
Col2.0E SEM/µCT - - Yes DSC - - - - I 
Chi SEM/µCT - - Yes - - - Yes Yes IV 
C1C1 SEM/µCT - - Yes - - - Yes Yes IV 
C2C1 SEM/µCT - - Yes - - - Yes Yes IV 
ColPLA SEM/µCT - - Yes - - - Yes Yes IV 
ChiPLA SEM/µCT - - Yes - - - Yes Yes IV 
C1C1PLA SEM/µCT - - Yes - - - Yes Yes IV 
C2C1PLA SEM/µCT - - Yes - - - Yes Yes IV 
Synthetic polymer-based scaffolds 
PLA2 ESEM - Yes Yes TGA Yes - - Yes II, III 
PLA3 ESEM - Yes Yes TGA Yes - - - III 
PLA2TCP5 ESEM - Yes Yes TGA Yes - - - III 
PLA2TCP10 ESEM - Yes Yes TGA Yes - - Yes II, III 
PLA2TCP20 ESEM - Yes Yes TGA Yes - - Yes II, III 
PLA3TCP5 ESEM - Yes Yes TGA Yes - - - III 
PLA3TCP10 ESEM - Yes Yes TGA Yes - - - III 
PLA3TCP20 ESEM - Yes Yes TGA Yes - - - III 
PLA2BG10 ESEM - - - - - - - Yes II 
PLA2BG20 ESEM - - - - - - - Yes II 
PLGA1 SEM/µCT Yes Yes Yes DSC/TGA - GPC - - V 
PLGA2 SEM/µCT Yes Yes Yes DSC/TGA - GPC - - V 
PLGA1BG1 SEM/µCT Yes Yes Yes DSC/TGA - GPC - - V 
PLGA2BG2 SEM/µCT Yes Yes Yes DSC/TGA - GPC - - V 
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7 Results 
The study was divided into natural polymer-based freeze-dried scaffolds aimed for cartilage tissue 
engineering and synthetic polymer based freeze-dried scaffolds aimed for bone or osteochondral 
tissue  engineering.  The  different  scaffold  types  studied  are  shown in  Table  10.  The  more  specific  
material compositions and characteristic of the scaffolds are shown in Appendix I and the schematic 
diagrams of the fabrication processes of the different scaffolds are shown in Appendix II. 
Table 10. The different scaffold types and their compositions. 
Scaffold type Scaffold composition Publication 
Natural polymer-based scaffolds 
Collagen Freeze-dried collagen scaffold I, IV 
Chitosan Freeze-dried chitosan scaffold IV 
Collagen+Chitosan Freeze-dried collagen+chitosan blend scaffold IV 
Collagen+PLA96 Freeze-dried collagen scaffold with PLA96 mesh IV 
Chitosan+PLA96 Freeze-dried chitosan scaffold with PLA96 mesh IV 
Collagen+Chitosan+PLA96 Freeze-dried collagen+chitosan blend scaffold with PLA96 
mesh 
IV 
Synthetic polymer-based scaffolds 
PLA70 Freeze-dried PLA70 scaffold II, III 
PLA70+TCP Freeze-dried PLA70 scaffold with TCP particles II, III 
PLA70+BG Freeze-dried PLA70 scaffold with BG particles II 
PLGA Freeze-dried PLGA scaffold V 
PLGA+BGf Freeze-dried PLGA scaffold with BG mesh V 
 
7.1 Characterization of freeze-dried natural polymer-based scaffolds 
7.1.1 Cross-linking of natural polymer-based scaffolds containing collagen 
The effect of cross-linking time on freeze-dried collagen scaffolds was studied in Publication I. The 
difference in cross-linking time, cross-linking used prior or post freeze-drying, was found to have 
an effect on the cross-linking ability of collagen scaffolds. The denaturation temperature (Td) indi-
cating the cross-linking degree of collagen can be determined with DSC (Duan & Sheardown 2005; 
Friess & Lee 1996). The Td of the studied collagen scaffolds varied mainly because of the collagen 
concentration, as the scaffolds with lower collagen concentration (0.3 and 0.5 wt%) showed higher 
Td values when cross-linked post freeze-drying (Figure 5A). The water uptake abilities of the scaf-
folds cross-linked post freeze-drying (with 1 or 10 mM EDC) were much higher (Figure 5B) indi-
cating improved wettability abilities of the scaffolds cross-linked post freeze-drying. Reference 
scaffolds for 2.0 wt% collagen scaffolds with no cross-linking were not manufactured as it was 
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shown in preliminary tests that scaffolds with high collagen concentration do need cross-linking to  
hold their structure and to be suitable for tissue engineering applications. 
 
Figure 5. A) Denaturation temperatures (Td) and B) water uptake of the collagen scaffolds indicat-
ing the degree of cross-linking and wettability abilities of the scaffolds using different cross-linking 
methods. 
The lower wettability characteristics of collagen scaffolds cross-linked prior to freeze-drying was 
most likely due to the shrinking of the scaffolds and the losing of their initial shape (visual charac-
terization of the scaffolds, data not shown). This also indicates that the cross-linking with EDC 
prior to freeze-drying is not an effective way to cross-link these collagen scaffolds even though the 
Td values of those scaffolds are relatively at the same level than the corresponding values of scaf-
folds cross-linked post freeze-drying. 
The average pore sizes of the collagen scaffolds cross-linked with EDC prior to freeze-drying was 
96–115 µm with all collagen concentrations. The cross-linking with EDC post freeze-drying low-
ered the pore sizes of most of the collagen scaffolds (Table 11), which was due to shrinking of the 
scaffolds during the cross-linking procedure. When cross-linking collagen scaffolds with EDC post 
freeze-drying, a noticeable difference was noticed between scaffolds with a lower collagen concen-
tration (0.3–0.5 wt%) with a lower amount of EDC (EDC 1 mM). The shrinkage of the pores was 
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over 20% compared with the pore sizes of scaffolds cross-linked with EDC prior to freeze-drying. 
For  the  scaffolds  with  the  lowest  collagen  concentration  (0.3  wt%),  the  shrinking  of  the  scaffolds  
was also high when cross-linking with a higher amount of EDC (EDC 10 mM). With a higher col-
lagen concentration (1.0 and 2.0 wt%), the pore sizes varied maximally only 7% compared with the 
scaffolds cross-linked prior to freeze-drying. Therefore, no major difference was observed between 
the different cross-linking methods of those scaffolds. 
Table 11. The effect of the cross-linking method on the pore size (mean ± SD) of the scaffolds us-
ing different concentrations of collagen. The high shrinkage of pore sizes compared with the initial 
pore structure (scaffolds cross-linked with EDC prior to freeze-drying) is marked in red. 
Scaffold 
Cross-linking method / pore size 
EDC prior 
freeze-drying/ 
[µm] 
EDC 1 mM 
post freeze-drying/ 
[µm] 
EDC 10 mM 
post freeze-drying/ 
[µm] 
Col0.3 115 ± 42 48 ± 12 80 ± 35 
Col0.5 96 ± 28 76 ± 22 86 ± 10 
Col1.0 106 ± 34 98 ± 21 99 ± 36 
Col2.0 103 ± 24 105 ± 37 98 ± 28 
 
7.1.2 Structure of the natural polymer-based scaffolds 
The natural polymer-based scaffolds were studied in Publications I and IV. The structure of the 
scaffolds in Publication I was plain freeze-dried collagen. The structure of the scaffolds in Publica-
tion IV was a hybrid with freeze-dried collagen/chitosan (collagen, chitosan or collgan+chitosan 
blend) polymer matrix combined with PLA96 fibrous mesh. Also, plain collagen, chitosan and col-
lagen+chitosan scaffolds were used as reference in the Publication IV. The structure of the hybrids 
in Publication IV was so-called sandwich structure with PLA96 fibrous mesh at the bottom and at 
the top of the scaffold. The microstructure of all freeze-dried natural polymer-based scaffolds (Pub-
lications I and IV) was highly similar. The overall structure of the freeze-dried component in the 
natural-based scaffolds was highly porous (Figure 6).  
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Figure 6. SEM image of the porous structure of the freeze-dried collagen scaffold (Col) on the left, 
and on the right the magnification of the area pointed out from the original image on the left (Scale 
bars 500 µm and 100 µm, respectively). 
For all freeze-dried scaffolds (Publications I-V), the skin formation on top of the scaffolds could be 
noticed as a result of the freeze-drying process (Figure 7). 
  
Figure 7. SEM image from the side of the freeze-dried chitosan scaffold (Chi) on the left, indicat-
ing  the  overall  porous  structure  of  the  scaffold  and  the  skin  on  top  of  the  scaffold.  On  the  right,  
magnification  of  the  area  pointed  out  from the  original  image  on  the  left  (Scale  bars  500  µm and 
100 µm, respectively). 
The 3D reconstructions of microCT images (Figure 8) show the highly porous structure of different 
natural polymer-based scaffolds. The PLA carded mesh was well attached to the matrix polymer, 
collagen, chitosan or collagen+chitosan blend and the matrix polymer filled the PLA carded mesh 
thoroughly.  
Pores 
Skin 
100 µm 
100 µm 
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Figure 8. Cross-sectional views and 3D reconstructions of microCT images of different natural 
polymer-based scaffolds. Natural polymer component in green and PLA in blue. 
The porosity in different freeze-dried natural polymer-based scaffolds was over 85% for all scaf-
folds (Publication IV), except for the collagen+chitosan (C1C1) scaffolds for which the porosity 
was only 66% (Table 12). The lower porosity for C1C1 scaffolds was, however, due to the shrink-
age of the scaffolds during processing, as the neutralization procedure was found to be inadequate 
(Publication IV). The pore structure was highly interconnected as there were no difference between 
the total porosity and the open porosity values. 
Table 12. Porosity values of different freeze-dried natural based polymer scaffolds (microCT data). 
Scaffold Col Chi C1C1 C2C1 ColPLA ChiPLA C1C1PLA C2C1PLA 
Total porosity [%] 86 89 66 87 93 88 85 88 
Open porosity [%] 86 89 66 87 93 88 85 88 
7.1.3 Wettability of the natural polymer-based scaffolds 
The wettability of the freeze-dried natural polymer-based scaffolds was relatively high (Figure 9). 
The water uptake was the highest for plain collagen scaffolds and, therefore, the higher amount of 
collagen in the collagen+chitosan blends as well as in the hybrids increased the water uptake of the 
scaffolds. The water uptake was much higher for the whole scaffold (scaffold and pore system) 
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when the water was also inside the pores of the scaffolds than for the scaffolds with no excess water 
inside the pores (scaffold only). Chitosan in the scaffolds lowered the water uptake ability of the 
scaffolds to a great extent, which was due to the shrinking of the scaffold in wet conditions. 
 
Figure 9. Water uptake of the different freeze-dried natural polymer-based scaffolds for the scaf-
fold and pore system (whole scaffold, also the water inside the pores) and for scaffold only (no ex-
cess water inside the pore system). 
7.1.4 Compression properties of the natural polymer-based scaffolds 
The compressive modulus and compressive stiffness values, of the different freeze-dried natural 
based scaffolds are shown in Figure 10. Over 50% higher compressive stiffness values were de-
tected for dry hybrid scaffolds compared with the corresponding plain scaffolds. In wet conditions, 
the compressive stiffness was over 70% higher for hybrid scaffolds compared with the correspond-
ing plain scaffolds, with the exception of the C1C1 scaffolds that had much higher compressive 
stiffness than the other plain scaffolds. The compressive modulus of dry hybrid scaffolds was much 
lower than the corresponding plain scaffolds, though the difference between wet hybrid and plain 
scaffolds was more moderate. The collagen component in the scaffolds showed good recovery to 
their original shape after immersing the scaffold in PBS for 1 h after compression testing. Therefore, 
the plain collagen scaffolds (Col) and the ColPLA scaffolds had the best ability of all the scaffolds 
to recover to their original shape.  
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Figure 10. Compressive modulus and compressive stiffness (mean ± SD) of different freeze-dried 
natural polymer-based scaffolds in dry and wet conditions. 
As described by Harley et al. (Harley et al. 2007), elastomeric foam compression curves were no-
ticed for all of the freeze-dried natural polymer-based scaffolds. The initial elastic region, a middle 
collapse plateau region, and final densification of the material could be distinguished from the 
graphs (Figure 11). The compressive stress–strain curves of dry scaffolds rose steadily after the 
linear elastic region until the point of 75% strain that occurred after the densification. The compres-
sive stress values stayed at  a relatively low level with the wet scaffolds until  60 to 70% of strain.  
The hybrids showed the highest compressive stress values when wet after the point of 70% of strain, 
except for the C1C1 scaffolds which had much higher compressive stress values than the other plain 
scaffolds in wet conditions. 
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Figure 11. Compressive stress–strain curves for A) dry and B) wet freeze-dried natural polymer-
based scaffolds indicating linear elastic, collapse plateau, and densification regimes. 
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7.2 Characterization of freeze-dried synthetic polymer-based scaffolds 
7.2.1 Structure of the synthetic polymer-based scaffolds 
The synthetic polymer-based scaffolds were studied in Publications II, III and V. The structure of 
the scaffolds in Publications II and III was heterogeneous, with TCP or BG particles at the bottom 
of the freeze-dried scaffold. The structure of the scaffolds in Publication V was homogenous with 
BG fibrous mesh inside the polymer matrix. As noticed with freeze-dried natural polymer-based 
scaffolds (Figure 7), the synthetic polymer-based scaffolds also suffered from skin formation on top 
of the top surface of the scaffold as a result of the freeze-drying process (Figure 12).  
 
 
Figure 12. ESEM images of the A) dense top surface (with skin formation), and B) porous bottom 
surface of freeze-dried PLA70 (PLA2) scaffold (Scale bars 50 µm). 
Scaffolds with PLA70/30 as matrix polymer 
Figure 13 shows the representative ESEM image of the overall cross-sectional view of the PLA70 
scaffolds  with  TCP  particles.  The  structure  of  the  PLA70  scaffolds  containing  BG  particles  was  
highly similar as well. As can be seen from the image of the overall structure of the freeze-dried 
PLA3TCP10 scaffold, the skin surface formed during the freeze-drying process is very thin show-
ing almost no clear denser surface in the top of the scaffold (on the right in the image) (Figure 13). 
Figure 13 also shows the layered structure of the PLA70 scaffolds containing either TCP or BG 
where the filler particles are laid down at the bottom of the scaffold and the rest of the structure is a 
porous PLA70 matrix. 
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Figure 13. ESEM image of the cross-section of a freeze-dried PLA70 (PLA3TCP10) scaffold 
showing the overall structure of the scaffold (top image). Magnification of the area pointed out from 
the original image on top (lower image). On the right hand side, the top surface of the scaffold and 
the bottom surface with most of the TCP particles on the left hand side (Scale bars 500 µm). 
The filler particles in the PLA scaffolds had good connectivity to the surrounding matrix polymer as 
seen in Figure 14A and B. 
A 
 
B 
 
Figure 14. ESEM images of a freeze-dried PLA70+TCP (PLA2TCP5) scaffold A) from the bottom 
of the scaffold, and B) from the side of the scaffold, showing the good interconnection of the TCP 
particle in the PLA matrix (Scale bars 20 and 50 µm, respectively). The arrows indicate the TCP 
particle in the images. 
The highly porous structure of the TCP particles is represented in Figure 15. The porous surface of 
the porous TCP particles was retained during the processing and could be seen even after 2 weeks 
in hydrolysis. 
500 µm 
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Figure 15. On the left, ESEM image of a freeze-dried PLA70+TCP (PLA2TCP20) scaffold after 2 
weeks in hydrolysis, showing the highly porous structure of the TCP particle. On the right, magnifi-
cation of the area pointed out from the original image on the left (Scale bars 50 µm). 
The processing of freeze-dried scaffolds with relatively large filler particles was challenging. There-
fore, the content of used filler particles (marked as desired TCP content in Table 13) in the process-
ing did not always lead to the same content of filler particles (marked as measured TCP content in 
Table 13) in the manufactured scaffolds (Table 13A and B). Table 13 indicates that with higher 
contents  of  particles  (over  5  wt% of  particles)  the  measured  particle  content  was  between 5  wt% 
and 10 wt% smaller compared with the desired contents of 15 wt% and 30 wt%, respectively. 
Therefore, with a higher content of filler particles in the solution, it is more difficult to achieve the 
desired content of filler particles for the scaffolds. This same phenomenon was noticed for PLA70 
scaffolds with BG as filler particles (data not shown). 
Table 13. The content of different components (matrix: PLA70 and filler: TCP)  in  A)  2wt%  
PLA70+TCP and B) 3wt% PLA70+TCP scaffolds. 
(A) 
 
Scaffold 
2 wt% PLA 
(wt%) 
TCP content: 
desired/measureda 
(wt%) 
(B) 
 
Scaffold 
3 wt% PLA 
(wt%) 
TCP content: 
desired/measureda 
(wt%) 
PLA2 100 0/0 PLA3 100 0/0 
PLA2TCP5 95 5/5 PLA3TCP5 95 5/5 
PLA2TCP10 85 15/10 PLA3TCP10 85 15/10 
PLA2TCP20 70 30/20 PLA3TCP20 70 30/20 
a by thermogravimetric analysis (TGA) 
 
The pore size distribution of the PLA70+TCP scaffolds was from 20 to 80 µm, and the mean pore 
size was around 50 µm, measured from the ESEM images (data not shown). As can be seen in Fig-
ure 13, a few larger macropores could be detected. The TCP particles in the composites or the 
PLA70 concentration (2 or 3 wt%) did not affect the pore size of the scaffolds. 
Scaffolds with PLGA as matrix polymer 
The porous structure of the PLGA and PLGA+BGf scaffolds are shown in SEM images in Figure 
16 and in microCT images in Figure 17. The overall structure of the matrix polymer, PLGA, is 
50 µm 
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highly  porous  in  all  of  the  scaffolds.  Good  interconnection  of  fibres,  BGf,  in  the  matrix  polymer  
was noticed for both, PLGA1BG1 and PLGA2BG2 composites.  
 
  
PLGA1 PLGA2 
  
PLGA1BG1 PLGA2BG2 
Figure 16. SEM  images  of  the  structure  of  the  different  PLGA  and  PLGA+BGf  scaffolds  (Scale  
bars 100 µm). 
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PLGA1 
 
PLGA2 
 
PLGA1BG1 
 
PLGA2BG2 
Figure 17. 3D  reconstructions  of  microCT  images  of  different  PLGA  and  PLGA+BGf  scaffolds.  
PLGA in green and BGf in blue (Scale bars 250 µm). 
High porosity values, porosity over 93% for all the PLGA and PLGA+BGf scaffolds were detected 
by microCT analysis (Table 14). Higher material thickness was noticed in composite, PLGA+BGf, 
scaffolds  when  compared  with  the  plain  PLGA  scaffolds.  The  mean  pore  sizes  varied  in  a  range  
from 49 to 77 µm, and the maximum pore sizes from 105 to 251 µm. The highest porosity, mean 
pore size and maximum pore size, were detected for the PLGA2BG2 scaffold. Furthermore, the 
PLGA2BG2 scaffold also showed broader pore size distribution (Figure 18) and a higher number of 
pores over the size of 100 µm compared with the other PLGA or PLGA1BG1 scaffolds.  
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Table 14. Porosity, material thickness, and pore size of different PLGA and PLGA+BGf scaffolds 
analysed by microCT. 
Scaffold  Porosity [%] 
Material thickness 
[µm] 
Material thickness 
max. [µm] 
Pore size 
[µm] 
Pore size 
max. [µm] 
PLGA1 93 9 ± 3 24 69 ± 24 173 
PLGA2 93 7 ± 2 18 49 ± 13 105 
PLGA1BG1 93 13 ± 5 30 53 ± 18 118 
PLGA2BG2 96 8 ± 3 20 77 ± 34 251 
 
 
 
Figure 18. Pore  size  distribution  of  different  PLGA  and  PLGA+BGf  scaffolds  analysed  by  mi-
croCT. 
The majority of the scaffolds comprise open pores, as the total porosity and open porosity graphs 
show (Figure 19). Open pore structure also indicates an interconnected pore structure. The PLGA1 
and PLGA2BG2 scaffolds also showed a considerable number of open pores at sizes even exceed-
ing 100 µm. 
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Figure 19. Total porosity and open porosity graphs of different PLGA and PLGA+BGf scaffolds 
analysed by microCT. 
7.2.2 Wettability of the synthetic polymer-based scaffolds 
Scaffolds with PLGA as matrix polymer 
The  contact  angle  measurements  were  done  for  PLGA  and  PLGA+BGf  scaffolds  to  analyze  the  
hydrophobisity of the scaffolds (Figure 20). The contact angle values of the different scaffolds var-
ied from 92 to 118°, and only some variation was noticed between different scaffold compositions 
or  between different  fluids.  The  PLGA1 scaffolds  showed significant  difference  in  water  with  re-
spect to PLGA1BG1 (p < 0.05), PLGA2 (p = 0.05) and PLGA2BG2 (p < 0.05) scaffolds. PLGA1 
showed relatively significant difference with respect to PLGA2BG2 (p = 0.055) scaffolds in blood. 
No significant difference in contact angle values was detected between different scaffolds when 
measured in PBS. 
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Figure 20.  Contact angle results in water, PBS and bovine blood for different dry PLGA+BG scaf-
folds. *p  0.05 with respect to PLGA1BG1, PLGA2 and PLGA2BG2. **p = 0.055 with respect to 
PLGA2BG2. 
The wettability of the PLGA and PLGA+BGf scaffolds was measured as water uptake of the scaf-
folds during 10-week hydrolysis (Figure 21). All the scaffolds had a constant water absorption rate 
during the hydrolysis until week 8. The PLGA+BGf composites had higher water absorption than 
the corresponding plain PLGA scaffolds during the first weeks in hydrolysis. After week 4, the wa-
ter absorption gradually increased with the plain PLGA scaffolds, and the plain PLGA1 had the 
highest water absorption at the end of the hydrolysis in week 10. 
 
Figure 21. Water uptake of the different PLGA and PLGA+BGf scaffolds during the hydrolysis (10 
weeks). 
7.2.3 In vitro hydrolytic degradation of the synthetic polymer-based scaffolds 
In vitro degradation tests of synthetic polymer-based scaffolds were done for PLA70+TCP and 
PLGA+BGf scaffolds for 26 and 10 weeks, respectively. The pH of the buffer, PBS, stayed within 
the given limits (7.35–7.45) with the scaffolds with PLA70 as the matrix polymer. The pH of the 
buffer with the scaffolds with PLGA as the matrix polymer, on the other hand, showed lower pH 
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values with plain PLGA scaffolds. The buffering effect of BGf was noticed in the PLGA+BGf scaf-
folds, as the BGf was shown to buffer the acidic degradation products of PLGA in the composites 
(PLGA1BG1 and PLGA2BG2). 
Scaffolds with PLA70/30 as matrix polymer 
The porous structure of plain PLA70 and PLA70+TCP composite scaffolds remained relatively 
stable during the 26 weeks in hydrolysis (Figure 22). In addition, the scaffolds with 2 wt% of 
PLA70 showed only little or no visual difference in the appearance of the scaffolds during the 26 
weeks of hydrolysis. During the hydrolysis, only the edges of the pores became smoother and more 
visible. This was caused by a minor degradation of the scaffolds. The TCP particles did not change 
in appearance after the 26 weeks of hydrolysis. 
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Figure 22. ESEM images of freeze-dried PLA70+TCP (with 3 wt% PLA) composite scaffolds from 
the porous bottom surface before hydrolysis at week 0 and at the end of the hydrolysis at week 26 
(Scale bars 200 µm). 
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Only partial degradation was noticed for the PLA70+TCP scaffolds during 26 weeks in hydrolysis. 
The weight change of the scaffolds during the 26 weeks in hydrolysis and after week 4, between 
weeks 8 and 16, all the scaffolds showed an increase in weight, a maximum increase of 5% (Figure 
23). After week 8 for most of the scaffolds and after week 16 for all of the scaffolds, a steady de-
crease in weight was seen until the end of the hydrolysis. Overall weight loss after the 26 weeks in 
hydrolysis was maximally 5% in all of the scaffolds. 
 
Figure 23. Weight loss of the PLA70+TCP scaffolds during hydrolysis. 
The i.v. value of the PLA70 raw material was 3.1 dl/g. The i.v. values of the PLA70+TCP scaffolds 
decreased by 22% and 25% during the processing for the PLA2 and PLA3 scaffolds, respectively 
(Figure 24). The solvent, 1,4-dioxane, was shown to lower the i.v. values of PLA70 because the i.v. 
of the polymer decreased significantly after the polymer was dissolved in the solvent. After process-
ing, the i.v. values decreased from 2.4 to 1.2 dl/g and 2.3 to 1.3 dl/g for the PLA2 and PLA3 scaf-
folds after 26 weeks in hydrolysis.  
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Figure 24. Inherent viscosity values of PLA2 and PLA3 scaffolds during hydrolysis, PLA raw ma-
terial and 2 wt% and 3 wt% PLA70 solutions in 1,4-dioxane. 
The  thermal  stability  of  the  plain  PLA70  and  PLA70+TCP  composite  scaffolds  was  shown  to  be  
improved after the processing, at week 0, compared with the thermal properties of the raw material 
(Figure 25). After two (scaffolds containing 20 wt% of TCP) to four weeks (scaffolds with  10 wt% 
of TCP) in hydrolysis, the thermal stability was shown to decrease again and the lowest thermal 
stability values were detected at the end of the hydrolysis, at week 26, for all scaffolds. 
 
Figure 25. Peak maximum values of the first derivate curve measured with TGA indicating the 
thermal stability of the scaffolds. 
Scaffolds with PLGA as matrix polymer 
The difference in the porous structure of plain PLGA compared to the composite structure of 
PLGA+BGf varied greatly during the 10 weeks in hydrolysis. The plain PLGA scaffolds suffered 
from severe shrinking and twisting already after 2 weeks in hydrolysis and the porous structure of 
the scaffolds was partially lost (PLGA1 scaffolds) or completely lost (PLGA2 scaffolds), as seen in 
Figure 26. The composite scaffolds retained their initial structure better and the porous structure of 
the PLGA matrix was still visible after 2 weeks in hydrolysis. 
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Week 2 
  
PLGA1 PLGA2 
  
PLGA1BG1 PLGA2BG2 
Figure 26. SEM images of plain PLGA and PLGA+BGf composite scaffolds after 2 weeks in hy-
drolysis (Scale bars 100 µm). 
The BGf in PLGA+BGf composites stabilised the structure of the composites during the whole hy-
drolysis time, 10 weeks, and the open porous structure could still be observed (Figure 27). The po-
rous structure of the plain PLGA1 scaffold was lost after 10 weeks in hydrolysis. This was expected 
because the porous structure was already partially lost in the PLGA1 scaffolds after 2 weeks in hy-
drolysis (Figure 26). 
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Week 10 
  
PLGA1 PLGA1BG1 
Figure 27. SEM  images  of  plain  PLGA  scaffold  (PLGA1)  and  PLGA+BGf  composite  scaffold  
(PLGA1BG1) after 10 weeks in hydrolysis (Scale bars 100 µm). 
The Mw and Mn of the PLGA decreased constantly during the hydrolysis (Figure 28). The highest 
drop in the molecular weight values was detected after processing and sterilization of the scaffolds. 
PLGA1 scaffolds with the highest initial molecular weight lost their molecular weight more se-
verely after the processing and sterilization, and the Mn of PLGA1 decreased to the same level as 
PLGA2. At the beginning of the hydrolysis, during the first two weeks, the Mn stayed relatively 
constant, after which the Mn started to decrease gradually. The trend in the decrease of molecular 
weights (Mw and Mn) was similar for all scaffolds. 
 
Figure 28. Molecular weight change of PLGA+BGf scaffolds during hydrolysis. 
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The core-accelerated bulk degradation process by chain scission of ester bonds for poly(ɲ-
hydroxyesters) can be described by a first order law (Pitt et al. 1981). More specifically, the Mn de-
crease during ester hydrolysis can be modelled by Equation 2 as follows:  
ଵ
ெ೙
= ଵ
ெబ೙
×  ݁௞௧       (2) 
or in its linearized form (Equation 3):   
݈݊ ൬
ெ೙
ெబ೙
൰ = െ݇ݐ       (3) 
where ܯ௡ (g/mol) is the number average molar mass of the polymer at any time point, ܯ
଴
௡ is the 
initial number average molar mass (g/mol), k is the ester hydrolysis rate constant (per day) and t is 
the degradation time (day). Assuming that the above model is also applicable to composite degrada-
tion, the values of ln(ܯ௡/ܯ
଴
௡)  as  a  function  of  t can be described by a linear function. Both the 
plain PLGA scaffolds and the PLGA+BG composites showed Mn decrease according to the first 
order law during hydrolysis, with straight lines with good fits indicating core accelerated bulk deg-
radation (Figure 29). 
 
Figure 29. Fitting the number average molecular weight decrease of PLGA+BGf composites during 
ester hydrolysis according to the first order law. 
The trend in weight loss of the scaffold with PLGA1 as the matrix polymer was constant during the 
hydrolysis, though the loss in plain PLGA1 scaffold was higher than in the corresponding compos-
ite scaffold,  PLGA1BG1 (Figure 30).  The trend in weight loss of the scaffold with PLGA2 as the 
matrix polymer was not that straightforward. Though, it is very likely that the results at week 2 for 
the PLGABG2 and at week 4 for the PLGA2 and the PLGA2BG2 scaffolds are incorrect due to an 
error in scale. At the end of the hydrolysis (at week 10), the overall weight loss of the scaffolds was 
63, 59, 41 and 63% for PLGA1, PLGA2, PLGA1BG1 and PLGA2BG2 scaffolds, respectively. 
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Figure 30. Weight loss of the PLGA+BG scaffolds during hydrolysis. 
The Tg values of the PLGA+BGf scaffolds decreased the most after the processing (from 51.9 to 
42.0 °C for PLGA1) and sterilization (from 47.3 to 37.5 °C for PLGA2) (Figure 31). After 2 weeks 
in hydrolysis, the Tg of plain PLGA scaffolds (PLGA1 and PLGA2) increased, and after that the Tg 
remained relatively constant during the hydrolysis. 
 
Figure 31. Glass transition temperatures of PLGA+BGf scaffolds during hydrolysis. 
The BG content in PLGA+BGf scaffolds was 50.7±5.2% and 41.9±3.0% in the PLGA1BG1 and 
PLGA2BG2 composites, respectively (Figure 32). The difference in BGf content between parallel 
samples was moderate, 5.2 and 3.0 for PLGA1BG1 and PLGA2BG2 composites, respectively. No 
major change in the BGf content in PLGA+BGf composites was noticed during the hydrolysis of 10 
weeks.  
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Figure 32. BG content of different PLGA+BGf composite scaffolds during hydrolysis. 
7.3 The feasibility of the freeze-dried scaffolds for tissue engineering 
applications 
7.3.1  Cellular responses to the natural polymer-based scaffolds 
Chondrocytes were seeded into the natural polymer-based scaffolds for one week and the viability 
and distribution was analysed in Publication IV. Cells were evenly distributed on the surfaces of the 
scaffolds and were viable after one week of culture. The cells were well attached to the freeze-dried 
collagen and chitosan networks as well as the PLA96 fibres (Figure 33).  
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Col ColPLA 
Chi ChiPLA 
C1C1 C1C1PLA 
C2C1 C2C1PLA 
Figure 33. SEM images of natural polymer-based scaffolds containing bovine chondrocytes after 
one week in culture (Scale bar 100 µm). 
The seeded chondrocytes expressed collagen type II in the cytoplasm, indicating that the cells had 
retained chondrogenic phenotype in the scaffolds (Figure 34). High variation in the penetration of 
the cells was detected between the different scaffolds. Most of the cells remained at the top surface 
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of the scaffolds where the cells were pipetted while seeding. In ColPLA and C2C1PLA scaffolds 
the penetration of the cells was good and the cells were detected throughout the scaffold. In 
ChiPLA and C1C1PLA scaffolds some penetration was detected. In plain scaffolds (Col, Chi, C1C1 
and C2C1), the penetration of the cells was weak. 
 
Figure 34. Evenly distributed and viable chondrocytes show collagen II expression in the natural 
polymer-based scaffolds after one week in culture. Collagen II in green, nuclei of the cells in blue 
(Scale bar 50 µm). 
7.3.2 Cellular responses to the synthetic polymer-based scaffold 
Cell attachment and growth was studied on PLA70+TCP and PLA70+BG composite scaffolds (2 wt% 
PLA70 + 10 or 20 wt% filler) and for plain PLA70 scaffold (PLA2) (Publication II). The number of 
viable cells was observed at 3 h and 2 weeks time points (2 weeks time point is shown in Figure 35). 
After 2 weeks, the number of cells had increased (compared with the 3 h time point), observed by 
Live/Dead staining. The cells were only attached close to the cell seeding area, in the region close 
to the surface in all of the scaffolds after the 3 h time period. After 2 weeks, the cells had spread 
inside the scaffolds. However, the cell density was the highest in the region close to the surface. 
Only a few cells were found on the dense top surface of the scaffolds. In the PLA2TCP20 scaffolds, 
the cells were spread more evenly, but in the other scaffolds the cells had formed cluster structures 
between the pores in the scaffold structure in the region close to the surface. 
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Figure 35. Representative images of viable (green fluorescence) and dead (red fluorescence) ASCs 
attached to A) PLA2BG10, B) PLA2BG20, C) PLA2TCP10, D) PLA2TCP20, composite scaffolds, 
and E) plain PLA2, after 2 weeks in culture (Scale bars 200 µm). 
The cell morphology and spreading was examined with ESEM and SEM imaging after the 2 week 
time period (Figures 36 and 37). The filler particles, TCP or BGp, were not found to affect the mor-
phology of the cells. During the culturing period of 2 weeks, the ASCs started to colonize the scaf-
folds without forming a homogenous monolayer. The ASCs were found to form bridges between 
the filler particles, TCP and BGp, in the composite scaffolds. The ASCs were seen to stretch and to 
form projections on the porous surface of the scaffolds, as seen in SEM images on the right in Fig-
ure 37.  
 
Figure 36. ESEM images of ASCs on the PLA2, PLA2TCP20 and PLA2BG20 scaffolds (Scale 
bars 50 µm). 
 
PLA PLA2TCP20 PLA2BG2
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Figure 37. SEM images of ASCs on the PLA2, PLA2TCP10 and PLA2BG10 scaffolds on the left 
(Scale bars 50 µm), and on the PLA2, PLA2TCP20 and PLA2BG20 scaffolds on the right (Scale 
bars 10 µm). 
The cell number in the scaffolds was assessed by measuring the total DNA content (Figure 38A). 
After 2 weeks,  the cell  number was significantly higher in scaffolds with TCP filler  than with the 
other scaffolds. The DNA content was significantly lower in scaffolds with BGp filler than with the 
other scaffolds. No considerable difference was noticed between the two filler ratios of TCP, 10 and 
20 wt%. The early differentiation of ASCs into an osteogenic pathway was evaluated by quantita-
tive measurement of ALP activity in the scaffolds (Figure 38B). The same magnitude of relative 
ALP activity was detected for PLA2TCP10 and PLA2TCP20 scaffolds. However, the PLA2TCP10 
scaffolds had significantly higher magnitude compared with the other scaffolds. The relative ALP 
activity of ASCs cultured on PLA2BG10, PLA2BG20 and PLA2 scaffolds was comparable after 2 
weeks of culture. This was due to the lower cell number in PLA2BG10 and PLA2BG20 scaffolds 
compared with PLA2 scaffolds.  
PLA PLA
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Figure 38. Relative A) DNA content and B) ALP activity of PLA70+TCP and PLA70+BG com-
posite scaffolds cultured with ASCs for 2 weeks. Results are expressed as mean + SD relative DNA 
content or ALP activity in three experiments (n = 4). *p < 0.005 with respect to PLA2, PLA2BG10 
and PLA2BG20; **p < 0.005 with respect to PLA2, PLA2TCP10 and PLA2TCP20; †p < 0.005 
with respect to PLA2TCP10 and PLA2TCP20, and PLA2BG10 and PLA2BG20. 
The culturing period was also found to have an effect on ASC proliferation. The relative DNA con-
tent was not increased when cells were cultured on scaffolds with BGp as a filler for 2 weeks com-
pared  to  1  week  (data  not  shown).  The  DNA  content  increased  for  plain  PLA2  scaffolds  and  the  
scaffolds with TCP as a filler when ASCs were cultured on scaffolds at 2 weeks. However, no sig-
nificant difference was noticed between weeks 1 and 2. The ALP activity of ASCs cultured on plain 
PLA2 scaffolds or scaffolds with BGp as a filler produced two times higher levels, but a significant 
increase was only seen at the 2-week time point when ASCs were cultured on PLA2TCP20 scaf-
folds. The ALP activity of ASCs cultured on PLA2TCP10 scaffolds was also three times higher at 
the 2-week time point than at the 1-week time point. 
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8 Discussion 
There are several different approaches that can be used for osteochondral tissue engineering (Nu-
kavarapu & Dorcemus 2013; Martin et al. 2007), categorised briefly into one component or two 
component scaffolds. The one-component scaffold can be manufactured with one or more compo-
nents in one scaffold with a homogenous or heterogeneous structure. The two-component scaffold 
is manufactured from separate cartilage and bone components and the different layers can be com-
bined during processing or at the time of implantation. Numerous studies are trying to solve the 
tissue engineering challenges of cartilage, bone and osteochondral lesions (Panseri et al. 2012; 
Hutmacher 2000; Castro et al. 2012; Puppi et al. 2010). Nevertheless, no optimal way to heal carti-
lage, bone, or osteochondral trauma exists and, therefore, the study is still ongoing. Publications II 
and III are mainly focused on osteochondral tissue engineering applications. Publication IV focuses 
on cartilage tissue engineering, and Publication V focuses on bone or osteochondral tissue engineer-
ing applications. 
Natural polymers are widely studied materials in the field of tissue engineering because of their 
high biocompatibility, biodegradability, and the ability to mimic certain aspects of native ECM, and 
thus facilitate cell adhesion, migration, differentiation, and ECM deposition (Panseri et al. 2012). 
Collagen is a structural protein in native articular cartilage, and chitosan, a natural polysaccharide 
(Iwasa et al. 2009), possesses a similar structure to naturally present GAGs found in articular carti-
lage (Kim et al. 2008; Francis Suh & Matthew 2000). Therefore, the natural polymers, collagen and 
chitosan, are studied in this thesis in order to best meet the characteristics of native cartilage tissue 
(Publication IV). However, the poor mechanical properties of natural polymer scaffolds, when used 
as highly porous structures, need to be overcome. Therefore, hybridisation with a fibrous network 
of synthetic polymer with PLA96/4 used as the reinforcing component was studied in this thesis. 
Synthetic polymers were selected as a matrix component for the studied bone or osteochondral tis-
sue engineering scaffolds (Publications II, III, and V) as they possess better mechanical properties 
(compared with natural polymer scaffolds) and their degradation rate can be altered more accurately 
(Panseri et al. 2012).  Also, the preliminary cell studies with ASCs showed improved properties for 
freeze-dried PLA70 scaffolds compared with freeze-dried collagen type I scaffolds (data not shown). 
Therefore, PLA70 was selected for the bone tissue engineering scaffolds (Publications II and III). 
For synthetic polymer-based composites, bioceramics and bioactive glasses were selected to obtain 
more osteoconductive properties for the synthetic scaffolds designed for bone or osteochondral tis-
sue engineering applications.  
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8.1 Cross-linking of collagen 
Untreated collagen has a fast degradation rate and low mechanical strength and, therefore, cross-
linking  is  a  conventional  way  to  improve  the  properties  of  collagen  scaffolds.  Either  chemical  or  
physical cross-linking can be used as a method to cross-link collagen. From the chemical methods 
glutaraldehyde (GA) is the most traditional agent used in the treatment of porous collagen scaffolds 
(Lee et al. 2001; Friess 1998).  However, GA is potentially cytotoxic and it can cause excessive 
cross-linking. As a result, several alternatives have been reported and EDC is widely studied for the 
cross-linking of collagen (Park et al. 2002; Powell & Boyce 2006; Duan & Sheardown 2005; Lee et 
al. 2001). EDC facilitates the formation of amide bonds between carboxylic and amino groups on 
the collagen molecules without becoming a part of the actual linkage (Park et al. 2002; Powell & 
Boyce 2006; Duan & Sheardown 2005; Friess 1998).  
To determine the effectiveness of different cross-linking methods (Publication I), DSC was used to 
measure the Td values  of  collagen  scaffolds  with  different  cross-linking  methods.  Higher  Td indi-
cates higher degree of cross-linking in collagen scaffolds (Duan & Sheardown 2005; Miles et al. 
2005). In Publication I, the cross-linking with EDC post freeze-drying was found to be a more ap-
plicable method to be used for freeze-dried collagen scaffolds. As the differences in Td values of the 
different collagen scaffolds were moderate, the improved wettability characteristics in scaffolds that 
were cross-linked post freeze-drying indicates that the scaffold structure can be improved by cross-
linking the collagen scaffolds with EDC post freeze-drying. Also, higher wettability was achieved 
with 10 mM EDC cross-linking than with 1 mM EDC. Therefore,  a higher amount of EDC in the 
cross-linking solution leads to improved scaffold properties.  
The scaffolds cross-linked with EDC prior to freeze-drying suffered from inferior dimensional sta-
bility in wet conditions. The use of a higher amount of EDC for cross-linking could solve this prob-
lem.  However,  even  though  EDC  is  a  zero-length  cross-linker  and  does  not  stay  as  a  part  of  the  
linkage, it is an irritant and should be leached out from the system. Therefore, higher amounts of the 
used cross-linker prior to freeze-drying could pose the risk that not all EDC is actually leaching out 
of the scaffold. That is why cross-linking with EDC post freeze-drying should be a more secure way 
to use EDC as it is possible to rinse the scaffolds carefully after the cross-linking to ensure no ex-
cess cross-linker remains in the system (Park et al. 2002).  
The post freeze-drying method of cross-linking with EDC is also preferred because with higher col-
lagen concentrations there is almost no change (no shrinking of the porous structure of the scaffolds) 
in the pore sizes of the scaffolds when cross-linking scaffolds with higher collagen concentrations 
(1.0–2.0 wt%) with either 1 mM or 10 mM EDC. To enhance the cross-linking of collagen scaffolds, 
even higher amounts of EDC (14 mM) together with NHS (6 mM) were used to improve the cross-
linking ability of EDC (Publication IV). The combination of EDC+NHS is a widely used method to 
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cross-link collagen scaffolds (Pieper et al. 2002; Yang 2012; Cao & Xu 2008) and was, therefore, 
selected as a cross-linking method for the collagen-based scaffolds in Publication IV. 
8.2 The effect of the freeze-drying parameters on the structure of the 
scaffolds 
When fabricating porous scaffolds for tissue engineering by freeze-drying, there are many factors 
that can be altered that affect the structure of the scaffold (Franks 1998). The concentration of the 
polymer solution and the freezing temperature affects the pore size. A higher amount of polymer 
leads to lower pore sizes and smaller pores are formed in lower freezing temperature (Madihally & 
Matthew 1999). The size of the pores in collagen scaffolds was found to get smaller when a higher 
than 0.3 wt% collagen concentration was used. However, the concentration of 2 or 3 wt% PLA70 in 
the PLA70+TCP scaffolds had no effect on the pore sizes of the scaffolds. This was probably due to 
the relatively low concentration of PLA70 in the scaffolds and the difference would become more 
visible with higher polymer concentrations. The freezing temperature was the same for all the scaf-
folds (–30 °C),  since  at  that  temperature  the  porous  structure  was  found  to  be  fairly  optimal.  At-
tempts at using lower freezing temperatures were tested as preliminary tests (data not shown), but 
by lowering the freezing temperature lower pore sizes were detected. The filler particles, TCP or 
BGp, or the filler fibres, PLA96 or BGf, in the composites did not have an effect on the pore sizes 
of the scaffolds. 
By using unidirectional freezing, the overall porous structure and its orientation can be altered as 
the pore structure of the freeze-dried scaffolds mirrors the ice-crystal morphology after freezing 
(Schoof et al. 2001). To achieve unidirectional freezing, some of the parts around the mould are 
first insulated and then the freezing takes place in the direction in which direction the pores are 
formed. Unidirectional freezing was used for the plain collagen scaffolds in Publication I where the 
PS moulds were insulated from the sides and from the top of the moulds. In this way, the freezing 
starts mainly from the bottom of the sample and leads to a more homogenised pore structure distri-
bution. The mould used for the other natural polymer-based scaffolds (as well as for other scaffolds 
with a synthetic polymer-based structure) was a PTFE mould with a high amount of mould material 
(PTFE) in the sides as well as at the bottom of the samples (Publications II, III, IV, and V). These 
PTFE moulds were found to work in a very similar way to the PS moulds together with the insula-
tor around the mould. The structures of the scaffolds manufactured with PTFE moulds were found 
to be highly homogenous as well. 
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8.3 Freeze-drying as a method to manufacture composite and hybrid 
scaffolds 
Natural polymer-based scaffolds manufactured by freeze-drying often lack the required mechanical 
strength needed for cartilage and bone tissue engineering. The highly porous structure of the matrix 
polymer can be reinforced by using a filler (Chen et al. 2002; Li et al. 2014). Filler components are 
often used to enhance other properties of scaffolds as well, for example, the osteoconductive prop-
erties of bone tissue engineering scaffolds (Maquet et al. 2004; Miki et al. 2000; Roether et al. 2002; 
Boccaccini & Maquet 2003). Filler particles were added into the porous freeze-dried polymer com-
ponent in Publications II and III to enhance the osteoconductivity of the scaffolds studied for bone 
and osteochondral tissue engineering. The interconnection of the filler particles, TCP and BGp, 
were found to be good and the matrix polymer PLA70 surrounded the particles. Fibrous structures 
have also been used to reinforce the tissue engineering scaffolds (Chen et al. 2004; Dai et al. 2010; 
Sato et al. 2001). By using two or more different processing methods, an even more complex struc-
ture that combines two 3D structures into one scaffold can be achieved. Freeze-drying can be used 
for matrix polymer processing (into a highly porous 3D matrix), and the processing of polymer or 
bioactive glass into fibres and, subsequently, the processing of the fibres into a 3D fibrous mesh (as 
a filler component). These two components, two 3D structures (highly porous matrix and fibrous 
mesh as filler) may then be combined into one scaffold. The method of combining two different 3D 
structures, a freeze-dried matrix and a fibrous filler component, was studied in Publications IV and 
V. The interconnection of fibres with the matrix polymer was good for both types of scaffolds, the 
natural polymer-based scaffolds with PLA96 fibres and the synthetic polymer-based scaffold with 
PLGA as the matrix polymer and BGf fibres as a filler.  
To manufacture a layered osteochondral structure into the PLA70+TCP scaffolds, relatively large 
TCP particles were used to ensure the formation of a particle-rich area at the bottom of the scaffolds. 
These relatively large particles were immersed thoroughly into the polymer solution during process-
ing, and before the freezing step the solution was held in the moulds to ensure that the TCP particles 
sank to the bottom of the scaffold structure. According to a study (Bohner & Baumgart 2004), the 
optimum radius for bone substitute particles should be in the range of 100–200 µm. In this range, 
the particle size is small enough to provide a large surface area and still large enough for bone in-
growth. The study also showed that with CaP bone substitutes with no macropores, small particles 
should be present to increase their resorption rate. By using large but porous TCP particles in Publi-
cations II and III, the positive effect of larger particles with a high surface area was also achieved. 
Larger particles could also be favourable since small particles (size of 2.2 µm) have been found to 
cause inflammation in vivo. Apparently, this inflammation is caused by small, slowly resorbable 
particles concentrating in the surrounding tissues (Heidemann et al. 2001).  
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8.4 Porous structure of the freeze-dried scaffolds 
A highly porous, interconnected and open pore structure is needed for tissue engineering scaffolds 
to ensure tissue ingrowth and the flow transport of nutrients and metabolic waste. For example, the 
porosity of natural bone is in the range of 50–90% porosity, depending on the type of the bone (Ste-
vens et al. 2008). The freeze-dried porous structure was highly similar in all of the freeze-dried 
scaffolds. A highly porous structure with high porosity and interconnected pores was detected in all 
natural polymer-based scaffolds (Publication IV) as well as in all synthetic polymer-based scaffolds 
(Publications III and V). The C1C1 scaffolds, with 50% of chitosan, were, however, an exception 
with  a  much lower  porosity  of  only  66%.  Therefore,  it  was  assumed that  the  scaffolds  containing  
chitosan suffered from shrinking as a result of inadequate neutralisation during processing, although 
the neutralisation process was evaluated in preliminary studies (data not shown). While cross-
linking with EDC+NHS, the inadequate neutralization of the chitosan component led to the collapse 
of the initial porous structure of the blend scaffold. Therefore, the C1C1 scaffold with higher 
amounts of chitosan (compared with C2C1 scaffolds) suffered from shrinking more extensively. 
This  is  also  the  reason  why  the  plain  chitosan  scaffold  (Chi)  showed  superior  porosity  values,  as  
those scaffolds were not cross-linked after the first freeze-drying step, as was the case with the other 
scaffolds with collagen in the blend structure. The shrinking of C1C1 scaffolds was also visible in 
the mechanical tests where the wet C1C1 scaffolds showed higher stiffness values than other plain 
natural polymer scaffolds, a phenomenon due to a denser scaffold structure.  
The pore structure of natural polymer-based scaffolds, as well as of PLGA+BGf scaffolds was also 
shown to be open as detected by microCT studies. The interconnectivity of pores was also verified 
for natural polymer-based scaffolds and for PLGA+BGf as synthetic polymer-based scaffolds. The 
optimal  pore  size  for  cartilage  (Griffon  et  al.  2006)  and  bone  (Hulbert  et  al.  1970;  Freyman et  al.  
2001; Hench & Polak 2002) tissue engineering scaffolds has been reported to be in the range of 70–
120 µm and ~100 µm, respectively. However, in the study of Itälä et al. (Itälä et al. 2001), pore 
sizes of 50–125 µm in porous titanium structures led to the formation of secondary osteonal struc-
tures. Therefore, the optimal pore size range for osteogenic scaffolds might only be slightly higher 
when compared with the chondrogenic scaffolds. The pore size of the studied natural polymer-
based scaffolds was for the optimally manufactured scaffolds (with a collagen concentration of 0.5–
1.0 wt% and cross-linking with EDC post freeze-drying with 10 mM EDC solution) ~100 µm. The 
pore size range of the PLA70+TCP scaffolds was 20–80 µm, with a mean pore size of ~50 µm. The 
pore size range of the PLGA+BGf scaffolds was around 50–80 µm, with maximum pore sizes in the 
range of 100–250 µm. Therefore, the pore size of the natural polymer-based scaffolds fits well to 
the limits given for an optimal cartilage (as well as bone) tissue engineering scaffold. The pore sizes 
of the synthetic polymer-based scaffolds are not the most optimal for bone tissue engineering and 
are slightly smaller than the preferred pore sizes. However, there are also larger pores (as well as 
macropores) that could help cell migration into scaffolds. Also, the synthetic polymer-based scaf-
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folds would fit in the requirements for cartilage tissue engineering scaffolds if used for osteo-
chondral applications. 
Skin formation was noticed on top of the freeze-dried scaffolds even though the overall structure of 
the freeze-dried scaffolds was highly porous. The skin formation was due to the freeze-drying proc-
ess where the sublimation of the solvent occurs from the top surface. If it is not possible to control 
the temperature during freeze-drying, the polymer matrix will not be rigid enough to resist the inter-
facial tension caused by solvent evaporation. As a result, the porous structure will collapse and a 
dense skin layer will form on the scaffold (Ho et al. 2004). With an increase in polymer concentra-
tion,  the  skin  surface  becomes  even  denser.  However,  this  enables  the  formation  of  two different  
functional surfaces into the scaffold. The formed skin surface could maintain transplanted cells in-
side the scaffold, while fluids, nutrients, and oxygen could diffuse through the porous surface (Boc-
caccini et al. 2005). 
8.5 Wettability of the freeze-dried scaffolds 
The surface of the tissue engineering scaffold is the first component that comes into contact with 
biological fluids. Therefore, for successful cell seeding the tissue engineering scaffold should con-
tain a highly porous structure as well as optimal wettability, indicating hydrophilic properties. High 
wettability, however, does not necessarily lead to a more biocompatible scaffold, as even moder-
ately wettable surfaces can result in enhanced biocompatibility. Therefore, the ideal balance of hy-
drophobic and hydrophilic surfaces still needs to be optimized (Menzies & Jones 2010). 
The wettability of natural polymer-based scaffolds was tested in Publications I and IV. The natural 
polymer-based scaffolds possessed high water uptake ability. The wettability of the plain collagen 
scaffolds was the highest. Improved water uptake was also noticed for the other plain natural poly-
mer scaffolds with increasing collagen amount. The higher the collagen amount the higher the water 
uptake.  For  hybrids,  the  best  water  uptake  was  in  the  scaffolds  with  only  collagen  as  a  natural  
polymer component. However, the wettability of collagen+chitosan+PLA96 hybrids was relatively 
high as well when compared with the ColPLA scaffolds. Chitosan scaffolds had the lowest wettabil-
ity because of the shrinking in wet conditions caused by inadequate neutralization during the proc-
essing. 
The wettability of the synthetic polymer-based scaffolds, PLGA+BGf, was studied in Publication V. 
The contact angle measurements revealed the highly hydrophobic nature of the PLGA and 
PLGA+BGf  scaffolds.  Material  with  contact  angle  values  over  80° is considered hydrophobic 
(Menzies & Jones 2010), and the contact angle of the studied scaffolds varied in a range of 92 to 
118°. The inhomogeneous highly porous structure of the freeze-dried scaffolds could have also af-
fected the results. It was noticed that the parallel contact angle results varied highly, more than 5° 
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between the two measuring points of each droplet, the contact angle measured from right and from 
left  in  the  same droplet.  This  indicates  highly  uneven  surface  structure  of  the  scaffolds.  That  was  
why the standard deviation in the contact angle results was high in almost all the scaffolds. No sig-
nificant change was noticed between the contact angle values of different scaffolds measured in 
PBS. The contact angle measured with water, less viscous liquid than PBS or blood, on the other 
hand showed significantly lower contact angle value for PLGA1 with respect to PLGA1BG1, 
PLGA2 and PLGA2BG2. As well, the PLGA1 showed relatively significant difference with respect 
to  PLGA2BG2  in  blood.  Interestingly,  the  contact  angle  of  the  parallel  composites,  PLGA1BG1  
and PLGA2BG2 was higher than the corresponding plain scaffolds, PLGA1 and PLGA2. This must 
be due to the structure of the composites, where the BGf fibres are embedded inside the PLGA ma-
trix  and  do  not  enhance  the  initial  wetting  of  the  scaffolds.  This  result  is  also  noticed  as  a  higher  
material  thickness  of  PLGA+BGf  composites  in  microCT  studies.  Therefore,  it  might  be  that  the  
BG  fibres  in  the  composites  make  the  surface  of  the  scaffolds  even  denser  than  the  plain  PLGA  
scaffolds. As well, the PLGA2 showed higher contact angle values than PLGA1 measured in water, 
indicating that PLGA1 would be less hydrophobic than the other studied scaffolds. However, these 
values were measured without pre-wetting of the scaffolds. Pre-wetting is known to enhance the 
wettability of otherwise highly hydrophobic synthetic polymer scaffolds. Therefore, the structure of 
the scaffolds should be optimised in order to have improved hydrophilicity with BGf. Another op-
tion is to use surfactants that are shown to enhance the hydrophilicity of polyester-based porous 
scaffolds (Sun et al. 2014). However, the BGf in the composites was seen to improve the wettability 
of the scaffolds in vitro when the  PLGA+BGf composites  possessed  a  higher  water  uptake  in  the  
first weeks in hydrolysis. 
8.6 Compression properties of the freeze-dried scaffolds 
The stiffness of the scaffold influences the mechanical environment of the cells, which in turn can 
influence cell differentiation and tissue growth (Kock et al. 2012). The compressive modulus of 
native cartilage varies between the different layers of cartilage, from 0.079 MPa (superficial layer) 
to 5.7 GPa (subchondral bone) (Castro et al. 2012). The compressive modulus of the studied natural 
polymer-based scaffolds was in the range of the native cartilage modulus values with dry scaffolds. 
However, the compressive modulus of the wet scaffolds was relatively low, only 3–10 kPa. The wet 
properties of the scaffolds could be more comparable to the properties of the scaffolds in in vivo 
conditions. The optimal mechanical properties for plain cartilage tissue engineering scaffolds are 
not  known and  the  optimal  properties  of  a  scaffold  may not  be  an  exact  copy of  the  native  tissue  
(Kock et al. 2012) because the cellular microenvironment changes during tissue development in 
vivo and  the  mechanical  properties  of  the  scaffolds  are  found to  improve  when compared  with  in 
vitro cultivation (Pulkkinen et al. 2010). Also, the structure of the studied hybrids was a so-called 
sandwich structure with only the natural  polymer component in the middle of the structure.  It  was 
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assumed that the compressive modulus values of the hybrid scaffolds were the compressive 
modulus of the natural polymer components in the middle of the scaffold, being the softer compo-
nent in the hybrids. Therefore, it can be assumed that the compressive modulus values of the hy-
brids, with PLA96 carded mesh, would be improved if the structure of the scaffold was homoge-
nous with the PLA96 carded mesh throughout the matrix. Nevertheless, the compressive stiffness of 
the hybrids was improved by the PLA96 carded mesh, and an improvement of over 70% for wet 
scaffolds was noticed. This improvement indicated that hybridisation with PLA96 fibres is an appli-
cable way to improve the compressive properties of the studied natural polymer-based scaffolds. 
The structure of the hybrid scaffold should still, however, be optimised. The collagen component in 
the  hybrids  was  also  found  to  improve  the  ability  of  the  scaffolds  to  recover  their  original  shape  
after the compression loading (data not shown). The ability to recover shape is also an important 
property because it enables the scaffold to work properly in a load-bearing surrounding in cartilage. 
This is an important property of a functional cartilage tissue engineering scaffold because the liquid 
and nutrition exchange of the tissue is implemented in the avascular tissue by this phenomenon (Ge 
et al. 2012). This phenomenon was verified in the compressive stress–strain curves of the wet scaf-
folds, where it can be seen that no densification in the ColPLA hybrid scaffold was detected before 
the compression of 70%. This indicates that no plastic deformation yet exists. 
The compressive properties of synthetic polymer scaffolds (Publication II, III, and V) were not 
tested because the scaffolds were fairly thin, only about 2 mm in height, and the compression test-
ing machine was not able to compress samples that thin with adequate accuracy. However, it can be 
assumed that the compressive properties of the PLA70 scaffolds with TCP or BGp as filler particles 
(Publications II and III) were not enhanced, or not at least from the porous polymer side of the scaf-
folds, as the filler particles were inhomogeneously in the scaffolds. The BGf fibres in the 
PLGA+BGf  scaffolds  (Publication  V)  could  have  improved  the  properties  of  the  composite  scaf-
folds, compared to plain PLGA scaffolds, since the structure of those composites was homogenous. 
However, those scaffolds were also too thin for adequate accuracy measurements. All of the studied 
synthetic polymer-based scaffolds were, however, found to be ductile and they were hard to halve 
with a cutter, yet being rather flexible. 
8.7 In vitro degradation of synthetic polymer-based scaffolds 
When using synthetic biodegradable polymers such as PLAs, the acidic degradation products of the 
polymer can be harmful to the surrounding tissue (Yang et al. 2001). Therefore, it would be prefer-
able to have some buffering component in the system. Bioactive glasses and bioceramics are known 
to  buffer  the  acidic  degradation  of  PLAs  (Huttunen  et  al.  2006;  Yang  et  al.  2006;  Niemelä  et  al.  
2008; Niemelä et al. 2005). For the PLA70+TCP scaffolds, the acidic degradation products of 
PLA70 were not noticed during the hydrolysis. However, the hydrolysis time, 26 weeks, was rela-
tively short for the polymer as the degradation of PLA70 is known to be much longer than the stud-
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ied period (Niemelä et al. 2008). Also, the degradation of the used, relatively large filler particles of 
TCP was not noticed during the 26 weeks of hydrolysis. This was why no buffering effect of the 
used filler TCP was noticed during the hydrolysis in Publication III. However, the buffering effect 
of BGf in the PLGA+BGf composite scaffolds was noticed because the degradation of PLGA70 is 
relatively fast, as noted in Publication V. Therefore, the degradation and leaching of acidic by-
products started relatively quickly. Also, the degradation rate of BGf fibres was found to be rela-
tively  the  same as  the  matrix  polymer,  PLGA70,  as  no  major  change  in  BGf  content  was  noticed  
during the hydrolysis. 
The studied degradation time, 26 weeks, for PLA70+TCP composite scaffolds was chosen since 
this period of degradation was thought to mimic the period of natural healing of fractured bone, 
since at that point the bone-healing is finished in vivo (Yu et al. 2008; von Doernberg et al. 2006). 
The degradation of PLA70+TCP composites (as well as the plain PLA70/30 scaffolds) was, how-
ever, still in the early beginning at that point, since the weight loss of the studied scaffolds was 
maximally  only  5%.  However,  the  early  degradation  showed  typical  characteristics  of  a  bulk-
eroding synthetic polymer, as the weight loss starts in the inner parts. The inner parts become a very 
viscous liquid with oligomers, and later the outer layer becomes thinner as the degradation propa-
gates towards the surface and weight loss occurs (Li et al. 1990). This phenomenon was also veri-
fied  by  the  results  of  water  penetrating  the  polymer  matrix  as  the  weight  of  the  scaffold  was  in-
creased at the time of 8 to 16 weeks in hydrolysis. This indicated water uptake by which the hy-
drolysis of aliphatic esters starts and is followed by hydrolytic splitting of the ester bonds (Shih 
1995). The i.v. values of the polymer also dropped steadily during the hydrolysis and the thermal 
stability steadily decreased after the first four weeks in hydrolysis. These results also verified the 
bulk-degradation of the polymer component during hydrolysis. Interestingly the i.v. of the PLA70 
was found to decrease even before the hydrolysis and indicates degradation of the polymer during 
the processing. However, the thermal stability of the PLA70 was found to be improved after the 
processing and during the first weeks in hydrolysis. The addition of the filler TCP did not increase 
the thermal stability of the scaffolds. The improvement in thermal stability after processing could be 
explained by the processing method, freeze-drying, which removed any excess water during proc-
essing. Furthermore, at the beginning of the hydrolysis, the early dissolution of resulting monomers 
and oligomers might also have improved the thermal stability. 
The degradation of PLGA+BGf scaffolds varied highly between the plain PLGA and the 
PLGA+BGf  composite  scaffolds.  High  degradation,  around  40  to  60%,  was  detected  for  all  scaf-
folds. However, the plain PLGA scaffolds suffered from severe shrinking and twisting during the 
hydrolysis and had already started at the beginning of the hydrolysis in week 2. The phenomenon 
where the plain PLGA scaffolds lose their initial porous structure was also detected in a previous 
study (Orava et al. 2007) with porous PLGA scaffolds manufactured by solvent casting and pres-
sure quenching with CO2.  The  porous  structure  of  PLGA+BGf  composite  scaffolds,  on  the  other  
hand, remained open until the end of the hydrolysis. This demonstrates the ability of the highly po-
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rous  BGf  fibre  structure  to  stabilize  the  dimensional  stability  of  the  PLGA+BGf  composite  scaf-
folds. The Mw and Mn results  of  the  PLGA  component  in  plain  PLGA  and  PLGA+BGf  scaffolds  
verified the core accelerated bulk degradation to be the degradation mechanism for the PLGA+BGf 
scaffolds. Interestingly, in contrast with this result, solid poly(L-lactide-co-DL-lactide) 
(PLDLA)/BG fibre composites studied previously (Lehtonen et al. 2013b) did not follow the typical 
core-accelerated degradation mechanism, with a combination of surface and bulk erosion. This 
though might be due to the highly porous polymer structure of the studied scaffolds. Therefore, the 
diffusion of water into the matrix and into the BGf fibre surface is different when compared with 
solid scaffolds. The steady decrease of Mw, Mn, steady weight loss and the minor changes in Tg val-
ues supports the core-accelerated bulk-erosion mechanism as well. The TGA studies demonstrate 
that the degradation of BG fibres in the PLGA+BGf composites is at a relatively similar level than 
the degradation of PLGA in the matrix, as the BG content remained at the same level during the 10 
weeks in hydrolysis. No further characterization of the BGf fibres was made. However, the studied 
BGf fibres have demonstrated bioactive characteristics when immersed in simulated body fluid with 
calcium phosphate formation occurring on the surface of the fibres (Lehtonen et al. 2013a). 
8.8 The feasibility of the freeze-dried natural polymer-based scaffolds 
for cartilage tissue engineering 
The natural polymer-based scaffolds in Publication IV were studied for cartilage tissue engineering. 
The feasibility of the scaffolds to be used for cartilage tissue engineering was demonstrated by 
seeding chondrocytes into the scaffolds. The cells were found to be viable after one week culture. 
The cells were evenly distributed on the surfaces of the scaffolds and attached to the collagen and 
chitosan porous structure as well as the PLA96 fibres. The cells expressed collagen type II in the 
cytoplasm, which verified that they retained their chondrogenic phenotype. However, there were 
high variations in the penetration of the cells into the scaffolds, as most of the cells remained at the 
top of the scaffolds. The penetration of the chondrocytes was improved in hybrid scaffolds PLA96 
fibres. The higher penetration of chondrocytes was most likely due to higher porosity of hybrid 
scaffolds and the cells were able to penetrate into the more porous scaffolds easier. The penetration 
was  the  best  in  ColPLA  and  C2C1PLA  scaffolds,  and  some  penetration  was  also  detected  in  
ChiPLA and C1C1PLA scaffolds. This indicates that collagen in the scaffolds also improved the 
penetration of the cells. Higher wettability of collagen containing scaffolds most likely improved 
the penetration of the cells as well as the cell medium was able to go inside the structure of the scaf-
folds more easily. Seeding of the cells was done with a pipette onto the top surface of the scaffolds. 
The seeding of the cells by other methods such as injecting with a needle could also improve the 
even distribution of the cells into the scaffolds. The incorporation of chitosan to collagen hydrogel 
has been found to improve the viability and metabolic activity of chondrocytes of collagen+chitosan 
dense hydrogels (Chicatun et al. 2013). Therefore, to study the ability of the collagen+chitosan 
blend scaffolds for cartilage tissue engineering, the neutralisation of the chitosan component still 
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needs to be verified in order to find out the actual properties of the scaffolds with chitosan, C1C1 
and C2C1, as a matrix.  
For articular cartilage tissue engineering, earlier studies have demonstrated that neither PLA nor 
collagen has been an optimal scaffold for articular cartilage. The PLA matrix was shown to be too 
hard (Pulliainen et al. 2007) and collagen gels suffered from contraction (Pulkkinen et al. 2010). 
Therefore, it was predicted that a study that combines these two structures with freeze-drying would 
overcome these limitations. When using the PLA96 carded mesh as a skeleton for the hybrid and 
freeze-drying and cross-linking the collagen component, a more optimal structure could be achieved. 
With natural polymer-based scaffolds, the best results for tissue engineering application were found 
with ColPLA and C2C1PLA hybrid scaffolds, and it indicates the positive outcome of the hybridi-
sation and potential for cartilage tissue engineering.  
Our group investigated the collagen+PLA96 hybrid with PLA96 fibrous mesh (needle punched 
carded mesh) inside the collagen component (Muhonen et al. 2015, unpublished data) with good 
results. In the study, a needle punched fibrous structure was used because the needle punching gives 
the PLA96 carded mesh more mechanical stability compared with PLA96 carded mesh without the 
needle punching procedure, as studied in Publication IV. Recombinant human collagen type II (an 
optimal collagen for cartilage tissue engineering because collagen type II is the most abundant col-
lagen in cartilage) together with PLA96 needle punched carded mesh were combined together into a 
structure where the PLA96 mesh was immersed in recombinant human collagen type II  to form a 
homogenous scaffold structure with two highly porous 3D structures combined in the hybrid. We 
studied the hybrids in vivo in a porcine model to investigate the ability of the scaffold to repair full-
thickness cartilage lesion. The scaffold was compared with spontaneous healing and a commercial 
biomaterial scaffold operated with a second-generation ACI together with autologous chondrocytes. 
The  repair  tissue  was  evaluated  after  4  months.  The  results  showed that  hyaline-like  repair  tissue  
was formed more frequently with the studied recombinant human type II collagen+PLA96 needle 
punched carded mesh than with the commercial control scaffold or spontaneous healing. Biome-
chanically, both studied scaffolds resulted in better repair tissue than the spontaneous healing. In 
addition, adverse bone reactions were less frequent in recombinant human type II collagen+PLA96 
needle punched carded mesh scaffolds than with the other groups studied. 
8.9 The feasibility of the freeze-dried synthetic polymer-based scaffolds 
for bone and osteochondral tissue engineering 
The synthetic polymer-based scaffolds, the PLA70+TCP and PLA70+BG composite scaffolds in 
Publications II and III, were studied for bone and osteochondral applications. The viability, distribu-
tion, proliferation and osteogenic differentiation of ASCs were studied on the scaffolds in Publica-
tion II. After 2 weeks in culture, the number of the cells was increased compared with the 3 h time 
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point. After 3 h, the cells were mainly attached to the porous bottom surface (where the cells were 
seeded), and after 2 weeks the cells were spread inside the scaffolds as well. Still, the majority of 
the cells were still in the region close to the surface and only a few cells were on the top surface of 
the scaffolds. The filler particles (TCP or BG) did not affect the morphology of the cells. The cell 
number was significantly higher in PLA70+TCP composite scaffolds, and PLA2TCP10 scaffolds 
had a significantly higher magnitude of ALP activity. The relative ALP activity increased in all 
scaffold types from week 1 to week 2. No significant difference was found between the two differ-
ent filler  ratios (10 or 20 wt% of TCP or BG) in the attachment,  proliferation or differentiation of 
ASCs. The PLA70+TCP composite scaffolds significantly enhanced the ASC proliferation and total 
ALP activity compared with the other scaffolds (PLA70+BG and plain PLA70) and demonstrates 
their potential as bone tissue engineering scaffolds. 
The  feasibility  of  the  PLGA+BGf  scaffolds  for  bone  tissue  engineering  still  needs  to  be  verified.  
We are subsequently performing in vivo studies in rabbit-model to study the suitability of these 
kinds of PLGA+BGf scaffolds for bone tissue regeneration. Earlier studies (Orava et al. 2007) have 
demonstrated the feasibility of PLGA+BG porous composites to show fast resorption of the scaffold 
with very good bone tissue regeneration when studied in a rat-model. Those scaffolds were, how-
ever, manufactured by solvent casting and pressure quenching with CO2 with an inhomogeneous 
scaffold structure and with a higher pore size in the scaffolds. The pore size was 50–500 µm, and 
the used filler was BG particles. 
8.10  Freeze-dried scaffolds for cartilage and osteochondral tissue engi-
neering 
For synthetic polymer-based scaffolds, the composite structure with TCP particles or BGf fibres as 
fillers resulted in a better outcome compared with plain polymer scaffolds. Also, the composites 
with TCP particles showed a better outcome than the scaffolds with BG particles as filler (Publica-
tions II and III). The use of a highly porous 3D fibrous structure as reinforcement seems to be an 
optimal way to overcome the limitations (low mechanical strength, poor dimensional stability or 
bioactivity) of both natural and synthetic polymer-based freeze-dried scaffolds (Publications IV and 
V). The more homogenous structure in Publication V with carded BG fibres immersed thoroughly 
inside the matrix polymer, PLGA70 would be a more favourable method than to use fibrous filler 
inside the freeze-dried polymer matrix of hybrids or composites.  
The structure of the optimal composite scaffolds manufactured by freeze-drying could be the com-
bination of two highly porous 3D structures: a highly porous polymer matrix and a highly porous 
fibrous mesh, as studied here. However, this will probably work optimally only for single tissue 
applications, i.e., for cartilage or bone tissue engineering. The solution for optimal osteochondral 
scaffolds is still unknown. It is assumed that these two components, a cartilage scaffold and a bone 
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scaffold, could be combined using freeze-drying. Using the freeze-drying technique, the combining 
of different layers (for cartilage and bone) is relatively easy (Levingstone et al. 2014). The two dif-
ferent layers could be fabricated separately and then glued together with a suitable polymer solution. 
Freeze-drying the structure again would then combine the layers. Alternatively, the different layers 
could be processed with a two-step process where the second layer is processed on top of the first 
layer to form a bi-layer osteochondral scaffold.  One possibility is  to use two different filler  struc-
tures, one for bone and one for cartilage, on top of each other and then to combine them into one 
scaffold with the addition of a suitable polymer solution as a combined matrix by freeze-drying.  
As the outcome of this thesis, the idea was to preferably use the two scaffolds, one for cartilage and 
one for bone, separately and to combine them if needed. With this method, the cultivation of the 
chondrogenic and osteogenic cells can be performed in separate media and environmental condi-
tions. These two layers could then be combined during the operation. However, with this method 
poor adhesion between the two layers could be a challenge (Shimomura et al. 2014). Also, the size 
of the lesion varies and, therefore, it might even be impossible to manufacture a one size combined 
scaffold for osteochondral lesions. Therefore, the method to use two different scaffolds with the 
correct scaffold size for both lesions would be a preferable way to overcome the problem. 
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9 Summary and conclusions 
Since osteochondral tissue engineering requires a scaffold for both cartilage and underlying bone 
(i.e. subchondral bone) for the regeneration of damaged tissues, there are several possibilities to 
achieve the goal. Using one scaffold for both tissues is the easiest method. However, the different 
characteristics  of  the  different  tissues  are  not  always  fulfilled  with  this  technique.  The  use  of  two 
distinct scaffolds, one for cartilage and one for bone tissues could, therefore, be an optimal way to 
solve the problem.  
Scaffolds suitable for cartilage (Publication IV), bone (Publications II, III, and V) and osteo-
chondral tissue engineering (Publications II and III) were successfully manufactured using the 
freeze-drying technique. Some of the scaffolds with a heterogeneous structure (Publications II and 
III) could be used for either only bone or as combined scaffolds for osteochondral tissue engineer-
ing. The structure of all of the studied scaffolds was highly porous and interconnected pores were 
detected in all the scaffolds. The filler in the scaffolds were not found to affect the pore structure, 
pore size or interconnectivity of the pores. The interconnection between the filler particles or fi-
brous filler mesh was good in all the composite or hybrid scaffolds. 
Cross-linking with EDC post freeze-drying was found to be the most effective way to cross-link 
collagen scaffolds (Publication I). The blending of collagen with chitosan was not found to improve 
the properties of the scaffolds (Publication IV). However, this was due to inadequate neutralization 
of chitosan. The natural polymer-based hybrids were found to have improved compressive stiffness 
compared with the plain scaffolds (Publication IV).  
The TCP or BG particles in the PLA70 composite scaffolds were found to improve the osteocon-
ductive properties of the scaffolds in Publications II and III. No significant difference was found 
between the different amounts of the filler in the composites. The composite structure in Publication 
V with a fibrous BG mesh in freeze-dried PLGA matrices was found to stabilise the structure of the 
composites, and the BGf buffered the acidic degradation products of PLGA in the composites.   
The TCP particles in the structure of the PLA70 composite scaffolds were found to improve the cell 
proliferation and total ALP activity of ASCs when compared with plain PLA70 or PLA70+BG 
composite scaffolds in Publication II. The viability and attachment of chondrocytes were good in all 
the natural polymer-based scaffolds in Publication IV. However, the PLA96 fibrous mesh in the 
hybrid scaffolds increased the penetration of the cells and the best penetration was found to be in 
the ColPLA and C2C1PLA hybrid scaffolds. 
The use of two highly porous 3D structures combined, a porous freeze-dried matrix polymer com-
bined with a porous fibrous mesh (manufactured from polymer or bioactive glass) led to improved 
properties of the studied scaffolds (Publications IV and V). The studied sandwich structure with a 
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softer freeze-dried polymer component in the middle of the scaffolds (Publication IV) was found 
not to be an optimal structure. Therefore, a homogenous structure with filler thoroughly inside the 
scaffold (Publication V) could lead to improved structure. 
Finding the optimal osteochondral scaffold is still in the future. However, if the optimal cartilage 
and bone scaffolds are developed and then combined, the possibility of developing an optimal os-
teochondral scaffold could be closer. The study of the optimal cartilage tissue engineering scaffold 
is still ongoing and the latest results are promising. However, the study of the optimal bone tissue 
engineering scaffold needs further evaluation. In addition, the method of using a two-component 
osteochondral scaffold with separate cartilage and bone layers still needs to be studied more exten-
sively to find out if the most convenient method for osteochondral scaffold is to combine the two 
layers. 
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10 Suggestions for future work 
Our latest study (Muhonen et al. 2015, unpublished data) led to the promising in vivo results when 
using the combination of recombinant human collagen type II and PLA96 needle punched carded 
mesh. We will take these scaffolds to the next experiments to apply them in cartilage tissue engi-
neering.  
For bone tissue engineering we will study how the above-mentioned structure of cartilage scaffold 
with porous freeze-dried polymer combined with needle punched carded mesh will act in bone. The 
literature indicates the pores in bone tissue engineering scaffolds should be bigger than 100 µm and 
our developed synthetic polymer-based scaffolds had lower pore sizes (compared to natural poly-
mer  based  scaffolds).  Therefore,  it  is  necessary  to  further  optimize  the  freeze-drying  of  synthetic  
polymer-based scaffolds to increase the pore sizes. Also, we found the synthetic polymer-based 
scaffolds rather hydrophobic. That is why we plan to improve hydrophilicity by combining the syn-
thetic polymer matrix with BG fibrous mesh so that the BG fibres are on the surface of the scaffolds 
as well. As an alternative, the synthetic polymer can be replaced with collagen type I for freeze-
dried component for better hydrophilicity and for better compatibility with bone. Although the natu-
ral polymers often suffer for inferior mechanical stability, collagen together with mechanically 
more stable BG fibrous mesh could give the required mechanical stability for the structure.  
The study of osteochondral tissue engineering will continue by combining the cartilage and bone 
tissue engineering scaffolds to achieve osteochondral scaffold structure. We will compare the char-
acteristics of two approaches: the two separate scaffolds (osteo-scaffold and cartilage-scaffold) 
combined in implantation or a single osteochondral scaffold. For an osteochondral scaffold and tis-
sue engineering we need to further develop the manufacturing of the scaffolds and co-culture of 
chondrocytes and osteoblasts, or mesenchymal stem cells.   
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 APPENDIX I 
Different freeze-dried scaffolds types, the used materials (matrix and filler) and amount of components, cross-linking method, the type of the molud in 
processing (the material used for the mould and the size of the mould), possible sterilization method, abbreviations for different scaffold types, and their related 
publications. 
Scaffold materials Matrix material Filler Cross-linking Used mould and size [Ø/height] Sterilized Abbreviation 
Publica-
tion 
Natural polymer-based scaffolds 
Collagen 
0.3 wt% collagen 
No No PSa, 21.5 mm/5 mm No Col0.3NoE I 
No EDC cross-linking prior to freeze-drying PS, 21.5 mm/5 mm No Col0.3(E) I 
No EDC cross-linking post freeze-drying PS, 21.5 mm/5 mm No Col0.3E I 
0.5 wt% collagen 
No No PS, 21.5 mm/5 mm No Col0.5NoE I 
No EDC cross-linking prior to freeze-drying PS, 21.5 mm/5 mm No Col0.5(E) I 
No EDC cross-linking post freeze-drying PS, 21.5 mm/5 mm No Col0.5E I 
1.0 wt% collagen 
No No PS, 21.5 mm/5 mm or PTFEb, 8 mm/4 mm No Col1.0NoE I 
No EDC cross-linking prior to freeze-drying PS, 21.5 mm/5 mm No Col1.0(E) I 
No EDC cross-linking post freeze-drying PS, 21.5 mm/5 mm No Col1.0E I 
No EDC+NHS cross-linking post freeze-drying PTFE, 8 mm/3 mm No Col IV 
2.0 wt% collagen 
No No PS, 21.5 mm/5 mm No Col2.0 I 
No EDC cross-linking prior to freeze-drying PS, 21.5 mm/5 mm No Col2.0(E) I 
No EDC cross-linking post freeze-drying PS, 21.5 mm/5 mm No Col2.0E I 
Chitosan 1.0 wt% chitosan No No  PTFE, 8 mm/4 mm No Chi IV 
Collagen+Chitosan 1.0 wt% collagen and chitosan 1:1 (v/v) No EDC+NHS cross-linking post freeze-drying PTFE, 8 mm/4 mm No C1C1 IV 1.0 wt% collagen and chitosan 2:1 (v/v) No EDC+NHS cross-linking post freeze-drying PTFE, 8 mm/4 mm No C2C1 IV 
Collagen+PLA96 0.5 wt% collagen PLA96 mesh EDC+NHS cross-linking post freeze-drying PTFE, 8 mm/4 mm No ColPLA IV 
Chitosan+PLA96 0.5 wt% chitosan PLA96 mesh EDC+NHS cross-linking post freeze-drying PTFE, 8 mm/4 mm No ChiPLA IV 
Collagen+Chitosan+PLA96 0.5 wt% collagen and chitosan 1:1 (v/v) PLA96 mesh EDC+NHS cross-linking post freeze-drying PTFE, 8 mm/4 mm No C1C1PLA IV 0.5 wt% collagen and chitosan 2:1 (v/v) PLA96 mesh EDC+NHS cross-linking post freeze-drying PTFE, 8 mm/4 mm No C2C1PLA IV 
Synthetic polymer-based scaffolds 
PLA70 2.0 wt% PLA70/30 No No PTFE, 15 mm/3 mm Gamma 25 kGy
c PLA2 II, III 
3.0 wt% PLA70/30 No No PTFE, 15 mm/3 mm No PLA3 III 
PLA70+TCP 
2.0 wt% PLA70/30 5 wt% ȕ-TCP No PTFE, 15 mm/3 mm No PLA2TCP5 III 
2.0 wt% PLA70/30 10 wt% ȕ-TCP No PTFE, 15 mm/3 mm Gamma 25 kGy PLA2TCP10 II, III 
2.0 wt% PLA70/30 20 wt% ȕ-TCP No PTFE, 15 mm/3 mm Gamma 25 kGy PLA2TCP20 II, III 
3.0 wt% PLA70/30 5 wt% ȕ-TCP No PTFE, 15 mm/3 mm No PLA3TCP5 III 
3.0 wt% PLA70/30 10 wt% ȕ-TCP No PTFE, 15 mm/3 mm No PLA3TCP10 III 
3.0 wt% PLA70/30 20 wt% ȕ-TCP No PTFE, 15 mm/3 mm No PLA3TCP20 III 
PLA70+BG 2.0 wt% PLA70/30 10 wt% BaG0127 No PTFE, 15 mm/3 mm Gamma 25 kGy PLA2BG10 II 2.0 wt% PLA70/30 20 wt% BaG0127 No PTFE, 15 mm/3 mm Gamma 25 kGy PLA2BG20 II 
PLGA1 5.0 wt% PLGA1 No No PTFE, 15 mm/3 mm Gamma 25 kGy PLGA1 V 
PLGA2 5.0 wt% PLGA1 No No PTFE, 15 mm/3 mm Gamma 25 kGy PLGA2 V 
PLGA1+BGf1 3 wt% PLGA1 BGf1 mesh No PTFE, 15 mm/3 mm Gamma 25 kGy PLGA1BG1 V 
PLGA2+BGf2 3 wt% PLGA1 BGf2 mesh No PTFE, 15 mm/3 mm Gamma 25 kGy PLGA2BG2 V 
aPS = polystyrene, bPTFE = Polytetrafluoroethylene (Teflon), cGamma 25 kGy = Gamma irradiation 25 kGy 
  
APPENDIX IIA 
Schematic diagram of the fabrication processes of natural polymer-based scaffolds. 
 
  
APPENDIX IIB 
Schematic diagram of the fabrication processes of synthetic polymer-based scaffolds. 
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Growth and Osteogenic Differentiation of Adipose Stem Cells
on PLA=Bioactive Glass and PLA=b-TCP Scaffolds
Suvi Haimi, M.Sc.,1,* Niina Suuriniemi, M.Sc.,1,* Anne-Marie Haaparanta, M.Sc.,2 Ville Ella¨, M.Sc.,2
Bettina Lindroos, M.Sc.,1 Heini Huhtala, M.Sc.,3 Sari Ra¨ty, M.D.,4 Hannu Kuokkanen, M.D., Ph.D.,5
George K. Sa´ndor, M.D., D.D.S., Ph.D.,1 Minna Kelloma¨ki, Dr. Tech.,2 Susanna Miettinen, M.Sc.,1,*
and Riitta Suuronen, M.D., D.D.S., Ph.D.1,2,6,*
The aim of this study was to compare the effects of novel three-dimensional composite scaffolds con-
sisting of a bioactive phase (bioactive glass or b-tricalcium phosphate [b-TCP] 10 and 20 wt%) incorporated
within a polylactic acid (PLA) matrix on viability, distribution, proliferation, and osteogenic differentiation
of human adipose stem cells (ASCs). The viability and distribution of ASCs on the bioactive composite scaf-
folds was evaluated using Live=Dead fluorescence staining, environmental scanning electron microscopy,
and scanning electron microscopy. There were no differences between the two concentrations of bioactive
glass and b-TCP in PLA scaffolds on proliferation and osteogenic differentiation of ASCs. After 2 weeks of
culture, DNA content and alkaline phosphatase (ALP) activity of ASCs cultured on PLA=b-TCP compos-
ite scaffolds were higher relative to other scaffold types. Interestingly, the cell number was significantly
lower, but the relative ALP=DNA ratio of ASCs was significantly higher in PLA=bioactive glass scaffolds than
in other three scaffold types. These results indicate that the PLA=b-TCP composite scaffolds significantly en-
hance ASC proliferation and total ALP activity compared to other scaffold types. This supports the potential
future use of PLA=b-TCP composites as effective scaffolds for tissue engineering and as bone replacement
materials.
Introduction
One approach for bone tissue engineering involvesharvesting of autologous stem cells from the patient,
which are at first cultured on a scaffold in vitro, and then
implanted with the scaffold in the defect of the patient,
where optimally the bone should regenerate at the rate at
which the scaffold resorbs.1–3
Mesenchymal stem cells (MSCs) have recently received
widespread attention in the field of tissue engineering. MSCs
can be derived from different types of tissues, but generally
bone marrow–derived MSCs or adipose stem cells (ASCs) are
used in bone tissue applications. ASCs can differentiate into
osteoblastic cells, among other mesenchymal lineages in vitro,
when treated with appropriate inducing factors.4,5 ASCs are
an ideal cell source for bone tissue engineering applications
because they are abundant, their procurement causes mini-
mal morbidity, and their expansion is rapid in vitro.6–8
Polylactic acid (PLA) polymers have been widely investi-
gated as tissue engineering scaffolds due to their excellent
mechanical properties and degradation profile even though
they are not generally considered osteoconductive.9–11 Com-
posite scaffolds that include bioceramic or bioactive glass
phases are one solution to improve the bioactivity. Bioactive
glass is a well-known bone substitute material in clinical
use because it is remarkably biocompatible, biodegradable,
and osteoconductive, and provokes no significant inflamma-
tory response.12–15 On the surfaces of the bioactive glasses,
a layer of calcium phosphate is formed in the presence of
body fluids. In vivo and in vitro studies have demonstrated
that the development of this bioactive layer stimulates the
adjacent tissues to form new bone (i.e., osteoinduction) in
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the absence of any osteogenic supplements.13,16–18 Another
well-known bone substitute material is b-tricalcium phos-
phate (b-TCP), which has been studied extensively and used
clinically as bone substitute material because of its similar
molecular composition to human bone.19–21 Among the bio-
ceramics, b-TCP has excellent osteoconductivity, bioactivity,
and an ability to form a strong bone–calcium phosphate
interface.22 However, clinical applications of b-TCP and bio-
active glass are limited due to their brittleness and low
mechanical strength.23,24 Our hypothesis was that the incor-
poration of bioactive glass or b-TCP into a biodegradable PLA
will result in an osteoconductive composite scaffold that
supports both cell proliferation as well as differentiation into
osteoblasts in a mechanically stable construct.
Even though there are many studies on different bio-
active glass and b-TCP=biodegradable polymer compos-
ites,25–29 only the effect of the concentration of bioactive glass
or b-TCP in the composite on cell activity has been evalu-
ated. However, no systematic comparison between PLA=
b-TCP and PLA=bioactive glass composite scaffolds has been
done. In the present study, we investigated and compared
the effects of two novel biomaterial composite scaffolds,
PLA=b-TCP and PLA=bioactive glass, upon human ASC
morphology, proliferation, and osteogenic differentiation.
Materials and Methods
Material fabrication
Poly(L=D, L-lactide) (PLA) 70=30 (PURAC biochem bv,
Gronichem, Netherlands) with inherent viscosity of
*3.1 dL=g was used as a matrix polymer. b-TCP (Beta
Whitlockite; Plasma Biotal, Tideswell, UK) and bioactive
glass (BaG0127; 5% Na2O, 7.5% K2O, 3% MgO, 25% CaO and
59.5% SiO2; A˚bo Akademi, Turku, Finland) were used as the
filler materials. The particle size distribution of porous b-TCP
granules was 75–106mm, and the bioactive glass was ground
down to 75–125 mm.
The PLA solution of concentration of 2.0 wt% was pre-
pared by dissolution of PLA in 1,4-dioxane (Sigma-Aldrich,
Helsinki, Finland). Either filler was added into the PLA so-
lution. The PLA filler ratios used are shown in Table 1. The
solutions were frozen at 308C before freeze-drying. The so-
lution was placed into custom-made Teflon molds (Ø15mm
and height 3mm) and frozen at 308C for 24 h before 24 h
freeze-drying. As a control, plain PLA scaffolds were pre-
pared with the same technique like composite scaffolds.
After freeze-drying, all the samples were held in room tem-
perature under vacuum for a minimum of 48 h before ster-
ilization with gamma irradiation at 25 kGy.
Scaffold characterization
The typical porous structure of the scaffolds is shown
in the scanning electron microscopy (SEM) micrographs
Table 1A. PLA=b-TCP Composite Scaffolds
PLA (wt%) b-TCP (wt%)
PLA 100 0
PLA=10 b-TCP 90 10
PLA=20 b-TCP 80 20
Table 1B. PLA=Bioactive Glass Composite Scaffolds
PLA (wt%) Bioactive glass (wt%)
PLA 100 0
PLA=10 bioactive glass 90 10
PLA=20 bioactive glass 80 20
FIG. 1. SEM images of
(A) dense top surface of PLA
scaffold, (B) cross section of
PLA=20 b-TCP scaffold,
(C) porous bottom surface of
PLA=10 b-TCP scaffold, and
(D) porous bottom surface of
PLA=20 b-TCP scaffold. Scale
bars: 500mm.
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(Fig. 1). Two different functional surfaces were formed dur-
ing the freeze-drying of the scaffolds. The denser top surface
of the scaffolds (Fig. 1A), also referred as the skin layer, was
formed on all scaffold types when the frozen solvent subli-
mated from the top surface during the freeze-drying process.
The structures of the bioactive glass and b-TCP composite
scaffolds were similar; therefore, only the b-TCP SEM images
are shown here. The b-TCP and bioactive glass granules
were dispersed into the porous bottom surface during
manufacturing (Fig. 1B–D). However, some granules can be
seen in the middle of the scaffold (Fig. 1B). The granule
distribution on the porous surface and the difference be-
tween 10 and 20wt% of filler material are shown in Figure
1C and D. The interconnectivity of the pores is shown in
Figure 2.
ASC isolation and culture
The study was conducted in accordance with the Ethics
Committee of the Pirkanmaa Hospital District, Tampere,
Finland. The ASCs were isolated from adipose tissue sam-
ples collected at operations and from liposuctions obtained
from six donors (mean age¼ 44 7). The adipose tissue
samples were received from the Department of Plastic Sur-
gery and from the Department of Gastroenterology and
Alimentary Tract Surgery, Tampere University Hospital.
The adipose tissue was digested with collagenase type I
(1.5mg=mL; Invitrogen, Paisley, UK). ASCs were expanded
in T-75 polystyrene flasks (Nunc, Roskilde, Denmark) in
maintenance medium consisting of Dulbecco’s modified
Eagle’s medium=F-12 1:1 (Invitrogen), 10% fetal bovine
serum (Invitrogen), 1% L-glutamine (GlutaMAX I; Invitro-
gen), and 1% antibiotics=antimycotic (100U=mL penicillin,
0.1mg=mL streptomycin, and 0.25 mg=mL amphotericin B;
Invitrogen). Cells from passages 4 to 7 were used for all
experiments.
Flow cytometric surface marker expression analysis
After primary culture in T-75 flasks, the ASCs were har-
vested and analyzed by a fluorescence-activated cell sorter
(FACSAria; BD Biosciences, Erembodegem, Belgium). Mono-
clonal antibodies (MAb) against CD9-PE, CD10-PE-Cy7,
CD13-PE, CD29-APC, CD49d-PE, CD90-APC, CD106-PE-
Cy5, and CD166-PE (BD Biosciences); CD45-FITC (Miltenyi
Biotech, Bergisch Gladbach, Germany); CD31-FITC, CD34-
APC, and CD44-FITC (Immunotools, Friesoythe, Germany);
and CD105-PE (R&D Systems, Minneapolis, MN) were used.
MAb against STRO-1 (R&D Systems) and human fibroblast
surface protein (hFSP; Sigma-Aldrich, St. Louis, MO) were
conjugated with IgM-PE (CalTag Laboratories, Burlingame,
CA). A total of 10,000 cells per sample were used, and pos-
itive expression was defined as a level of fluorescence that
was 99% of the corresponding unstained cell sample.
Cell seeding and culture of ASC-seeded
composite scaffolds
In each experiment, three to four patient samples were
pooled together to yield enough cells for one experiment.
Each scaffold was pretreated with maintenance medium for
48 h at 378C. The porous surfaces of the scaffolds were see-
ded with 350,000 cells in a 0.175mL drop. The cells were
allowed to attach to the scaffolds for 3 h at 378C in 5% carbon
dioxide before additional medium was added. The cell-
seeded scaffolds were cultured in maintenance medium until
analyses.
Cell attachment and growth
Cell attachment and viability were studied using Live=
Dead staining. Briefly, ASC–biomaterial constructs were in-
cubated for 45min at room temperature with a mixture of
5mM CellTracker green (5-chloromethylfluorescein diace-
tate; Molecular Probes, Eugene, OR) and 2.5 mM ethidium
homodimer-1 (Molecular Probes). The viable cells (green
fluorescence) and necrotic cells (red fluorescence) were ex-
amined using a fluorescence microscope.
Cell morphology evaluation
After the cells were cultured for 2 weeks, the scaffolds were
fixed in 5% glutaraldehyde (Sigma-Aldrich) in 0.1M phos-
phate buffer, pH 7.4, for 48h. After phosphate buffered saline
rinsing, the samples were dehydrated through a series of in-
creasing concentrations of ethanol (70%, 96%, and 100%).
After the final dehydration step in absolute ethanol, the
samples were transferred to liquid carbon dioxide and dried
in a critical point dryer. A gold–palladium coating was
sputtered on the specimens for SEM observations. Two par-
allel scaffolds of each type were observed using a scanning
electron microscope ( Jeol JSM-5500, Sundbyberg, Sweden).
Additionally, Philips XL30 E-SEM-TMP environmental
scanning electron microscope (BioMater Centre, University of
Kuopio, Finland) was used to evaluate the microstructure and
morphology of the biomaterial scaffolds seeded with ASCs.
The environmental scanning electron microscopy (E-SEM)
images were taken using beam intensity at 8.0–12.0 kV and the
gaseous secondary electron detectors at 1.0–4.0 torr.
Cell proliferation and quantitative analysis
of alkaline phosphatase activity
The DNA content of ASC–biomaterial constructs was
measured using a CyQUANT Cell proliferation assay kit
(Molecular Probes–Invitrogen) as described earlier.30 The
quantitative alkaline phosphatase (ALP) measurement was
FIG. 2. E-SEM image of porous bottom surface of PLA scaf-
fold. Scale bar: 100mm.
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performed according to the Sigma ALP procedure as de-
scribed earlier.30
Statistical analysis
Statistical analysis of the results was performed with SPSS,
version 13. The effect of scaffold material and time of culture
(1 week vs. 2 weeks) were studied using a paired Student’s
t-test. The effects between b-TCP and bioactive glass com-
posite material on the DNA content and ALP activity were
compared using a one-way ANOVA, after checking for
normal distribution and homogeneity of variance. Post hoc
tests were performed to detect significant differences be-
tween groups. Data were reported as mean standard
deviation values, and p< 0.05 was considered significant.
The experiments were repeated three times.
Results
Flow cytometric surface marker expression
analysis of ASCs
The FACS analysis demonstrated that the ASCs express the
surface markers CD9, CD29, CD34, CD49d, CD105, CD166,
CD44, CD10, CD13, CD90, STRO-1, and hFSP. TheASCswere
negative for the hematopoietic markers CD31 and CD45 and
for the vascular cell adhesion molecule CD106.
Cell attachment and growth on scaffolds
By 2 weeks, the number of viable cells had increased
compared to the 3-h time point (data not shown), as ob-
served by Live=Dead staining. At the 3-h time point the cells
were attached only on the region close to surface, that is, cell
seeding area. No difference was observed in different scaf-
fold types at 3 h. The spreading of the cells inside the scaf-
folds had changed during the 2-week culturing period.
Generally, in each scaffold type the cells had migrated from
the porous bottom surface toward the inner parts of the
scaffolds, which confirmed the interconnectivity of the pores,
but only a few cells were found on the dense top surface. The
cell density at the region close to the porous surface was
higher than at the core of each scaffold type. At the region
close to the surface, cells had formed cluster structures be-
tween the pores in all other scaffold types but not in PLA=20
b-TCP, where the cells had spread more evenly (Fig. 3).
There was no difference between different scaffold types on
cell number or the cell viability in visual inspection.
Cell morphology
After the 2-week cell culture period, SEM and E-SEM
imaging were used to examine the cell morphology and
spreading on the cell–biomaterial interface (Fig. 4). The cell
FIG. 3. Representative images of viable (green fluores-
cence) and dead (red fluorescence) ASCs attached to (A)
PLA=10 bioactive glass scaffold, (B) PLA=20 bioactive glass
scaffold, (C) PLA=10 b-TCP scaffold, (D) PLA=20 b-TCP
scaffold, and (E) PLA scaffold after 2 weeks in culture.
Scale bars: 200 mm.
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morphology was unaffected by b-TCP or bioactive glass
component in the scaffolds. During the 2-week culture
period, ASCs started to colonize the scaffolds without
forming a homogenous monolayer. Images with higher
magnification (Fig. 3C) show ASCs stretching and forming
projections on the porous surface of the scaffolds. The b-TCP
and bioactive glass granules were clearly distinguished on
the porous surface of the scaffolds, and the ASCs were
forming bridges between the granules on the PLA=b-TCP
and PLA=bioactive glass composite scaffolds (Fig. 4A). ASCs
were also detected inside the pores in different scaffolds. In
each scaffold type the majority of ASCs were spread at the
region close to the porous surface, which supports the ob-
servations made in Live=Dead staining.
Cell proliferation
The number of cells present on the scaffolds was assessed
by measuring the total DNA content (Fig. 5). After 2 weeks of
culture, the cell number was significantly higher in both
PLA=b-TCP scaffolds than in other three scaffold types.
Conversely, DNA content of ASC cultured on PLA=bioactive
glass scaffolds was significantly lower compared to the other
scaffold types. There was no significant difference detected
between the two concentrations of both b-TCP and bioactive
glass (i.e., 10wt% vs. 20wt%).
ASC differentiation
The effects of the five different scaffold types on the early
differentiation of ASCs into osteogenic pathway were eval-
uated by quantitative measurement of ALP activity. At 2
weeks the relative ALP activity of ASCs cultured on PLA=10
b-TCP scaffolds had the same magnitude as ASCs cultured
on PLA=20 b-TCP scaffolds, but it was significantly higher
than that of the other scaffold types (PLA, p¼ 0.017; bioac-
tive glass 10wt%, p¼ 0.023; and bioactive glass 20wt%,
p¼ 0.022; Fig. 6). At 2 weeks the relative ALP activity of
ASCs cultured on PLA=bioactive glass and PLA scaffold was
comparable, but it is due to the lower cell number in
PLA=bioactive glass scaffolds than in PLA scaffolds. These
results indicate that relative ALP=DNA ratio was higher on
PLA=bioactive glass scaffolds than in PLA and PLA=b-TCP
scaffolds.
The effect of culturing period on ASCs proliferation
and differentiation
We studied the effect of culturing period on ASC prolif-
eration, and we found no increase of relative DNA content
when the cells were cultured on bioactive glass composites
for 2 weeks compared to 1 week (data not shown). In con-
trast, the DNA content of ASCs cultured on PLA=b-TCP
FIG. 4. (A) E-SEM images of ASCs on the PLA, PLA=20 b-TCP (TCP), and PLA=bioactive glass (BG) 20 wt% (scale bars:
50 mm). (B) SEM micrographs of ASCs on the PLA, PLA=10b-TCP, and PLA=10 bioactive glass (scale bars: 50 mm). (C) SEM
micrographs of ASCs on the PLA, PLA=20b-TCP, and PLA=20 bioactive glass (scale bars: 10 mm).
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composites and PLA scaffolds was increased at 2 weeks;
however, no significant difference between 1 and 2 weeks
was detected.
ASCs cultured on PLA and bioactive glass composite
scaffolds produced two times higher levels of ALP activity at
2 weeks than at 1 week (data not shown). A significant in-
crease at the 2-week time point was only seen when ASCs
were cultured on PLA=20 b-TCP scaffolds, although ALP
activity of ASCs cultured on PLA=10 b-TCP scaffolds was
also three times higher at 2 weeks than at 1 week.
Discussion
To our knowledge, this is the first reported study
that compares the in vitro effects of PLA=b-TCP and PLA=
bioactive glass composite scaffolds on ASC attachment,
proliferation, and osteogenic differentiation. We also studied
the effect of culturing period on proliferation and ALP ac-
tivity of ASC cultured on different scaffold types in two time
points.
The identity of ACSs was confirmed using FACS analysis.
The FACS analysis results were consistent with previous
results for MSCs.31 A culture system using ASCs was chosen
because these cells have the ability to differentiate into os-
teoblasts, similar to bone marrow–derived MSCs. A second
advantage of using ACSs is that unlike bone marrow MSCs,
their use is not limited by a low harvest number of cells.6,32
Live=Dead staining and SEM imaging showed that the cell
density at the region close to the surface was higher than at
the core of each scaffold type, which is attributed to the
heterogenic structure of the composite scaffolds. The bioac-
tive glass and b-TCP particles were clustered on the porous
side of the composite scaffold, which made this region of the
scaffold more hydrophilic. It is not surprising that the hy-
drophilic nature of this region enhanced the cell attachment
and growth compared to other more hydrophobic parts of
the scaffold. These results are also in agreement with previ-
ously published in vitro experiments, which have confirmed
the positive effect of increasing concentration of bioactive
glass particles on poly(DL-lactide) (PDLLA) scaffolds to
promote osteoblast and osteoblast-like cell adhesion and
growth.28,33 In PLA scaffolds the cells spread also to the re-
gion close to the porous surface, which may be explained by
the overall hydrophobicity of the scaffold.
Our SEM results show that the cell morphology was un-
affected by b-TCP or bioactive glass component in the scaf-
fold material. This result differs from the findings of Tsigkou
et al.,17 where the authors found that human fetal osteoblasts
were less spread and elongated on PDLLA and PDLLA-
bioactive glass 5wt% composite films, whereas cells on
PDLLA-bioactive glass 40wt% composite films were elon-
gated but with multiple protrusions spreading over the bio-
active glass particles.
Bioactive glass has been studied intensively for over three
decades in the bone regeneration applications. Specific
bioactive glass compositions have been shown to promote
proliferation and differentiation of human osteoblasts and
rat MSCs into osteogenic lineages.34–36 These publications
have shown that bioactive glasses are superior scaffold ma-
terials in inducing osteogenic differentiation, although con-
tradictory results also exist. Reilly et al. have recently shown
that the positive effects of bioactive glass on bone growth in
human patients are not mediated by accelerated differ-
entiation of MSCs.37 In addition, a poly(lactide-co-glycolide)
(PLGA) scaffold coated with bioactive glass had no effect on
ALP activity or osteocalcin production of human MSCs
compared with uncoated scaffolds.38 Our findings suggest
that bioactive glass particles do not induce total ALP ac-
tivity of ASCs more than PLA alone, although the relative
ALP activity of a single cell, that is, ALP=DNA ratio on
PLA=bioactive glass scaffolds, was higher than in other
scaffolds. This result is in contrast to Mayr-Wohlfart et al.,
who demonstrated that osteoblast-like cells grown on a-TCP
have significantly higher ALP=DNA ratio than on bioactive
glass.39
It has been shown that adding increasing percentages
of b-TCP to a lactic acid polymer matrix stimulates the pro-
liferation and differentiation of human MSCs and osteogen-
ous cells.27,40 While it is difficult to compare our results
with those of others who have used different composites,
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our results are similar to previous work which showed
that proliferation and total ALP activity of ASCs was signifi-
cantly higher in PLA=b-TCP scaffolds than in PLA scaffolds.
In the present study, no significant differences between
the effects of the two concentrations of bioactive glass and
b-TCP were found on ASC attachment, proliferation, and
differentiation. This may be explained by the heterogeneous
structure of the composite scaffold. If the filler particles
would have been homogeneously arranged on the scaffold,
the difference between the filler concentration may have
been more evident.
Interestingly, the results of the effect of the culturing pe-
riod on ASC proliferation showed that the cell number was
at the same level on PLA=bioactive composite scaffolds,
while the cell number was increased in three other scaffold
types (in PLA=10 b-TCP significantly) at 2 weeks compared
to 1 week. The relative ALP activity of ACSs, however, in-
creased with time in all scaffold types.
This study demonstrated that, of the studied scaffolds,
PLA=bioactive glass scaffolds supported proliferation of
ASCs the weakest, although ASCs exhibited the strongest
differentiation capacity when cultured on PLA=bioactive
glass scaffolds. An ideal scaffold for bone tissue engineering
should, however, promote both cell proliferation and osteo-
genic differentiation. Our results show that PLA=b-TCP
composite scaffolds significantly enhance ASC proliferation
and total ALP activity compared to PLA alone or composite
forms of PLA=bioactive glass scaffolds. We conclude that
PLA=b-TCP composite scaffolds demonstrate significant
potential in future hard tissue engineering.
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